id	sid	tid	token	lemma	pos
ajlm-1555	1	1	abstract	abstract	ADJ
ajlm-1555	1	2	introduction	introduction	NOUN
ajlm-1555	1	3	methods	method	NOUN
ajlm-1555	1	4	results	result	VERB
ajlm-1555	1	5	discussion	discussion	NOUN
ajlm-1555	1	6	acknowledgements	acknowledgement	NOUN
ajlm-1555	1	7	references	reference	NOUN
ajlm-1555	1	8	about	about	ADP
ajlm-1555	1	9	the	the	DET
ajlm-1555	1	10	author(s	author(s	NOUN
ajlm-1555	1	11	)	)	PUNCT
ajlm-1555	1	12	adedayo	adedayo	PROPN
ajlm-1555	1	13	o.	o.	PROPN
ajlm-1555	1	14	faneye	faneye	PROPN
ajlm-1555	1	15	department	department	PROPN
ajlm-1555	1	16	of	of	ADP
ajlm-1555	1	17	virology	virology	NOUN
ajlm-1555	1	18	,	,	PUNCT
ajlm-1555	1	19	faculty	faculty	NOUN
ajlm-1555	1	20	of	of	ADP
ajlm-1555	1	21	basic	basic	ADJ
ajlm-1555	1	22	medical	medical	ADJ
ajlm-1555	1	23	sciences	science	NOUN
ajlm-1555	1	24	,	,	PUNCT
ajlm-1555	1	25	university	university	NOUN
ajlm-1555	1	26	of	of	ADP
ajlm-1555	1	27	ibadan	ibadan	PROPN
ajlm-1555	1	28	,	,	PUNCT
ajlm-1555	1	29	ibadan	ibadan	PROPN
ajlm-1555	1	30	,	,	PUNCT
ajlm-1555	1	31	nigeria	nigeria	PROPN
ajlm-1555	1	32	oyeteju	oyeteju	PROPN
ajlm-1555	1	33	s.	s.	PROPN
ajlm-1555	1	34	babalola	babalola	PROPN
ajlm-1555	1	35	department	department	PROPN
ajlm-1555	1	36	of	of	ADP
ajlm-1555	1	37	virology	virology	NOUN
ajlm-1555	1	38	,	,	PUNCT
ajlm-1555	1	39	faculty	faculty	NOUN
ajlm-1555	1	40	of	of	ADP
ajlm-1555	1	41	basic	basic	ADJ
ajlm-1555	1	42	medical	medical	ADJ
ajlm-1555	1	43	sciences	science	NOUN
ajlm-1555	1	44	,	,	PUNCT
ajlm-1555	1	45	university	university	NOUN
ajlm-1555	1	46	of	of	ADP
ajlm-1555	1	47	ibadan	ibadan	PROPN
ajlm-1555	1	48	,	,	PUNCT
ajlm-1555	1	49	ibadan	ibadan	PROPN
ajlm-1555	1	50	,	,	PUNCT
ajlm-1555	1	51	nigeria	nigeria	PROPN
ajlm-1555	1	52	georgina	georgina	PROPN
ajlm-1555	1	53	n.	n.	PROPN
ajlm-1555	1	54	odaibo	odaibo	PROPN
ajlm-1555	1	55	department	department	PROPN
ajlm-1555	1	56	of	of	ADP
ajlm-1555	1	57	virology	virology	NOUN
ajlm-1555	1	58	,	,	PUNCT
ajlm-1555	1	59	faculty	faculty	NOUN
ajlm-1555	1	60	of	of	ADP
ajlm-1555	1	61	basic	basic	ADJ
ajlm-1555	1	62	medical	medical	ADJ
ajlm-1555	1	63	sciences	science	NOUN
ajlm-1555	1	64	,	,	PUNCT
ajlm-1555	1	65	university	university	NOUN
ajlm-1555	1	66	of	of	ADP
ajlm-1555	1	67	ibadan	ibadan	PROPN
ajlm-1555	1	68	,	,	PUNCT
ajlm-1555	1	69	ibadan	ibadan	PROPN
ajlm-1555	1	70	,	,	PUNCT
ajlm-1555	1	71	nigeria	nigeria	PROPN
ajlm-1555	1	72	juwon	juwon	VERB
ajlm-1555	1	73	arotiba	arotiba	PROPN
ajlm-1555	1	74	department	department	PROPN
ajlm-1555	1	75	of	of	ADP
ajlm-1555	1	76	oral	oral	ADJ
ajlm-1555	1	77	and	and	CCONJ
ajlm-1555	1	78	maxilofacial	maxilofacial	ADJ
ajlm-1555	1	79	surgery	surgery	NOUN
ajlm-1555	1	80	,	,	PUNCT
ajlm-1555	1	81	faculty	faculty	NOUN
ajlm-1555	1	82	of	of	ADP
ajlm-1555	1	83	dentistry	dentistry	NOUN
ajlm-1555	1	84	,	,	PUNCT
ajlm-1555	1	85	university	university	PROPN
ajlm-1555	1	86	of	of	ADP
ajlm-1555	1	87	ibadan	ibadan	PROPN
ajlm-1555	1	88	,	,	PUNCT
ajlm-1555	1	89	ibadan	ibadan	PROPN
ajlm-1555	1	90	,	,	PUNCT
ajlm-1555	1	91	nigeria	nigeria	PROPN
ajlm-1555	1	92	olufemi	olufemi	PROPN
ajlm-1555	1	93	d.	d.	PROPN
ajlm-1555	1	94	olaleye	olaleye	PROPN
ajlm-1555	1	95	department	department	PROPN
ajlm-1555	1	96	of	of	ADP
ajlm-1555	1	97	virology	virology	NOUN
ajlm-1555	1	98	,	,	PUNCT
ajlm-1555	1	99	faculty	faculty	NOUN
ajlm-1555	1	100	of	of	ADP
ajlm-1555	1	101	basic	basic	ADJ
ajlm-1555	1	102	medical	medical	ADJ
ajlm-1555	1	103	sciences	science	NOUN
ajlm-1555	1	104	,	,	PUNCT
ajlm-1555	1	105	university	university	NOUN
ajlm-1555	1	106	of	of	ADP
ajlm-1555	1	107	ibadan	ibadan	PROPN
ajlm-1555	1	108	,	,	PUNCT
ajlm-1555	1	109	ibadan	ibadan	PROPN
ajlm-1555	1	110	,	,	PUNCT
ajlm-1555	1	111	nigeria	nigeria	PROPN
ajlm-1555	2	1	citation	citation	PROPN
ajlm-1555	2	2	faneye	faneye	PROPN
ajlm-1555	2	3	ao	ao	PROPN
ajlm-1555	2	4	,	,	PUNCT
ajlm-1555	2	5	babalola	babalola	PROPN
ajlm-1555	2	6	os	os	PROPN
ajlm-1555	2	7	,	,	PUNCT
ajlm-1555	2	8	odaibo	odaibo	PROPN
ajlm-1555	2	9	gn	gn	PROPN
ajlm-1555	2	10	,	,	PUNCT
ajlm-1555	2	11	arotiba	arotiba	PROPN
ajlm-1555	2	12	j	j	PROPN
ajlm-1555	2	13	,	,	PUNCT
ajlm-1555	2	14	olaleye	olaleye	PROPN
ajlm-1555	2	15	od	od	PROPN
ajlm-1555	2	16	.	.	PUNCT
ajlm-1555	3	1	oral	oral	ADJ
ajlm-1555	3	2	human	human	ADJ
ajlm-1555	3	3	papilloma	papilloma	PROPN
ajlm-1555	3	4	virus	virus	NOUN
ajlm-1555	3	5	infection	infection	NOUN
ajlm-1555	3	6	among	among	ADP
ajlm-1555	3	7	dental	dental	ADJ
ajlm-1555	3	8	clinic	clinic	NOUN
ajlm-1555	3	9	attendees	attendee	NOUN
ajlm-1555	3	10	in	in	ADP
ajlm-1555	3	11	ibadan	ibadan	PROPN
ajlm-1555	3	12	,	,	PUNCT
ajlm-1555	3	13	nigeria	nigeria	PROPN
ajlm-1555	3	14	.	.	PUNCT
ajlm-1555	4	1	afr	afr	PROPN
ajlm-1555	4	2	j	j	PROPN
ajlm-1555	4	3	lab	lab	PROPN
ajlm-1555	4	4	med	med	PROPN
ajlm-1555	4	5	.	.	PUNCT
ajlm-1555	5	1	2022;11(1	2022;11(1	NUM
ajlm-1555	5	2	)	)	PUNCT
ajlm-1555	5	3	,	,	PUNCT
ajlm-1555	6	1	a1555	a1555	PROPN
ajlm-1555	6	2	.	.	PUNCT
ajlm-1555	7	1	https://doi.org/10.4102/ajlm.v11i1.1555	https://doi.org/10.4102/ajlm.v11i1.1555	AUX
ajlm-1555	7	2	original	original	ADJ
ajlm-1555	7	3	research	research	NOUN
ajlm-1555	7	4	oral	oral	ADJ
ajlm-1555	7	5	human	human	ADJ
ajlm-1555	7	6	papilloma	papilloma	NOUN
ajlm-1555	7	7	virus	virus	NOUN
ajlm-1555	7	8	infection	infection	NOUN
ajlm-1555	7	9	among	among	ADP
ajlm-1555	7	10	dental	dental	ADJ
ajlm-1555	7	11	clinic	clinic	NOUN
ajlm-1555	7	12	attendees	attendee	NOUN
ajlm-1555	7	13	in	in	ADP
ajlm-1555	7	14	ibadan	ibadan	PROPN
ajlm-1555	7	15	,	,	PUNCT
ajlm-1555	7	16	nigeria	nigeria	PROPN
ajlm-1555	7	17	adedayo	adedayo	PROPN
ajlm-1555	7	18	o.	o.	PROPN
ajlm-1555	7	19	faneye	faneye	PROPN
ajlm-1555	7	20	,	,	PUNCT
ajlm-1555	7	21	oyeteju	oyeteju	NOUN
ajlm-1555	7	22	s.	s.	PROPN
ajlm-1555	7	23	babalola	babalola	PROPN
ajlm-1555	7	24	,	,	PUNCT
ajlm-1555	7	25	georgina	georgina	PROPN
ajlm-1555	7	26	n.	n.	PROPN
ajlm-1555	7	27	odaibo	odaibo	PROPN
ajlm-1555	7	28	,	,	PUNCT
ajlm-1555	7	29	juwon	juwon	VERB
ajlm-1555	7	30	arotiba	arotiba	PROPN
ajlm-1555	7	31	,	,	PUNCT
ajlm-1555	7	32	olufemi	olufemi	PROPN
ajlm-1555	7	33	d.	d.	PROPN
ajlm-1555	7	34	olaleye	olaleye	PROPN
ajlm-1555	7	35	received	receive	VERB
ajlm-1555	7	36	:	:	PUNCT
ajlm-1555	7	37	17	17	NUM
ajlm-1555	7	38	feb	feb	X
ajlm-1555	7	39	.	.	PROPN
ajlm-1555	7	40	2021	2021	NUM
ajlm-1555	7	41	;	;	PUNCT
ajlm-1555	7	42	accepted	accept	VERB
ajlm-1555	7	43	:	:	PUNCT
ajlm-1555	7	44	26	26	NUM
ajlm-1555	7	45	may	may	PROPN
ajlm-1555	7	46	2022	2022	NUM
ajlm-1555	7	47	;	;	PUNCT
ajlm-1555	7	48	published	publish	VERB
ajlm-1555	7	49	:	:	PUNCT
ajlm-1555	7	50	25	25	NUM
ajlm-1555	7	51	nov	nov	PROPN
ajlm-1555	7	52	.	.	PROPN
ajlm-1555	8	1	2022	2022	NUM
ajlm-1555	9	1	copyright	copyright	NOUN
ajlm-1555	9	2	:	:	PUNCT
ajlm-1555	9	3	©	©	PROPN
ajlm-1555	9	4	2022	2022	NUM
ajlm-1555	9	5	.	.	PUNCT
ajlm-1555	10	1	the	the	DET
ajlm-1555	10	2	author(s	author(s	PROPN
ajlm-1555	10	3	)	)	PUNCT
ajlm-1555	10	4	.	.	PUNCT
ajlm-1555	11	1	licensee	licensee	NOUN
ajlm-1555	11	2	:	:	PUNCT
ajlm-1555	11	3	aosis	aosis	NOUN
ajlm-1555	11	4	.	.	PUNCT
ajlm-1555	12	1	this	this	PRON
ajlm-1555	12	2	is	be	AUX
ajlm-1555	12	3	an	an	DET
ajlm-1555	12	4	open	open	ADJ
ajlm-1555	12	5	access	access	NOUN
ajlm-1555	12	6	article	article	NOUN
ajlm-1555	12	7	distributed	distribute	VERB
ajlm-1555	12	8	under	under	ADP
ajlm-1555	12	9	the	the	DET
ajlm-1555	12	10	terms	term	NOUN
ajlm-1555	12	11	of	of	ADP
ajlm-1555	12	12	the	the	DET
ajlm-1555	12	13	creative	creative	ADJ
ajlm-1555	12	14	commons	common	NOUN
ajlm-1555	12	15	attribution	attribution	NOUN
ajlm-1555	12	16	license	license	NOUN
ajlm-1555	12	17	,	,	PUNCT
ajlm-1555	12	18	which	which	PRON
ajlm-1555	12	19	permits	permit	VERB
ajlm-1555	12	20	unrestricted	unrestricted	ADJ
ajlm-1555	12	21	use	use	NOUN
ajlm-1555	12	22	,	,	PUNCT
ajlm-1555	12	23	distribution	distribution	NOUN
ajlm-1555	12	24	,	,	PUNCT
ajlm-1555	12	25	and	and	CCONJ
ajlm-1555	12	26	reproduction	reproduction	NOUN
ajlm-1555	12	27	in	in	ADP
ajlm-1555	12	28	any	any	DET
ajlm-1555	12	29	medium	medium	NOUN
ajlm-1555	12	30	,	,	PUNCT
ajlm-1555	12	31	provided	provide	VERB
ajlm-1555	12	32	the	the	DET
ajlm-1555	12	33	original	original	ADJ
ajlm-1555	12	34	work	work	NOUN
ajlm-1555	12	35	is	be	AUX
ajlm-1555	12	36	properly	properly	ADV
ajlm-1555	12	37	cited	cite	VERB
ajlm-1555	12	38	.	.	PUNCT
ajlm-1555	13	1	abstract	abstract	ADJ
ajlm-1555	13	2	background	background	NOUN
ajlm-1555	13	3	:	:	PUNCT
ajlm-1555	13	4	human	human	ADJ
ajlm-1555	13	5	papilloma	papilloma	PROPN
ajlm-1555	13	6	virus	virus	NOUN
ajlm-1555	13	7	(	(	PUNCT
ajlm-1555	13	8	hpv	hpv	NOUN
ajlm-1555	13	9	)	)	PUNCT
ajlm-1555	13	10	is	be	AUX
ajlm-1555	13	11	associated	associate	VERB
ajlm-1555	13	12	with	with	ADP
ajlm-1555	13	13	a	a	DET
ajlm-1555	13	14	subset	subset	NOUN
ajlm-1555	13	15	of	of	ADP
ajlm-1555	13	16	oropharyngeal	oropharyngeal	ADJ
ajlm-1555	13	17	squamous	squamous	ADJ
ajlm-1555	13	18	cell	cell	NOUN
ajlm-1555	13	19	carcinoma	carcinoma	NOUN
ajlm-1555	13	20	and	and	CCONJ
ajlm-1555	13	21	mouth	mouth	NOUN
ajlm-1555	13	22	or	or	CCONJ
ajlm-1555	13	23	throat	throat	NOUN
ajlm-1555	13	24	warts	wart	NOUN
ajlm-1555	13	25	.	.	PUNCT
ajlm-1555	14	1	however	however	ADV
ajlm-1555	14	2	,	,	PUNCT
ajlm-1555	14	3	there	there	PRON
ajlm-1555	14	4	is	be	VERB
ajlm-1555	14	5	currently	currently	ADV
ajlm-1555	14	6	limited	limited	ADJ
ajlm-1555	14	7	information	information	NOUN
ajlm-1555	14	8	about	about	ADP
ajlm-1555	14	9	oral	oral	ADJ
ajlm-1555	14	10	hpv	hpv	NOUN
ajlm-1555	14	11	infections	infection	NOUN
ajlm-1555	14	12	in	in	ADP
ajlm-1555	14	13	nigeria	nigeria	PROPN
ajlm-1555	14	14	.	.	PUNCT
ajlm-1555	15	1	objective	objective	NOUN
ajlm-1555	15	2	:	:	PUNCT
ajlm-1555	16	1	this	this	DET
ajlm-1555	16	2	study	study	NOUN
ajlm-1555	16	3	aimed	aim	VERB
ajlm-1555	16	4	to	to	PART
ajlm-1555	16	5	provide	provide	VERB
ajlm-1555	16	6	information	information	NOUN
ajlm-1555	16	7	on	on	ADP
ajlm-1555	16	8	the	the	DET
ajlm-1555	16	9	occurrence	occurrence	NOUN
ajlm-1555	16	10	and	and	CCONJ
ajlm-1555	16	11	circulating	circulate	VERB
ajlm-1555	16	12	genotypes	genotype	NOUN
ajlm-1555	16	13	of	of	ADP
ajlm-1555	16	14	hpv	hpv	NOUN
ajlm-1555	16	15	among	among	ADP
ajlm-1555	16	16	patients	patient	NOUN
ajlm-1555	16	17	attending	attend	VERB
ajlm-1555	16	18	three	three	NUM
ajlm-1555	16	19	(	(	PUNCT
ajlm-1555	16	20	one	one	NUM
ajlm-1555	16	21	government	government	NOUN
ajlm-1555	16	22	and	and	CCONJ
ajlm-1555	16	23	two	two	NUM
ajlm-1555	16	24	private	private	ADJ
ajlm-1555	16	25	)	)	PUNCT
ajlm-1555	16	26	dental	dental	ADJ
ajlm-1555	16	27	clinics	clinic	NOUN
ajlm-1555	16	28	in	in	ADP
ajlm-1555	16	29	ibadan	ibadan	PROPN
ajlm-1555	16	30	,	,	PUNCT
ajlm-1555	16	31	nigeria	nigeria	PROPN
ajlm-1555	16	32	.	.	PUNCT
ajlm-1555	17	1	methods	method	NOUN
ajlm-1555	17	2	:	:	PUNCT
ajlm-1555	17	3	an	an	DET
ajlm-1555	17	4	oral	oral	ADJ
ajlm-1555	17	5	swab	swab	NOUN
ajlm-1555	17	6	was	be	AUX
ajlm-1555	17	7	collected	collect	VERB
ajlm-1555	17	8	from	from	ADP
ajlm-1555	17	9	231	231	NUM
ajlm-1555	17	10	dental	dental	ADJ
ajlm-1555	17	11	clinic	clinic	NOUN
ajlm-1555	17	12	attendees	attendee	NOUN
ajlm-1555	17	13	in	in	ADP
ajlm-1555	17	14	ibadan	ibadan	PROPN
ajlm-1555	17	15	between	between	ADP
ajlm-1555	17	16	january	january	PROPN
ajlm-1555	17	17	2016	2016	NUM
ajlm-1555	17	18	and	and	CCONJ
ajlm-1555	17	19	march	march	PROPN
ajlm-1555	17	20	2017	2017	NUM
ajlm-1555	17	21	and	and	CCONJ
ajlm-1555	17	22	tested	test	VERB
ajlm-1555	17	23	for	for	ADP
ajlm-1555	17	24	hpv	hpv	PROPN
ajlm-1555	17	25	dna	dna	PROPN
ajlm-1555	17	26	by	by	ADP
ajlm-1555	17	27	polymerase	polymerase	NOUN
ajlm-1555	17	28	chain	chain	NOUN
ajlm-1555	17	29	reaction	reaction	NOUN
ajlm-1555	17	30	targeting	target	VERB
ajlm-1555	17	31	the	the	DET
ajlm-1555	17	32	e6/7	e6/7	ADJ
ajlm-1555	17	33	genes	gene	NOUN
ajlm-1555	17	34	of	of	ADP
ajlm-1555	17	35	the	the	DET
ajlm-1555	17	36	virus	virus	NOUN
ajlm-1555	17	37	.	.	PUNCT
ajlm-1555	18	1	results	result	NOUN
ajlm-1555	18	2	:	:	PUNCT
ajlm-1555	18	3	twenty	twenty	NUM
ajlm-1555	18	4	-	-	PUNCT
ajlm-1555	18	5	three	three	NUM
ajlm-1555	18	6	of	of	ADP
ajlm-1555	18	7	the	the	DET
ajlm-1555	18	8	231	231	NUM
ajlm-1555	18	9	swab	swab	NOUN
ajlm-1555	18	10	samples	sample	NOUN
ajlm-1555	18	11	were	be	AUX
ajlm-1555	18	12	hpv	hpv	ADJ
ajlm-1555	18	13	dna	dna	PROPN
ajlm-1555	18	14	positive	positive	ADJ
ajlm-1555	18	15	comprising	comprise	VERB
ajlm-1555	18	16	16	16	NUM
ajlm-1555	18	17	mono	mono	NOUN
ajlm-1555	18	18	-	-	PUNCT
ajlm-1555	18	19	infections	infection	NOUN
ajlm-1555	18	20	and	and	CCONJ
ajlm-1555	18	21	seven	seven	NUM
ajlm-1555	18	22	co	co	NOUN
ajlm-1555	18	23	-	-	NOUN
ajlm-1555	18	24	infections	infection	NOUN
ajlm-1555	18	25	in	in	ADP
ajlm-1555	18	26	13	13	NUM
ajlm-1555	18	27	males	male	NOUN
ajlm-1555	18	28	and	and	CCONJ
ajlm-1555	18	29	ten	ten	NUM
ajlm-1555	18	30	females	female	NOUN
ajlm-1555	18	31	.	.	PUNCT
ajlm-1555	19	1	genotype	genotype	NOUN
ajlm-1555	19	2	16	16	NUM
ajlm-1555	19	3	was	be	AUX
ajlm-1555	19	4	present	present	ADJ
ajlm-1555	19	5	in	in	ADP
ajlm-1555	19	6	ten	ten	NUM
ajlm-1555	19	7	patients	patient	NOUN
ajlm-1555	19	8	,	,	PUNCT
ajlm-1555	19	9	genotype	genotype	NOUN
ajlm-1555	19	10	6/11	6/11	NUM
ajlm-1555	19	11	in	in	ADP
ajlm-1555	19	12	five	five	NUM
ajlm-1555	19	13	,	,	PUNCT
ajlm-1555	19	14	genotype	genotype	NOUN
ajlm-1555	19	15	18	18	NUM
ajlm-1555	19	16	and	and	CCONJ
ajlm-1555	19	17	genotype	genotype	NOUN
ajlm-1555	19	18	33	33	NUM
ajlm-1555	19	19	in	in	ADP
ajlm-1555	19	20	four	four	NUM
ajlm-1555	19	21	each	each	DET
ajlm-1555	19	22	,	,	PUNCT
ajlm-1555	19	23	genotype	genotype	NOUN
ajlm-1555	19	24	31	31	NUM
ajlm-1555	19	25	in	in	ADP
ajlm-1555	19	26	three	three	NUM
ajlm-1555	19	27	and	and	CCONJ
ajlm-1555	19	28	genotype	genotype	NOUN
ajlm-1555	19	29	39	39	NUM
ajlm-1555	19	30	in	in	ADP
ajlm-1555	19	31	one	one	NUM
ajlm-1555	19	32	.	.	PUNCT
ajlm-1555	20	1	twenty	twenty	NUM
ajlm-1555	20	2	-	-	PUNCT
ajlm-1555	20	3	one	one	NUM
ajlm-1555	20	4	cases	case	NOUN
ajlm-1555	20	5	were	be	AUX
ajlm-1555	20	6	high	high	ADJ
ajlm-1555	20	7	-	-	PUNCT
ajlm-1555	20	8	risk	risk	NOUN
ajlm-1555	20	9	hpv	hpv	NOUN
ajlm-1555	20	10	genotypes	genotype	NOUN
ajlm-1555	20	11	,	,	PUNCT
ajlm-1555	20	12	while	while	SCONJ
ajlm-1555	20	13	two	two	NUM
ajlm-1555	20	14	were	be	AUX
ajlm-1555	20	15	low	low	ADJ
ajlm-1555	20	16	-	-	PUNCT
ajlm-1555	20	17	risk	risk	NOUN
ajlm-1555	20	18	.	.	PUNCT
ajlm-1555	21	1	samples	sample	NOUN
ajlm-1555	21	2	had	have	VERB
ajlm-1555	21	3	co	co	NOUN
ajlm-1555	21	4	-	-	NOUN
ajlm-1555	21	5	infection	infection	NOUN
ajlm-1555	21	6	and	and	CCONJ
ajlm-1555	21	7	five	five	NUM
ajlm-1555	21	8	had	have	VERB
ajlm-1555	21	9	low	low	ADJ
ajlm-1555	21	10	risk	risk	NOUN
ajlm-1555	21	11	type	type	NOUN
ajlm-1555	21	12	6/11	6/11	NOUN
ajlm-1555	21	13	either	either	CCONJ
ajlm-1555	21	14	as	as	ADV
ajlm-1555	21	15	single	single	ADJ
ajlm-1555	21	16	or	or	CCONJ
ajlm-1555	21	17	as	as	ADP
ajlm-1555	21	18	co	co	NOUN
ajlm-1555	21	19	-	-	NOUN
ajlm-1555	21	20	infection	infection	NOUN
ajlm-1555	21	21	.	.	PUNCT
ajlm-1555	22	1	persons	person	NOUN
ajlm-1555	22	2	who	who	PRON
ajlm-1555	22	3	had	have	AUX
ajlm-1555	22	4	engaged	engage	VERB
ajlm-1555	22	5	in	in	ADP
ajlm-1555	22	6	oral	oral	ADJ
ajlm-1555	22	7	sex	sex	NOUN
ajlm-1555	22	8	as	as	ADV
ajlm-1555	22	9	well	well	ADV
ajlm-1555	22	10	as	as	ADP
ajlm-1555	22	11	those	those	DET
ajlm-1555	22	12	aged	aged	ADJ
ajlm-1555	22	13	21	21	NUM
ajlm-1555	22	14	-	-	SYM
ajlm-1555	22	15	30	30	NUM
ajlm-1555	22	16	years	year	NOUN
ajlm-1555	22	17	has	have	VERB
ajlm-1555	22	18	significantly	significantly	ADV
ajlm-1555	22	19	higher	high	ADJ
ajlm-1555	22	20	prevalence	prevalence	NOUN
ajlm-1555	22	21	.	.	PUNCT
ajlm-1555	23	1	conclusion	conclusion	NOUN
ajlm-1555	23	2	:	:	PUNCT
ajlm-1555	23	3	this	this	DET
ajlm-1555	23	4	study	study	NOUN
ajlm-1555	23	5	showed	show	VERB
ajlm-1555	23	6	that	that	SCONJ
ajlm-1555	23	7	although	although	SCONJ
ajlm-1555	23	8	hpv	hpv	ADJ
ajlm-1555	23	9	genotype	genotype	NOUN
ajlm-1555	23	10	16	16	NUM
ajlm-1555	23	11	is	be	AUX
ajlm-1555	23	12	the	the	DET
ajlm-1555	23	13	most	most	ADV
ajlm-1555	23	14	common	common	ADJ
ajlm-1555	23	15	type	type	NOUN
ajlm-1555	23	16	among	among	ADP
ajlm-1555	23	17	dental	dental	ADJ
ajlm-1555	23	18	clinic	clinic	NOUN
ajlm-1555	23	19	attendees	attendee	NOUN
ajlm-1555	23	20	in	in	ADP
ajlm-1555	23	21	ibadan	ibadan	PROPN
ajlm-1555	23	22	,	,	PUNCT
ajlm-1555	23	23	other	other	ADJ
ajlm-1555	23	24	genotypes	genotype	NOUN
ajlm-1555	23	25	are	be	AUX
ajlm-1555	23	26	also	also	ADV
ajlm-1555	23	27	circulating	circulate	VERB
ajlm-1555	23	28	and	and	CCONJ
ajlm-1555	23	29	that	that	PRON
ajlm-1555	23	30	oral	oral	ADJ
ajlm-1555	23	31	sex	sex	NOUN
ajlm-1555	23	32	is	be	AUX
ajlm-1555	23	33	a	a	DET
ajlm-1555	23	34	risk	risk	NOUN
ajlm-1555	23	35	factor	factor	NOUN
ajlm-1555	23	36	for	for	ADP
ajlm-1555	23	37	the	the	DET
ajlm-1555	23	38	infection	infection	NOUN
ajlm-1555	23	39	.	.	PUNCT
ajlm-1555	24	1	therefore	therefore	ADV
ajlm-1555	24	2	,	,	PUNCT
ajlm-1555	24	3	introducing	introduce	VERB
ajlm-1555	24	4	a	a	DET
ajlm-1555	24	5	multivalent	multivalent	ADJ
ajlm-1555	24	6	hpv	hpv	ADJ
ajlm-1555	24	7	vaccine	vaccine	NOUN
ajlm-1555	24	8	will	will	AUX
ajlm-1555	24	9	reduce	reduce	VERB
ajlm-1555	24	10	the	the	DET
ajlm-1555	24	11	risk	risk	NOUN
ajlm-1555	24	12	of	of	ADP
ajlm-1555	24	13	hpv	hpv	NOUN
ajlm-1555	24	14	-	-	PUNCT
ajlm-1555	24	15	associated	associate	VERB
ajlm-1555	24	16	oropharyngeal	oropharyngeal	NOUN
ajlm-1555	24	17	carcinoma	carcinoma	NOUN
ajlm-1555	24	18	and	and	CCONJ
ajlm-1555	24	19	other	other	ADJ
ajlm-1555	24	20	cancers	cancer	NOUN
ajlm-1555	24	21	in	in	ADP
ajlm-1555	24	22	nigeria	nigeria	PROPN
ajlm-1555	24	23	.	.	PUNCT
ajlm-1555	25	1	keywords	keyword	NOUN
ajlm-1555	25	2	:	:	PUNCT
ajlm-1555	25	3	oral	oral	ADJ
ajlm-1555	25	4	hpv	hpv	ADJ
ajlm-1555	25	5	infection	infection	NOUN
ajlm-1555	25	6	;	;	PUNCT
ajlm-1555	25	7	dental	dental	ADJ
ajlm-1555	25	8	clinic	clinic	NOUN
ajlm-1555	25	9	attendees	attendee	NOUN
ajlm-1555	25	10	;	;	PUNCT
ajlm-1555	25	11	molecular	molecular	ADJ
ajlm-1555	25	12	detection	detection	NOUN
ajlm-1555	25	13	;	;	PUNCT
ajlm-1555	25	14	hpv	hpv	ADJ
ajlm-1555	25	15	vaccine	vaccine	NOUN
ajlm-1555	25	16	;	;	PUNCT
ajlm-1555	25	17	nigeria	nigeria	PROPN
ajlm-1555	25	18	.	.	PUNCT
ajlm-1555	26	1	introduction	introduction	NOUN
ajlm-1555	26	2	human	human	ADJ
ajlm-1555	26	3	papilloma	papilloma	NOUN
ajlm-1555	26	4	viruses	virus	NOUN
ajlm-1555	26	5	(	(	PUNCT
ajlm-1555	26	6	hpv	hpv	NOUN
ajlm-1555	26	7	)	)	PUNCT
ajlm-1555	26	8	are	be	AUX
ajlm-1555	26	9	associated	associate	VERB
ajlm-1555	26	10	with	with	ADP
ajlm-1555	26	11	anogenital	anogenital	ADJ
ajlm-1555	26	12	cancer	cancer	NOUN
ajlm-1555	26	13	,	,	PUNCT
ajlm-1555	26	14	including	include	VERB
ajlm-1555	26	15	vulval	vulval	NOUN
ajlm-1555	26	16	,	,	PUNCT
ajlm-1555	26	17	penile	penile	NOUN
ajlm-1555	26	18	,	,	PUNCT
ajlm-1555	26	19	vaginal	vaginal	ADJ
ajlm-1555	26	20	,	,	PUNCT
ajlm-1555	26	21	anal	anal	ADJ
ajlm-1555	26	22	,	,	PUNCT
ajlm-1555	26	23	and	and	CCONJ
ajlm-1555	26	24	cervical	cervical	ADJ
ajlm-1555	26	25	cancer	cancer	NOUN
ajlm-1555	26	26	.	.	PUNCT
ajlm-1555	27	1	these	these	DET
ajlm-1555	27	2	viruses	virus	NOUN
ajlm-1555	27	3	have	have	AUX
ajlm-1555	27	4	also	also	ADV
ajlm-1555	27	5	been	be	AUX
ajlm-1555	27	6	associated	associate	VERB
ajlm-1555	27	7	with	with	ADP
ajlm-1555	27	8	a	a	DET
ajlm-1555	27	9	subset	subset	NOUN
ajlm-1555	27	10	of	of	ADP
ajlm-1555	27	11	head	head	NOUN
ajlm-1555	27	12	and	and	CCONJ
ajlm-1555	27	13	neck	neck	NOUN
ajlm-1555	27	14	cancers	cancer	NOUN
ajlm-1555	27	15	causing	cause	VERB
ajlm-1555	27	16	oropharyngeal	oropharyngeal	ADJ
ajlm-1555	27	17	squamous	squamous	ADJ
ajlm-1555	27	18	cell	cell	NOUN
ajlm-1555	27	19	carcinoma.1	carcinoma.1	NOUN
ajlm-1555	27	20	apart	apart	ADV
ajlm-1555	27	21	from	from	ADP
ajlm-1555	27	22	hpv	hpv	ADJ
ajlm-1555	27	23	genotypes	genotype	NOUN
ajlm-1555	27	24	associated	associate	VERB
ajlm-1555	27	25	with	with	ADP
ajlm-1555	27	26	oropharyngeal	oropharyngeal	ADJ
ajlm-1555	27	27	carcinoma	carcinoma	NOUN
ajlm-1555	27	28	,	,	PUNCT
ajlm-1555	27	29	infections	infection	NOUN
ajlm-1555	27	30	with	with	ADP
ajlm-1555	27	31	a	a	DET
ajlm-1555	27	32	few	few	ADJ
ajlm-1555	27	33	other	other	ADJ
ajlm-1555	27	34	genotypes	genotype	NOUN
ajlm-1555	27	35	of	of	ADP
ajlm-1555	27	36	hpv	hpv	NOUN
ajlm-1555	27	37	can	can	AUX
ajlm-1555	27	38	cause	cause	VERB
ajlm-1555	27	39	warts	wart	NOUN
ajlm-1555	27	40	in	in	ADP
ajlm-1555	27	41	the	the	DET
ajlm-1555	27	42	mouth	mouth	NOUN
ajlm-1555	27	43	or	or	CCONJ
ajlm-1555	27	44	throat.2	throat.2	PROPN
ajlm-1555	27	45	oral	oral	ADJ
ajlm-1555	27	46	hpv	hpv	ADJ
ajlm-1555	27	47	infection	infection	NOUN
ajlm-1555	27	48	is	be	AUX
ajlm-1555	27	49	a	a	DET
ajlm-1555	27	50	common	common	ADJ
ajlm-1555	27	51	infection	infection	NOUN
ajlm-1555	27	52	worldwide	worldwide	ADV
ajlm-1555	27	53	.	.	PUNCT
ajlm-1555	28	1	a	a	DET
ajlm-1555	28	2	4.9	4.9	NUM
ajlm-1555	28	3	%	%	NOUN
ajlm-1555	28	4	oral	oral	ADJ
ajlm-1555	28	5	hpv	hpv	NOUN
ajlm-1555	28	6	infection	infection	NOUN
ajlm-1555	28	7	prevalence	prevalence	NOUN
ajlm-1555	28	8	among	among	ADP
ajlm-1555	28	9	healthy	healthy	ADJ
ajlm-1555	28	10	individuals	individual	NOUN
ajlm-1555	28	11	worldwide	worldwide	ADV
ajlm-1555	28	12	has	have	AUX
ajlm-1555	28	13	been	be	AUX
ajlm-1555	28	14	reported	report	VERB
ajlm-1555	28	15	.	.	PUNCT
ajlm-1555	29	1	southern	southern	PROPN
ajlm-1555	29	2	europe	europe	PROPN
ajlm-1555	29	3	has	have	VERB
ajlm-1555	29	4	the	the	DET
ajlm-1555	29	5	highest	high	ADJ
ajlm-1555	29	6	oral	oral	ADJ
ajlm-1555	29	7	hpv	hpv	NOUN
ajlm-1555	29	8	prevalence	prevalence	NOUN
ajlm-1555	29	9	(	(	PUNCT
ajlm-1555	29	10	9.5	9.5	NUM
ajlm-1555	29	11	%	%	NOUN
ajlm-1555	29	12	)	)	PUNCT
ajlm-1555	29	13	,	,	PUNCT
ajlm-1555	29	14	while	while	SCONJ
ajlm-1555	29	15	central	central	PROPN
ajlm-1555	29	16	america	america	PROPN
ajlm-1555	29	17	has	have	VERB
ajlm-1555	29	18	6.6	6.6	NUM
ajlm-1555	29	19	%	%	NOUN
ajlm-1555	29	20	and	and	CCONJ
ajlm-1555	29	21	east	east	PROPN
ajlm-1555	29	22	asia	asia	PROPN
ajlm-1555	29	23	0.6	0.6	NUM
ajlm-1555	29	24	%	%	NOUN
ajlm-1555	29	25	.	.	PUNCT
ajlm-1555	30	1	from	from	ADP
ajlm-1555	30	2	the	the	DET
ajlm-1555	30	3	few	few	ADJ
ajlm-1555	30	4	studies	study	NOUN
ajlm-1555	30	5	in	in	ADP
ajlm-1555	30	6	africa	africa	PROPN
ajlm-1555	30	7	,	,	PUNCT
ajlm-1555	30	8	the	the	DET
ajlm-1555	30	9	prevalence	prevalence	NOUN
ajlm-1555	30	10	of	of	ADP
ajlm-1555	30	11	oral	oral	ADJ
ajlm-1555	30	12	hpv	hpv	NOUN
ajlm-1555	30	13	ranges	range	VERB
ajlm-1555	30	14	from	from	ADP
ajlm-1555	30	15	2.3	2.3	NUM
ajlm-1555	30	16	%	%	NOUN
ajlm-1555	30	17	to	to	ADP
ajlm-1555	30	18	6.5%.3	6.5%.3	PROPN
ajlm-1555	30	19	the	the	DET
ajlm-1555	30	20	situation	situation	NOUN
ajlm-1555	30	21	of	of	ADP
ajlm-1555	30	22	hiv	hiv	PROPN
ajlm-1555	30	23	infection	infection	NOUN
ajlm-1555	30	24	has	have	AUX
ajlm-1555	30	25	caused	cause	VERB
ajlm-1555	30	26	an	an	DET
ajlm-1555	30	27	increase	increase	NOUN
ajlm-1555	30	28	in	in	ADP
ajlm-1555	30	29	the	the	DET
ajlm-1555	30	30	prevalence	prevalence	NOUN
ajlm-1555	30	31	of	of	ADP
ajlm-1555	30	32	oral	oral	ADJ
ajlm-1555	30	33	hpv	hpv	ADJ
ajlm-1555	30	34	infection	infection	NOUN
ajlm-1555	30	35	,	,	PUNCT
ajlm-1555	30	36	especially	especially	ADV
ajlm-1555	30	37	among	among	ADP
ajlm-1555	30	38	hiv	hiv	PROPN
ajlm-1555	30	39	-	-	PUNCT
ajlm-1555	30	40	infected	infect	VERB
ajlm-1555	30	41	individuals	individual	NOUN
ajlm-1555	30	42	in	in	ADP
ajlm-1555	30	43	developed	develop	VERB
ajlm-1555	30	44	countries.4	countries.4	PROPN
ajlm-1555	30	45	however	however	ADV
ajlm-1555	30	46	,	,	PUNCT
ajlm-1555	30	47	information	information	NOUN
ajlm-1555	30	48	on	on	ADP
ajlm-1555	30	49	the	the	DET
ajlm-1555	30	50	effect	effect	NOUN
ajlm-1555	30	51	of	of	ADP
ajlm-1555	30	52	hiv	hiv	PROPN
ajlm-1555	30	53	on	on	ADP
ajlm-1555	30	54	the	the	DET
ajlm-1555	30	55	prevalence	prevalence	NOUN
ajlm-1555	30	56	of	of	ADP
ajlm-1555	30	57	oral	oral	ADJ
ajlm-1555	30	58	hpv	hpv	NOUN
ajlm-1555	30	59	in	in	ADP
ajlm-1555	30	60	africa	africa	PROPN
ajlm-1555	30	61	,	,	PUNCT
ajlm-1555	30	62	and	and	CCONJ
ajlm-1555	30	63	nigeria	nigeria	PROPN
ajlm-1555	30	64	in	in	ADP
ajlm-1555	30	65	particular	particular	ADJ
ajlm-1555	30	66	,	,	PUNCT
ajlm-1555	30	67	is	be	AUX
ajlm-1555	30	68	limited	limit	VERB
ajlm-1555	30	69	.	.	PUNCT
ajlm-1555	31	1	human	human	ADJ
ajlm-1555	31	2	papilloma	papilloma	NOUN
ajlm-1555	31	3	viruses	virus	NOUN
ajlm-1555	31	4	are	be	AUX
ajlm-1555	31	5	small	small	ADJ
ajlm-1555	31	6	,	,	PUNCT
ajlm-1555	31	7	non	non	ADJ
ajlm-1555	31	8	-	-	ADJ
ajlm-1555	31	9	enveloped	envelop	VERB
ajlm-1555	31	10	,	,	PUNCT
ajlm-1555	31	11	double	double	ADJ
ajlm-1555	31	12	-	-	PUNCT
ajlm-1555	31	13	stranded	strand	VERB
ajlm-1555	31	14	dna	dna	NOUN
ajlm-1555	31	15	viruses	virus	NOUN
ajlm-1555	31	16	belonging	belong	VERB
ajlm-1555	31	17	to	to	ADP
ajlm-1555	31	18	the	the	DET
ajlm-1555	31	19	papovaviridae	papovaviridae	NOUN
ajlm-1555	31	20	family	family	NOUN
ajlm-1555	31	21	.	.	PUNCT
ajlm-1555	32	1	the	the	DET
ajlm-1555	32	2	family	family	NOUN
ajlm-1555	32	3	has	have	VERB
ajlm-1555	32	4	five	five	NUM
ajlm-1555	32	5	major	major	ADJ
ajlm-1555	32	6	genera	genera	NOUN
ajlm-1555	32	7	:	:	PUNCT
ajlm-1555	32	8	alpha	alpha	NOUN
ajlm-1555	32	9	,	,	PUNCT
ajlm-1555	32	10	beta	beta	NOUN
ajlm-1555	32	11	,	,	PUNCT
ajlm-1555	32	12	gamma	gamma	NOUN
ajlm-1555	32	13	,	,	PUNCT
ajlm-1555	32	14	mu	mu	NOUN
ajlm-1555	32	15	,	,	PUNCT
ajlm-1555	32	16	and	and	CCONJ
ajlm-1555	32	17	nu	nu	INTJ
ajlm-1555	32	18	,	,	PUNCT
ajlm-1555	32	19	with	with	ADP
ajlm-1555	32	20	those	those	PRON
ajlm-1555	32	21	in	in	ADP
ajlm-1555	32	22	the	the	DET
ajlm-1555	32	23	alpha	alpha	NOUN
ajlm-1555	32	24	genus	genus	NOUN
ajlm-1555	32	25	having	have	VERB
ajlm-1555	32	26	the	the	DET
ajlm-1555	32	27	most	most	ADV
ajlm-1555	32	28	medical	medical	ADJ
ajlm-1555	32	29	importance	importance	NOUN
ajlm-1555	32	30	.	.	PUNCT
ajlm-1555	33	1	human	human	ADJ
ajlm-1555	33	2	papilloma	papilloma	NOUN
ajlm-1555	33	3	viruses	virus	NOUN
ajlm-1555	33	4	are	be	AUX
ajlm-1555	33	5	further	far	ADV
ajlm-1555	33	6	categorised	categorise	VERB
ajlm-1555	33	7	into	into	ADP
ajlm-1555	33	8	high	high	ADJ
ajlm-1555	33	9	risk	risk	NOUN
ajlm-1555	33	10	or	or	CCONJ
ajlm-1555	33	11	low	low	ADJ
ajlm-1555	33	12	risk	risk	NOUN
ajlm-1555	33	13	based	base	VERB
ajlm-1555	33	14	on	on	ADP
ajlm-1555	33	15	their	their	PRON
ajlm-1555	33	16	epidemiological	epidemiological	ADJ
ajlm-1555	33	17	associated	associated	ADJ
ajlm-1555	33	18	malignancies.5,6,7,8	malignancies.5,6,7,8	NOUN
ajlm-1555	33	19	there	there	PRON
ajlm-1555	33	20	are	be	VERB
ajlm-1555	33	21	14	14	NUM
ajlm-1555	33	22	hpv	hpv	NOUN
ajlm-1555	33	23	genotypes	genotype	NOUN
ajlm-1555	33	24	classified	classify	VERB
ajlm-1555	33	25	as	as	ADP
ajlm-1555	33	26	high	high	ADJ
ajlm-1555	33	27	risk	risk	NOUN
ajlm-1555	33	28	and	and	CCONJ
ajlm-1555	33	29	they	they	PRON
ajlm-1555	33	30	include	include	VERB
ajlm-1555	33	31	hpv	hpv	ADJ
ajlm-1555	33	32	types	type	NOUN
ajlm-1555	33	33	16	16	NUM
ajlm-1555	33	34	,	,	PUNCT
ajlm-1555	33	35	18	18	NUM
ajlm-1555	33	36	,	,	PUNCT
ajlm-1555	33	37	31	31	NUM
ajlm-1555	33	38	,	,	PUNCT
ajlm-1555	33	39	33	33	NUM
ajlm-1555	33	40	,	,	PUNCT
ajlm-1555	33	41	35	35	NUM
ajlm-1555	33	42	,	,	PUNCT
ajlm-1555	33	43	39	39	NUM
ajlm-1555	33	44	,	,	PUNCT
ajlm-1555	33	45	45	45	NUM
ajlm-1555	33	46	,	,	PUNCT
ajlm-1555	33	47	51	51	NUM
ajlm-1555	33	48	,	,	PUNCT
ajlm-1555	33	49	52	52	NUM
ajlm-1555	33	50	,	,	PUNCT
ajlm-1555	33	51	56	56	NUM
ajlm-1555	33	52	,	,	PUNCT
ajlm-1555	33	53	58	58	NUM
ajlm-1555	33	54	,	,	PUNCT
ajlm-1555	33	55	59	59	NUM
ajlm-1555	33	56	,	,	PUNCT
ajlm-1555	33	57	66	66	NUM
ajlm-1555	33	58	and	and	CCONJ
ajlm-1555	33	59	68	68	NUM
ajlm-1555	33	60	,	,	PUNCT
ajlm-1555	33	61	while	while	SCONJ
ajlm-1555	33	62	genotypes	genotype	NOUN
ajlm-1555	33	63	6	6	NUM
ajlm-1555	33	64	,	,	PUNCT
ajlm-1555	33	65	11	11	NUM
ajlm-1555	33	66	,	,	PUNCT
ajlm-1555	33	67	42	42	NUM
ajlm-1555	33	68	,	,	PUNCT
ajlm-1555	33	69	43	43	NUM
ajlm-1555	33	70	and	and	CCONJ
ajlm-1555	33	71	44	44	NUM
ajlm-1555	33	72	are	be	AUX
ajlm-1555	33	73	classified	classify	VERB
ajlm-1555	33	74	as	as	ADP
ajlm-1555	33	75	low	low	ADJ
ajlm-1555	33	76	-	-	PUNCT
ajlm-1555	33	77	risk	risk	NOUN
ajlm-1555	33	78	types	type	NOUN
ajlm-1555	33	79	.	.	PUNCT
ajlm-1555	34	1	human	human	ADJ
ajlm-1555	34	2	papilloma	papilloma	PROPN
ajlm-1555	34	3	virus	virus	NOUN
ajlm-1555	34	4	infection	infection	NOUN
ajlm-1555	34	5	of	of	ADP
ajlm-1555	34	6	the	the	DET
ajlm-1555	34	7	mouth	mouth	NOUN
ajlm-1555	34	8	and	and	CCONJ
ajlm-1555	34	9	the	the	DET
ajlm-1555	34	10	oropharynx	oropharynx	NOUN
ajlm-1555	34	11	,	,	PUNCT
ajlm-1555	34	12	like	like	ADP
ajlm-1555	34	13	hpv	hpv	ADJ
ajlm-1555	34	14	infection	infection	NOUN
ajlm-1555	34	15	of	of	ADP
ajlm-1555	34	16	the	the	DET
ajlm-1555	34	17	uterine	uterine	ADJ
ajlm-1555	34	18	cervix	cervix	NOUN
ajlm-1555	34	19	,	,	PUNCT
ajlm-1555	34	20	is	be	AUX
ajlm-1555	34	21	associated	associate	VERB
ajlm-1555	34	22	with	with	ADP
ajlm-1555	34	23	high	high	ADJ
ajlm-1555	34	24	-	-	PUNCT
ajlm-1555	34	25	risk	risk	NOUN
ajlm-1555	34	26	sexual	sexual	ADJ
ajlm-1555	34	27	behaviours	behaviour	NOUN
ajlm-1555	34	28	(	(	PUNCT
ajlm-1555	34	29	orogenital	orogenital	ADJ
ajlm-1555	34	30	sex	sex	NOUN
ajlm-1555	34	31	)	)	PUNCT
ajlm-1555	34	32	.	.	PUNCT
ajlm-1555	35	1	high	high	ADJ
ajlm-1555	35	2	-	-	PUNCT
ajlm-1555	35	3	risk	risk	NOUN
ajlm-1555	35	4	hpv	hpv	NOUN
ajlm-1555	35	5	genotypes	genotype	NOUN
ajlm-1555	35	6	,	,	PUNCT
ajlm-1555	35	7	especially	especially	ADV
ajlm-1555	35	8	hpv-16	hpv-16	NUM
ajlm-1555	35	9	,	,	PUNCT
ajlm-1555	35	10	are	be	AUX
ajlm-1555	35	11	present	present	ADJ
ajlm-1555	35	12	in	in	ADP
ajlm-1555	35	13	many	many	ADJ
ajlm-1555	35	14	oral	oral	ADJ
ajlm-1555	35	15	and	and	CCONJ
ajlm-1555	35	16	oropharyngeal	oropharyngeal	ADJ
ajlm-1555	35	17	squamous	squamous	ADJ
ajlm-1555	35	18	cell	cell	NOUN
ajlm-1555	35	19	carcinoma	carcinoma	NOUN
ajlm-1555	35	20	where	where	SCONJ
ajlm-1555	35	21	,	,	PUNCT
ajlm-1555	35	22	in	in	ADP
ajlm-1555	35	23	some	some	DET
ajlm-1555	35	24	cases	case	NOUN
ajlm-1555	35	25	,	,	PUNCT
ajlm-1555	35	26	they	they	PRON
ajlm-1555	35	27	play	play	VERB
ajlm-1555	35	28	an	an	DET
ajlm-1555	35	29	essential	essential	ADJ
ajlm-1555	35	30	aetiological	aetiological	ADJ
ajlm-1555	35	31	role.7	role.7	NOUN
ajlm-1555	35	32	presently	presently	ADV
ajlm-1555	35	33	,	,	PUNCT
ajlm-1555	35	34	the	the	DET
ajlm-1555	35	35	prevalence	prevalence	NOUN
ajlm-1555	35	36	of	of	ADP
ajlm-1555	35	37	anogenital	anogenital	ADJ
ajlm-1555	35	38	hpv	hpv	NOUN
ajlm-1555	35	39	infection	infection	NOUN
ajlm-1555	35	40	in	in	ADP
ajlm-1555	35	41	africa	africa	PROPN
ajlm-1555	35	42	ranges	range	VERB
ajlm-1555	35	43	from	from	ADP
ajlm-1555	35	44	9.8	9.8	NUM
ajlm-1555	35	45	%	%	NOUN
ajlm-1555	35	46	in	in	ADP
ajlm-1555	35	47	central	central	PROPN
ajlm-1555	35	48	africa	africa	PROPN
ajlm-1555	35	49	to	to	ADP
ajlm-1555	35	50	19.5	19.5	NUM
ajlm-1555	35	51	%	%	NOUN
ajlm-1555	35	52	in	in	ADP
ajlm-1555	35	53	western	western	ADJ
ajlm-1555	35	54	africa9	africa9	NOUN
ajlm-1555	35	55	;	;	PUNCT
ajlm-1555	35	56	in	in	ADP
ajlm-1555	35	57	nigeria	nigeria	PROPN
ajlm-1555	35	58	,	,	PUNCT
ajlm-1555	35	59	it	it	PRON
ajlm-1555	35	60	ranges	range	VERB
ajlm-1555	35	61	from	from	ADP
ajlm-1555	35	62	3.5	3.5	NUM
ajlm-1555	35	63	%	%	NOUN
ajlm-1555	35	64	to	to	ADP
ajlm-1555	35	65	28.8	28.8	NUM
ajlm-1555	35	66	%	%	NOUN
ajlm-1555	35	67	.	.	PUNCT
ajlm-1555	36	1	the	the	DET
ajlm-1555	36	2	common	common	ADJ
ajlm-1555	36	3	anogenital	anogenital	ADJ
ajlm-1555	36	4	hpv	hpv	NOUN
ajlm-1555	36	5	genotypes	genotype	NOUN
ajlm-1555	36	6	circulating	circulate	VERB
ajlm-1555	36	7	in	in	ADP
ajlm-1555	36	8	nigeria	nigeria	PROPN
ajlm-1555	36	9	are	be	AUX
ajlm-1555	36	10	hpv	hpv	ADJ
ajlm-1555	36	11	types	type	NOUN
ajlm-1555	36	12	16	16	NUM
ajlm-1555	36	13	,	,	PUNCT
ajlm-1555	36	14	18	18	NUM
ajlm-1555	36	15	,	,	PUNCT
ajlm-1555	36	16	31	31	NUM
ajlm-1555	36	17	,	,	PUNCT
ajlm-1555	36	18	35	35	NUM
ajlm-1555	36	19	,	,	PUNCT
ajlm-1555	36	20	33	33	NUM
ajlm-1555	36	21	,	,	PUNCT
ajlm-1555	36	22	39	39	NUM
ajlm-1555	36	23	,	,	PUNCT
ajlm-1555	36	24	45	45	NUM
ajlm-1555	36	25	,	,	PUNCT
ajlm-1555	36	26	51	51	NUM
ajlm-1555	36	27	,	,	PUNCT
ajlm-1555	36	28	52	52	NUM
ajlm-1555	36	29	,	,	PUNCT
ajlm-1555	36	30	56	56	NUM
ajlm-1555	36	31	,	,	PUNCT
ajlm-1555	36	32	59	59	NUM
ajlm-1555	36	33	,	,	PUNCT
ajlm-1555	36	34	70	70	NUM
ajlm-1555	36	35	and	and	CCONJ
ajlm-1555	36	36	82,10	82,10	NUM
ajlm-1555	36	37	while	while	SCONJ
ajlm-1555	36	38	those	those	PRON
ajlm-1555	36	39	associated	associate	VERB
ajlm-1555	36	40	with	with	ADP
ajlm-1555	36	41	cancer	cancer	NOUN
ajlm-1555	36	42	in	in	ADP
ajlm-1555	36	43	nigeria	nigeria	PROPN
ajlm-1555	36	44	include	include	VERB
ajlm-1555	36	45	genotypes	genotype	NOUN
ajlm-1555	36	46	16	16	NUM
ajlm-1555	36	47	,	,	PUNCT
ajlm-1555	36	48	18	18	NUM
ajlm-1555	36	49	,	,	PUNCT
ajlm-1555	36	50	33	33	NUM
ajlm-1555	36	51	,	,	PUNCT
ajlm-1555	36	52	35	35	NUM
ajlm-1555	36	53	,	,	PUNCT
ajlm-1555	36	54	45	45	NUM
ajlm-1555	36	55	,	,	PUNCT
ajlm-1555	36	56	52	52	NUM
ajlm-1555	36	57	and	and	CCONJ
ajlm-1555	36	58	56.10	56.10	NUM
ajlm-1555	36	59	although	although	SCONJ
ajlm-1555	36	60	various	various	ADJ
ajlm-1555	36	61	hpv	hpv	NOUN
ajlm-1555	36	62	strains	strain	NOUN
ajlm-1555	36	63	are	be	AUX
ajlm-1555	36	64	circulating	circulate	VERB
ajlm-1555	36	65	in	in	ADP
ajlm-1555	36	66	nigeria	nigeria	PROPN
ajlm-1555	36	67	,	,	PUNCT
ajlm-1555	36	68	the	the	DET
ajlm-1555	36	69	easily	easily	ADV
ajlm-1555	36	70	available	available	ADJ
ajlm-1555	36	71	vaccine	vaccine	NOUN
ajlm-1555	36	72	is	be	AUX
ajlm-1555	36	73	only	only	ADV
ajlm-1555	36	74	against	against	ADP
ajlm-1555	36	75	genotypes	genotype	NOUN
ajlm-1555	36	76	16	16	NUM
ajlm-1555	36	77	and	and	CCONJ
ajlm-1555	36	78	18	18	NUM
ajlm-1555	36	79	.	.	PUNCT
ajlm-1555	37	1	yet	yet	ADV
ajlm-1555	37	2	,	,	PUNCT
ajlm-1555	37	3	the	the	DET
ajlm-1555	37	4	available	available	ADJ
ajlm-1555	37	5	hpv	hpv	ADJ
ajlm-1555	37	6	vaccine	vaccine	NOUN
ajlm-1555	37	7	is	be	AUX
ajlm-1555	37	8	not	not	PART
ajlm-1555	37	9	included	include	VERB
ajlm-1555	37	10	in	in	ADP
ajlm-1555	37	11	the	the	DET
ajlm-1555	37	12	national	national	ADJ
ajlm-1555	37	13	vaccination	vaccination	NOUN
ajlm-1555	37	14	programme	programme	NOUN
ajlm-1555	37	15	,	,	PUNCT
ajlm-1555	37	16	and	and	CCONJ
ajlm-1555	37	17	only	only	ADV
ajlm-1555	37	18	a	a	DET
ajlm-1555	37	19	few	few	ADJ
ajlm-1555	37	20	informed	informed	ADJ
ajlm-1555	37	21	individuals	individual	NOUN
ajlm-1555	37	22	make	make	VERB
ajlm-1555	37	23	private	private	ADJ
ajlm-1555	37	24	arrangements	arrangement	NOUN
ajlm-1555	37	25	for	for	ADP
ajlm-1555	37	26	the	the	DET
ajlm-1555	37	27	vaccination	vaccination	NOUN
ajlm-1555	37	28	.	.	PUNCT
ajlm-1555	38	1	the	the	DET
ajlm-1555	38	2	population	population	NOUN
ajlm-1555	38	3	of	of	ADP
ajlm-1555	38	4	people	people	NOUN
ajlm-1555	38	5	making	make	VERB
ajlm-1555	38	6	this	this	DET
ajlm-1555	38	7	arrangement	arrangement	NOUN
ajlm-1555	38	8	is	be	AUX
ajlm-1555	38	9	also	also	ADV
ajlm-1555	38	10	low	low	ADJ
ajlm-1555	38	11	due	due	ADJ
ajlm-1555	38	12	to	to	ADP
ajlm-1555	38	13	cost	cost	NOUN
ajlm-1555	38	14	and	and	CCONJ
ajlm-1555	38	15	awareness11,12	awareness11,12	NOUN
ajlm-1555	38	16	;	;	PUNCT
ajlm-1555	38	17	thus	thus	ADV
ajlm-1555	38	18	,	,	PUNCT
ajlm-1555	38	19	the	the	DET
ajlm-1555	38	20	hpv	hpv	PROPN
ajlm-1555	38	21	vaccine	vaccine	NOUN
ajlm-1555	38	22	coverage	coverage	NOUN
ajlm-1555	38	23	in	in	ADP
ajlm-1555	38	24	nigeria	nigeria	PROPN
ajlm-1555	38	25	is	be	AUX
ajlm-1555	38	26	meagre	meagre	ADJ
ajlm-1555	38	27	.	.	PUNCT
ajlm-1555	39	1	there	there	PRON
ajlm-1555	39	2	is	be	VERB
ajlm-1555	39	3	limited	limited	ADJ
ajlm-1555	39	4	information	information	NOUN
ajlm-1555	39	5	on	on	ADP
ajlm-1555	39	6	the	the	DET
ajlm-1555	39	7	prevalence	prevalence	NOUN
ajlm-1555	39	8	and	and	CCONJ
ajlm-1555	39	9	circulating	circulating	ADJ
ajlm-1555	39	10	genotypes	genotype	NOUN
ajlm-1555	39	11	of	of	ADP
ajlm-1555	39	12	oral	oral	ADJ
ajlm-1555	39	13	hpv	hpv	NOUN
ajlm-1555	39	14	in	in	ADP
ajlm-1555	39	15	africa	africa	PROPN
ajlm-1555	39	16	and	and	CCONJ
ajlm-1555	39	17	especially	especially	ADV
ajlm-1555	39	18	nigeria	nigeria	PROPN
ajlm-1555	39	19	.	.	PUNCT
ajlm-1555	40	1	this	this	DET
ajlm-1555	40	2	information	information	NOUN
ajlm-1555	40	3	is	be	AUX
ajlm-1555	40	4	essential	essential	ADJ
ajlm-1555	40	5	to	to	PART
ajlm-1555	40	6	know	know	VERB
ajlm-1555	40	7	if	if	SCONJ
ajlm-1555	40	8	available	available	ADJ
ajlm-1555	40	9	vaccines	vaccine	NOUN
ajlm-1555	40	10	will	will	AUX
ajlm-1555	40	11	be	be	AUX
ajlm-1555	40	12	effective	effective	ADJ
ajlm-1555	40	13	in	in	ADP
ajlm-1555	40	14	preventing	prevent	VERB
ajlm-1555	40	15	oral	oral	ADJ
ajlm-1555	40	16	hpv	hpv	NOUN
ajlm-1555	40	17	infection	infection	NOUN
ajlm-1555	40	18	and	and	CCONJ
ajlm-1555	40	19	associated	associated	ADJ
ajlm-1555	40	20	oral	oral	ADJ
ajlm-1555	40	21	cancers	cancer	NOUN
ajlm-1555	40	22	in	in	ADP
ajlm-1555	40	23	nigeria	nigeria	PROPN
ajlm-1555	40	24	.	.	PUNCT
ajlm-1555	41	1	this	this	DET
ajlm-1555	41	2	study	study	NOUN
ajlm-1555	41	3	was	be	AUX
ajlm-1555	41	4	carried	carry	VERB
ajlm-1555	41	5	out	out	ADP
ajlm-1555	41	6	to	to	PART
ajlm-1555	41	7	provide	provide	VERB
ajlm-1555	41	8	information	information	NOUN
ajlm-1555	41	9	on	on	ADP
ajlm-1555	41	10	oral	oral	ADJ
ajlm-1555	41	11	hpv	hpv	NOUN
ajlm-1555	41	12	and	and	CCONJ
ajlm-1555	41	13	the	the	DET
ajlm-1555	41	14	circulating	circulate	VERB
ajlm-1555	41	15	genotypes	genotype	NOUN
ajlm-1555	41	16	among	among	ADP
ajlm-1555	41	17	patients	patient	NOUN
ajlm-1555	41	18	presenting	present	VERB
ajlm-1555	41	19	in	in	ADP
ajlm-1555	41	20	dental	dental	ADJ
ajlm-1555	41	21	clinics	clinic	NOUN
ajlm-1555	41	22	in	in	ADP
ajlm-1555	41	23	ibadan	ibadan	PROPN
ajlm-1555	41	24	,	,	PUNCT
ajlm-1555	41	25	nigeria	nigeria	PROPN
ajlm-1555	41	26	.	.	PUNCT
ajlm-1555	42	1	methods	method	NOUN
ajlm-1555	42	2	ethical	ethical	ADJ
ajlm-1555	42	3	considerations	consideration	NOUN
ajlm-1555	42	4	this	this	DET
ajlm-1555	42	5	study	study	NOUN
ajlm-1555	42	6	was	be	AUX
ajlm-1555	42	7	approved	approve	VERB
ajlm-1555	42	8	by	by	ADP
ajlm-1555	42	9	the	the	DET
ajlm-1555	42	10	ethics	ethic	NOUN
ajlm-1555	42	11	review	review	PROPN
ajlm-1555	42	12	committee	committee	NOUN
ajlm-1555	42	13	of	of	ADP
ajlm-1555	42	14	the	the	DET
ajlm-1555	42	15	university	university	PROPN
ajlm-1555	42	16	of	of	ADP
ajlm-1555	42	17	ibadan	ibadan	PROPN
ajlm-1555	42	18	and	and	CCONJ
ajlm-1555	42	19	university	university	PROPN
ajlm-1555	42	20	college	college	PROPN
ajlm-1555	42	21	hospital	hospital	PROPN
ajlm-1555	42	22	ibadan	ibadan	PROPN
ajlm-1555	42	23	with	with	ADP
ajlm-1555	42	24	approval	approval	NOUN
ajlm-1555	42	25	number	number	NOUN
ajlm-1555	42	26	160057	160057	NUM
ajlm-1555	42	27	,	,	PUNCT
ajlm-1555	42	28	and	and	CCONJ
ajlm-1555	42	29	participants	participant	NOUN
ajlm-1555	42	30	provided	provide	VERB
ajlm-1555	42	31	written	write	VERB
ajlm-1555	42	32	informed	inform	VERB
ajlm-1555	42	33	consent	consent	NOUN
ajlm-1555	42	34	.	.	PUNCT
ajlm-1555	43	1	confidentiality	confidentiality	NOUN
ajlm-1555	43	2	of	of	ADP
ajlm-1555	43	3	the	the	DET
ajlm-1555	43	4	study	study	NOUN
ajlm-1555	43	5	participants	participant	NOUN
ajlm-1555	43	6	was	be	AUX
ajlm-1555	43	7	maintained	maintain	VERB
ajlm-1555	43	8	;	;	PUNCT
ajlm-1555	43	9	participants	participant	NOUN
ajlm-1555	43	10	’	'	PUNCT
ajlm-1555	43	11	identities	identity	NOUN
ajlm-1555	43	12	were	be	AUX
ajlm-1555	43	13	codified	codify	VERB
ajlm-1555	43	14	,	,	PUNCT
ajlm-1555	43	15	and	and	CCONJ
ajlm-1555	43	16	only	only	ADV
ajlm-1555	43	17	the	the	DET
ajlm-1555	43	18	authorised	authorised	ADJ
ajlm-1555	43	19	party	party	NOUN
ajlm-1555	43	20	could	could	AUX
ajlm-1555	43	21	link	link	VERB
ajlm-1555	43	22	the	the	DET
ajlm-1555	43	23	identity	identity	NOUN
ajlm-1555	43	24	of	of	ADP
ajlm-1555	43	25	the	the	DET
ajlm-1555	43	26	participants	participant	NOUN
ajlm-1555	43	27	to	to	ADP
ajlm-1555	43	28	the	the	DET
ajlm-1555	43	29	given	give	VERB
ajlm-1555	43	30	code	code	NOUN
ajlm-1555	43	31	when	when	SCONJ
ajlm-1555	43	32	the	the	DET
ajlm-1555	43	33	result	result	NOUN
ajlm-1555	43	34	is	be	AUX
ajlm-1555	43	35	given	give	VERB
ajlm-1555	43	36	to	to	ADP
ajlm-1555	43	37	the	the	DET
ajlm-1555	43	38	dentist	dentist	NOUN
ajlm-1555	43	39	to	to	PART
ajlm-1555	43	40	notify	notify	VERB
ajlm-1555	43	41	the	the	DET
ajlm-1555	43	42	participants	participant	NOUN
ajlm-1555	43	43	of	of	ADP
ajlm-1555	43	44	their	their	PRON
ajlm-1555	43	45	result	result	NOUN
ajlm-1555	43	46	.	.	PUNCT
ajlm-1555	44	1	study	study	NOUN
ajlm-1555	44	2	design	design	NOUN
ajlm-1555	44	3	this	this	DET
ajlm-1555	44	4	study	study	NOUN
ajlm-1555	44	5	was	be	AUX
ajlm-1555	44	6	a	a	DET
ajlm-1555	44	7	descriptive	descriptive	ADJ
ajlm-1555	44	8	cross	cross	ADJ
ajlm-1555	44	9	-	-	ADJ
ajlm-1555	44	10	sectional	sectional	ADJ
ajlm-1555	44	11	study	study	NOUN
ajlm-1555	44	12	carried	carry	VERB
ajlm-1555	44	13	out	out	ADP
ajlm-1555	44	14	among	among	ADP
ajlm-1555	44	15	231	231	NUM
ajlm-1555	44	16	patients	patient	NOUN
ajlm-1555	44	17	attending	attend	VERB
ajlm-1555	44	18	three	three	NUM
ajlm-1555	44	19	dental	dental	ADJ
ajlm-1555	44	20	clinics	clinic	NOUN
ajlm-1555	44	21	comprising	comprise	VERB
ajlm-1555	44	22	one	one	NUM
ajlm-1555	44	23	government	government	NOUN
ajlm-1555	44	24	(	(	PUNCT
ajlm-1555	44	25	university	university	NOUN
ajlm-1555	44	26	college	college	NOUN
ajlm-1555	44	27	hospital	hospital	PROPN
ajlm-1555	44	28	ibadan	ibadan	PROPN
ajlm-1555	44	29	dental	dental	PROPN
ajlm-1555	44	30	clinic	clinic	NOUN
ajlm-1555	44	31	)	)	PUNCT
ajlm-1555	44	32	and	and	CCONJ
ajlm-1555	44	33	two	two	NUM
ajlm-1555	44	34	private	private	ADJ
ajlm-1555	44	35	dental	dental	ADJ
ajlm-1555	44	36	clinics	clinic	NOUN
ajlm-1555	44	37	in	in	ADP
ajlm-1555	44	38	ibadan	ibadan	PROPN
ajlm-1555	44	39	,	,	PUNCT
ajlm-1555	44	40	oyo	oyo	NOUN
ajlm-1555	44	41	state	state	NOUN
ajlm-1555	44	42	,	,	PUNCT
ajlm-1555	44	43	nigeria	nigeria	PROPN
ajlm-1555	44	44	,	,	PUNCT
ajlm-1555	44	45	from	from	ADP
ajlm-1555	44	46	august	august	PROPN
ajlm-1555	44	47	2016	2016	NUM
ajlm-1555	44	48	to	to	ADP
ajlm-1555	44	49	february	february	PROPN
ajlm-1555	44	50	2017	2017	NUM
ajlm-1555	44	51	.	.	PUNCT
ajlm-1555	45	1	government	government	NOUN
ajlm-1555	45	2	dental	dental	ADJ
ajlm-1555	45	3	clinics	clinic	NOUN
ajlm-1555	45	4	in	in	ADP
ajlm-1555	45	5	ibadan	ibadan	PROPN
ajlm-1555	45	6	provide	provide	VERB
ajlm-1555	45	7	dental	dental	ADJ
ajlm-1555	45	8	services	service	NOUN
ajlm-1555	45	9	for	for	ADP
ajlm-1555	45	10	the	the	DET
ajlm-1555	45	11	population	population	NOUN
ajlm-1555	45	12	of	of	ADP
ajlm-1555	45	13	ibadan	ibadan	PROPN
ajlm-1555	45	14	and	and	CCONJ
ajlm-1555	45	15	its	its	PRON
ajlm-1555	45	16	environment	environment	NOUN
ajlm-1555	45	17	.	.	PUNCT
ajlm-1555	46	1	the	the	DET
ajlm-1555	46	2	minimum	minimum	ADJ
ajlm-1555	46	3	sample	sample	NOUN
ajlm-1555	46	4	size	size	NOUN
ajlm-1555	46	5	calculated	calculate	VERB
ajlm-1555	46	6	was	be	AUX
ajlm-1555	46	7	196	196	NUM
ajlm-1555	46	8	but	but	CCONJ
ajlm-1555	46	9	a	a	DET
ajlm-1555	46	10	total	total	NOUN
ajlm-1555	46	11	of	of	ADP
ajlm-1555	46	12	231	231	NUM
ajlm-1555	46	13	individuals	individual	NOUN
ajlm-1555	46	14	was	be	AUX
ajlm-1555	46	15	recruited	recruit	VERB
ajlm-1555	46	16	for	for	ADP
ajlm-1555	46	17	the	the	DET
ajlm-1555	46	18	study	study	NOUN
ajlm-1555	46	19	.	.	PUNCT
ajlm-1555	47	1	the	the	DET
ajlm-1555	47	2	sample	sample	NOUN
ajlm-1555	47	3	size	size	NOUN
ajlm-1555	47	4	was	be	AUX
ajlm-1555	47	5	determined	determine	VERB
ajlm-1555	47	6	using	use	VERB
ajlm-1555	47	7	the	the	DET
ajlm-1555	47	8	formula	formula	NOUN
ajlm-1555	47	9	:	:	PUNCT
ajlm-1555	47	10	a	a	DET
ajlm-1555	47	11	prevalence	prevalence	NOUN
ajlm-1555	47	12	of	of	ADP
ajlm-1555	47	13	15%13	15%13	NUM
ajlm-1555	47	14	at	at	ADP
ajlm-1555	47	15	95	95	NUM
ajlm-1555	47	16	%	%	NOUN
ajlm-1555	47	17	confidence	confidence	NOUN
ajlm-1555	47	18	interval	interval	NOUN
ajlm-1555	47	19	and	and	CCONJ
ajlm-1555	47	20	0.02	0.02	NUM
ajlm-1555	47	21	level	level	NOUN
ajlm-1555	47	22	of	of	ADP
ajlm-1555	47	23	variability	variability	NOUN
ajlm-1555	47	24	of	of	ADP
ajlm-1555	47	25	the	the	DET
ajlm-1555	47	26	target	target	NOUN
ajlm-1555	47	27	population	population	NOUN
ajlm-1555	47	28	(	(	PUNCT
ajlm-1555	47	29	n	n	X
ajlm-1555	47	30	=	=	PRON
ajlm-1555	47	31	the	the	DET
ajlm-1555	47	32	sample	sample	NOUN
ajlm-1555	47	33	size	size	NOUN
ajlm-1555	47	34	,	,	PUNCT
ajlm-1555	47	35	a	a	DET
ajlm-1555	47	36	=	=	NOUN
ajlm-1555	47	37	1.96	1.96	NUM
ajlm-1555	47	38	,	,	PUNCT
ajlm-1555	47	39	p	p	NOUN
ajlm-1555	47	40	=	=	NOUN
ajlm-1555	47	41	prevalence	prevalence	NOUN
ajlm-1555	47	42	,	,	PUNCT
ajlm-1555	47	43	q	q	NOUN
ajlm-1555	47	44	=	=	NOUN
ajlm-1555	47	45	1	1	NUM
ajlm-1555	47	46	–	–	PUNCT
ajlm-1555	47	47	p	p	X
ajlm-1555	47	48	,	,	PUNCT
ajlm-1555	47	49	and	and	CCONJ
ajlm-1555	47	50	d	d	NOUN
ajlm-1555	47	51	=	=	NOUN
ajlm-1555	47	52	0.05	0.05	NUM
ajlm-1555	47	53	)	)	PUNCT
ajlm-1555	47	54	.	.	PUNCT
ajlm-1555	48	1	study	study	NOUN
ajlm-1555	48	2	population	population	NOUN
ajlm-1555	48	3	a	a	DET
ajlm-1555	48	4	total	total	NOUN
ajlm-1555	48	5	of	of	ADP
ajlm-1555	48	6	231	231	NUM
ajlm-1555	48	7	individuals	individual	NOUN
ajlm-1555	48	8	who	who	PRON
ajlm-1555	48	9	consented	consent	VERB
ajlm-1555	48	10	and	and	CCONJ
ajlm-1555	48	11	were	be	AUX
ajlm-1555	48	12	aged	age	VERB
ajlm-1555	48	13	18	18	NUM
ajlm-1555	48	14	years	year	NOUN
ajlm-1555	48	15	or	or	CCONJ
ajlm-1555	48	16	older	old	ADJ
ajlm-1555	48	17	were	be	AUX
ajlm-1555	48	18	recruited	recruit	VERB
ajlm-1555	48	19	for	for	ADP
ajlm-1555	48	20	the	the	DET
ajlm-1555	48	21	study	study	NOUN
ajlm-1555	48	22	.	.	PUNCT
ajlm-1555	49	1	the	the	DET
ajlm-1555	49	2	participants	participant	NOUN
ajlm-1555	49	3	were	be	AUX
ajlm-1555	49	4	first	first	ADJ
ajlm-1555	49	5	-	-	PUNCT
ajlm-1555	49	6	time	time	NOUN
ajlm-1555	49	7	attendees	attendee	NOUN
ajlm-1555	49	8	of	of	ADP
ajlm-1555	49	9	dental	dental	ADJ
ajlm-1555	49	10	clinics	clinic	NOUN
ajlm-1555	49	11	(	(	PUNCT
ajlm-1555	49	12	one	one	NUM
ajlm-1555	49	13	public	public	NOUN
ajlm-1555	49	14	and	and	CCONJ
ajlm-1555	49	15	two	two	NUM
ajlm-1555	49	16	private	private	ADJ
ajlm-1555	49	17	)	)	PUNCT
ajlm-1555	49	18	in	in	ADP
ajlm-1555	49	19	ibadan	ibadan	PROPN
ajlm-1555	49	20	,	,	PUNCT
ajlm-1555	49	21	oyo	oyo	NOUN
ajlm-1555	49	22	state	state	NOUN
ajlm-1555	49	23	,	,	PUNCT
ajlm-1555	49	24	nigeria	nigeria	PROPN
ajlm-1555	49	25	,	,	PUNCT
ajlm-1555	49	26	presenting	present	VERB
ajlm-1555	49	27	with	with	ADP
ajlm-1555	49	28	various	various	ADJ
ajlm-1555	49	29	dental	dental	ADJ
ajlm-1555	49	30	complaints	complaint	NOUN
ajlm-1555	49	31	.	.	PUNCT
ajlm-1555	50	1	a	a	DET
ajlm-1555	50	2	convenient	convenient	ADJ
ajlm-1555	50	3	sampling	sampling	NOUN
ajlm-1555	50	4	method	method	NOUN
ajlm-1555	50	5	was	be	AUX
ajlm-1555	50	6	used.14	used.14	NUM
ajlm-1555	50	7	individuals	individual	NOUN
ajlm-1555	50	8	were	be	AUX
ajlm-1555	50	9	excluded	exclude	VERB
ajlm-1555	50	10	if	if	SCONJ
ajlm-1555	50	11	they	they	PRON
ajlm-1555	50	12	were	be	AUX
ajlm-1555	50	13	unable	unable	ADJ
ajlm-1555	50	14	or	or	CCONJ
ajlm-1555	50	15	unwilling	unwilling	ADJ
ajlm-1555	50	16	to	to	PART
ajlm-1555	50	17	provide	provide	VERB
ajlm-1555	50	18	consent	consent	NOUN
ajlm-1555	50	19	or	or	CCONJ
ajlm-1555	50	20	were	be	AUX
ajlm-1555	50	21	in	in	ADP
ajlm-1555	50	22	severe	severe	ADJ
ajlm-1555	50	23	pain	pain	NOUN
ajlm-1555	50	24	or	or	CCONJ
ajlm-1555	50	25	with	with	ADP
ajlm-1555	50	26	symptoms	symptom	NOUN
ajlm-1555	50	27	of	of	ADP
ajlm-1555	50	28	oropharyngeal	oropharyngeal	ADJ
ajlm-1555	50	29	cancer	cancer	NOUN
ajlm-1555	50	30	.	.	PUNCT
ajlm-1555	51	1	sample	sample	NOUN
ajlm-1555	51	2	collection	collection	NOUN
ajlm-1555	51	3	and	and	CCONJ
ajlm-1555	51	4	processing	processing	NOUN
ajlm-1555	51	5	socio	socio	NOUN
ajlm-1555	51	6	-	-	PUNCT
ajlm-1555	51	7	demographic	demographic	ADJ
ajlm-1555	51	8	and	and	CCONJ
ajlm-1555	51	9	risk	risk	NOUN
ajlm-1555	51	10	behaviour	behaviour	NOUN
ajlm-1555	51	11	information	information	NOUN
ajlm-1555	51	12	(	(	PUNCT
ajlm-1555	51	13	presence	presence	NOUN
ajlm-1555	51	14	of	of	ADP
ajlm-1555	51	15	oral	oral	ADJ
ajlm-1555	51	16	warts	wart	NOUN
ajlm-1555	51	17	,	,	PUNCT
ajlm-1555	51	18	smoking	smoking	NOUN
ajlm-1555	51	19	,	,	PUNCT
ajlm-1555	51	20	number	number	NOUN
ajlm-1555	51	21	of	of	ADP
ajlm-1555	51	22	sexual	sexual	ADJ
ajlm-1555	51	23	partners	partner	NOUN
ajlm-1555	51	24	,	,	PUNCT
ajlm-1555	51	25	previous	previous	ADJ
ajlm-1555	51	26	oral	oral	ADJ
ajlm-1555	51	27	infection	infection	NOUN
ajlm-1555	51	28	,	,	PUNCT
ajlm-1555	51	29	and	and	CCONJ
ajlm-1555	51	30	engaging	engage	VERB
ajlm-1555	51	31	in	in	ADP
ajlm-1555	51	32	oral	oral	ADJ
ajlm-1555	51	33	sex	sex	NOUN
ajlm-1555	51	34	)	)	PUNCT
ajlm-1555	51	35	was	be	AUX
ajlm-1555	51	36	collected	collect	VERB
ajlm-1555	51	37	from	from	ADP
ajlm-1555	51	38	each	each	DET
ajlm-1555	51	39	participant	participant	NOUN
ajlm-1555	51	40	using	use	VERB
ajlm-1555	51	41	a	a	DET
ajlm-1555	51	42	semi	semi	ADJ
ajlm-1555	51	43	-	-	ADJ
ajlm-1555	51	44	structured	structured	ADJ
ajlm-1555	51	45	questionnaire	questionnaire	NOUN
ajlm-1555	51	46	.	.	PUNCT
ajlm-1555	52	1	a	a	DET
ajlm-1555	52	2	dental	dental	ADJ
ajlm-1555	52	3	technician	technician	NOUN
ajlm-1555	52	4	trained	train	VERB
ajlm-1555	52	5	in	in	ADP
ajlm-1555	52	6	collecting	collect	VERB
ajlm-1555	52	7	oral	oral	ADJ
ajlm-1555	52	8	swabs	swab	NOUN
ajlm-1555	52	9	for	for	ADP
ajlm-1555	52	10	hpv	hpv	NOUN
ajlm-1555	52	11	testing	testing	NOUN
ajlm-1555	52	12	collected	collect	VERB
ajlm-1555	52	13	oral	oral	ADJ
ajlm-1555	52	14	swab	swab	NOUN
ajlm-1555	52	15	samples	sample	NOUN
ajlm-1555	52	16	from	from	ADP
ajlm-1555	52	17	all	all	DET
ajlm-1555	52	18	participants	participant	NOUN
ajlm-1555	52	19	.	.	PUNCT
ajlm-1555	53	1	briefly	briefly	ADV
ajlm-1555	53	2	,	,	PUNCT
ajlm-1555	53	3	the	the	DET
ajlm-1555	53	4	tip	tip	NOUN
ajlm-1555	53	5	of	of	ADP
ajlm-1555	53	6	the	the	DET
ajlm-1555	53	7	swab	swab	PROPN
ajlm-1555	53	8	stick	stick	PROPN
ajlm-1555	53	9	was	be	AUX
ajlm-1555	53	10	rubbed	rub	VERB
ajlm-1555	53	11	several	several	ADJ
ajlm-1555	53	12	times	time	NOUN
ajlm-1555	53	13	in	in	ADP
ajlm-1555	53	14	the	the	DET
ajlm-1555	53	15	mouth	mouth	NOUN
ajlm-1555	53	16	and	and	CCONJ
ajlm-1555	53	17	base	base	NOUN
ajlm-1555	53	18	of	of	ADP
ajlm-1555	53	19	the	the	DET
ajlm-1555	53	20	tongue	tongue	NOUN
ajlm-1555	53	21	.	.	PUNCT
ajlm-1555	54	1	the	the	DET
ajlm-1555	54	2	swab	swab	NOUN
ajlm-1555	54	3	sticks	stick	NOUN
ajlm-1555	54	4	were	be	AUX
ajlm-1555	54	5	then	then	ADV
ajlm-1555	54	6	placed	place	VERB
ajlm-1555	54	7	in	in	ADP
ajlm-1555	54	8	vials	vial	NOUN
ajlm-1555	54	9	containing	contain	VERB
ajlm-1555	54	10	500	500	NUM
ajlm-1555	54	11	µl	µl	NOUN
ajlm-1555	54	12	of	of	ADP
ajlm-1555	54	13	transport	transport	NOUN
ajlm-1555	54	14	medium	medium	NOUN
ajlm-1555	54	15	containing	contain	VERB
ajlm-1555	54	16	minimum	minimum	ADJ
ajlm-1555	54	17	essential	essential	ADJ
ajlm-1555	54	18	medium	medium	NOUN
ajlm-1555	54	19	and	and	CCONJ
ajlm-1555	54	20	2	2	NUM
ajlm-1555	54	21	%	%	NOUN
ajlm-1555	54	22	bovine	bovine	NOUN
ajlm-1555	54	23	serum	serum	NOUN
ajlm-1555	54	24	albumin	albumin	NOUN
ajlm-1555	54	25	with	with	ADP
ajlm-1555	54	26	antibiotics	antibiotic	NOUN
ajlm-1555	54	27	(	(	PUNCT
ajlm-1555	54	28	gentamicin	gentamicin	X
ajlm-1555	54	29	)	)	PUNCT
ajlm-1555	54	30	in	in	ADP
ajlm-1555	54	31	a	a	DET
ajlm-1555	54	32	secured	secure	VERB
ajlm-1555	54	33	capped	cap	VERB
ajlm-1555	54	34	vial	vial	NOUN
ajlm-1555	54	35	.	.	PUNCT
ajlm-1555	55	1	samples	sample	NOUN
ajlm-1555	55	2	were	be	AUX
ajlm-1555	55	3	stored	store	VERB
ajlm-1555	55	4	and	and	CCONJ
ajlm-1555	55	5	transported	transport	VERB
ajlm-1555	55	6	at	at	ADP
ajlm-1555	55	7	4	4	NUM
ajlm-1555	55	8	°	°	NOUN
ajlm-1555	55	9	c	c	NOUN
ajlm-1555	55	10	to	to	ADP
ajlm-1555	55	11	the	the	DET
ajlm-1555	55	12	laboratory	laboratory	NOUN
ajlm-1555	55	13	.	.	PUNCT
ajlm-1555	56	1	initial	initial	ADJ
ajlm-1555	56	2	processing	processing	NOUN
ajlm-1555	56	3	in	in	ADP
ajlm-1555	56	4	the	the	DET
ajlm-1555	56	5	laboratory	laboratory	NOUN
ajlm-1555	56	6	was	be	AUX
ajlm-1555	56	7	done	do	VERB
ajlm-1555	56	8	within	within	ADP
ajlm-1555	56	9	24	24	NUM
ajlm-1555	56	10	h	h	NOUN
ajlm-1555	56	11	of	of	ADP
ajlm-1555	56	12	sample	sample	NOUN
ajlm-1555	56	13	collection	collection	NOUN
ajlm-1555	56	14	,	,	PUNCT
ajlm-1555	56	15	and	and	CCONJ
ajlm-1555	56	16	included	include	VERB
ajlm-1555	56	17	vortexing	vortexe	VERB
ajlm-1555	56	18	each	each	DET
ajlm-1555	56	19	vial	vial	ADJ
ajlm-1555	56	20	containing	contain	VERB
ajlm-1555	56	21	transport	transport	NOUN
ajlm-1555	56	22	medium	medium	NOUN
ajlm-1555	56	23	,	,	PUNCT
ajlm-1555	56	24	removing	remove	VERB
ajlm-1555	56	25	the	the	DET
ajlm-1555	56	26	swab	swab	NOUN
ajlm-1555	56	27	;	;	PUNCT
ajlm-1555	56	28	the	the	DET
ajlm-1555	56	29	medium	medium	NOUN
ajlm-1555	56	30	was	be	AUX
ajlm-1555	56	31	aliquoted	aliquote	VERB
ajlm-1555	56	32	and	and	CCONJ
ajlm-1555	56	33	stored	store	VERB
ajlm-1555	56	34	at	at	ADP
ajlm-1555	56	35	–	–	PUNCT
ajlm-1555	56	36	80	80	NUM
ajlm-1555	56	37	°	°	NUM
ajlm-1555	56	38	c	c	NOUN
ajlm-1555	56	39	until	until	SCONJ
ajlm-1555	56	40	analysed	analyse	VERB
ajlm-1555	56	41	for	for	ADP
ajlm-1555	56	42	hpv	hpv	PROPN
ajlm-1555	56	43	dna	dna	PROPN
ajlm-1555	56	44	by	by	ADP
ajlm-1555	56	45	polymerase	polymerase	NOUN
ajlm-1555	56	46	chain	chain	NOUN
ajlm-1555	56	47	reaction	reaction	NOUN
ajlm-1555	56	48	(	(	PUNCT
ajlm-1555	56	49	pcr	pcr	PROPN
ajlm-1555	56	50	)	)	PUNCT
ajlm-1555	56	51	.	.	PUNCT
ajlm-1555	57	1	laboratory	laboratory	NOUN
ajlm-1555	57	2	analysis	analysis	NOUN
ajlm-1555	57	3	total	total	ADJ
ajlm-1555	57	4	dna	dna	PROPN
ajlm-1555	57	5	was	be	AUX
ajlm-1555	57	6	extracted	extract	VERB
ajlm-1555	57	7	from	from	ADP
ajlm-1555	57	8	each	each	DET
ajlm-1555	57	9	sample	sample	NOUN
ajlm-1555	57	10	using	use	VERB
ajlm-1555	57	11	a	a	DET
ajlm-1555	57	12	commercially	commercially	ADV
ajlm-1555	57	13	available	available	ADJ
ajlm-1555	57	14	dna	dna	PROPN
ajlm-1555	57	15	purification	purification	NOUN
ajlm-1555	57	16	kit	kit	NOUN
ajlm-1555	57	17	(	(	PUNCT
ajlm-1555	57	18	jena	jena	PROPN
ajlm-1555	57	19	bioscience	bioscience	PROPN
ajlm-1555	57	20	,	,	PUNCT
ajlm-1555	57	21	jena	jena	PROPN
ajlm-1555	57	22	,	,	PUNCT
ajlm-1555	57	23	germany	germany	PROPN
ajlm-1555	57	24	)	)	PUNCT
ajlm-1555	57	25	per	per	ADP
ajlm-1555	57	26	the	the	DET
ajlm-1555	57	27	manufacturer	manufacturer	NOUN
ajlm-1555	57	28	’s	’s	PART
ajlm-1555	57	29	instruction	instruction	NOUN
ajlm-1555	57	30	.	.	PUNCT
ajlm-1555	58	1	the	the	DET
ajlm-1555	58	2	extracted	extract	VERB
ajlm-1555	58	3	dna	dna	NOUN
ajlm-1555	58	4	was	be	AUX
ajlm-1555	58	5	tested	test	VERB
ajlm-1555	58	6	for	for	ADP
ajlm-1555	58	7	the	the	DET
ajlm-1555	58	8	presence	presence	NOUN
ajlm-1555	58	9	of	of	ADP
ajlm-1555	58	10	the	the	DET
ajlm-1555	58	11	e6	e6	PROPN
ajlm-1555	58	12	/	/	SYM
ajlm-1555	58	13	e7	e7	PROPN
ajlm-1555	58	14	hpv	hpv	ADJ
ajlm-1555	58	15	viral	viral	ADJ
ajlm-1555	58	16	gene	gene	NOUN
ajlm-1555	58	17	by	by	ADP
ajlm-1555	58	18	pcr	pcr	NOUN
ajlm-1555	58	19	using	use	VERB
ajlm-1555	58	20	previously	previously	ADV
ajlm-1555	58	21	described	describe	VERB
ajlm-1555	58	22	primers	primer	NOUN
ajlm-1555	58	23	(	(	PUNCT
ajlm-1555	58	24	gp	gp	NOUN
ajlm-1555	58	25	e6	e6	PROPN
ajlm-1555	58	26	-	-	PUNCT
ajlm-1555	58	27	3f	3f	PROPN
ajlm-1555	58	28	,	,	PUNCT
ajlm-1555	58	29	gp	gp	NOUN
ajlm-1555	58	30	-	-	PUNCT
ajlm-1555	58	31	e6	e6	NOUN
ajlm-1555	58	32	-	-	PUNCT
ajlm-1555	58	33	5b	5b	NOUN
ajlm-1555	58	34	and	and	CCONJ
ajlm-1555	58	35	gp	gp	NOUN
ajlm-1555	58	36	-	-	PUNCT
ajlm-1555	58	37	e6	e6	NOUN
ajlm-1555	58	38	-	-	PUNCT
ajlm-1555	58	39	6b	6b	NOUN
ajlm-1555	58	40	)	)	PUNCT
ajlm-1555	58	41	and	and	CCONJ
ajlm-1555	58	42	protocol.15	protocol.15	NOUN
ajlm-1555	58	43	amplification	amplification	NOUN
ajlm-1555	58	44	was	be	AUX
ajlm-1555	58	45	achieved	achieve	VERB
ajlm-1555	58	46	using	use	VERB
ajlm-1555	58	47	a	a	DET
ajlm-1555	58	48	abi	abi	PROPN
ajlm-1555	58	49	9700	9700	NUM
ajlm-1555	58	50	geneamp	geneamp	PROPN
ajlm-1555	58	51	thermal	thermal	ADJ
ajlm-1555	58	52	cycler	cycler	NOUN
ajlm-1555	58	53	(	(	PUNCT
ajlm-1555	58	54	applied	apply	VERB
ajlm-1555	58	55	biosystems	biosystems	PROPN
ajlm-1555	58	56	®	®	PROPN
ajlm-1555	58	57	,	,	PUNCT
ajlm-1555	58	58	waltham	waltham	PROPN
ajlm-1555	58	59	,	,	PUNCT
ajlm-1555	58	60	massachusetts	massachusetts	PROPN
ajlm-1555	58	61	,	,	PUNCT
ajlm-1555	58	62	united	united	PROPN
ajlm-1555	58	63	states	states	PROPN
ajlm-1555	58	64	)	)	PUNCT
ajlm-1555	58	65	using	use	VERB
ajlm-1555	58	66	the	the	DET
ajlm-1555	58	67	following	follow	VERB
ajlm-1555	58	68	cycling	cycling	NOUN
ajlm-1555	58	69	condition	condition	NOUN
ajlm-1555	58	70	:	:	PUNCT
ajlm-1555	58	71	5	5	NUM
ajlm-1555	58	72	min	min	NOUN
ajlm-1555	58	73	at	at	ADP
ajlm-1555	58	74	95	95	NUM
ajlm-1555	58	75	°	°	ADP
ajlm-1555	58	76	c	c	NOUN
ajlm-1555	58	77	for	for	ADP
ajlm-1555	58	78	dna	dna	PROPN
ajlm-1555	58	79	denaturation	denaturation	NOUN
ajlm-1555	58	80	followed	follow	VERB
ajlm-1555	58	81	by	by	ADP
ajlm-1555	58	82	65	65	NUM
ajlm-1555	58	83	cycles	cycle	NOUN
ajlm-1555	58	84	of	of	ADP
ajlm-1555	58	85	30	30	NUM
ajlm-1555	58	86	s	s	NOUN
ajlm-1555	58	87	of	of	ADP
ajlm-1555	58	88	denaturation	denaturation	NOUN
ajlm-1555	58	89	at	at	ADP
ajlm-1555	58	90	95	95	NUM
ajlm-1555	58	91	°	°	NOUN
ajlm-1555	58	92	c	c	NOUN
ajlm-1555	58	93	,	,	PUNCT
ajlm-1555	58	94	30	30	NUM
ajlm-1555	58	95	s	s	NOUN
ajlm-1555	58	96	of	of	ADP
ajlm-1555	58	97	annealing	anneal	VERB
ajlm-1555	58	98	at	at	ADP
ajlm-1555	58	99	45	45	NUM
ajlm-1555	58	100	°	°	NOUN
ajlm-1555	58	101	c	c	NOUN
ajlm-1555	58	102	,	,	PUNCT
ajlm-1555	58	103	30	30	NUM
ajlm-1555	58	104	s	s	NOUN
ajlm-1555	58	105	of	of	ADP
ajlm-1555	58	106	elongation	elongation	NOUN
ajlm-1555	58	107	at	at	ADP
ajlm-1555	58	108	68	68	NUM
ajlm-1555	58	109	°	°	NOUN
ajlm-1555	58	110	c	c	NOUN
ajlm-1555	58	111	and	and	CCONJ
ajlm-1555	58	112	a	a	DET
ajlm-1555	58	113	final	final	ADJ
ajlm-1555	58	114	elongation	elongation	NOUN
ajlm-1555	58	115	of	of	ADP
ajlm-1555	58	116	5	5	NUM
ajlm-1555	58	117	min	min	NOUN
ajlm-1555	58	118	at	at	ADP
ajlm-1555	58	119	72	72	NUM
ajlm-1555	58	120	°	°	NOUN
ajlm-1555	58	121	c	c	NOUN
ajlm-1555	58	122	.	.	PUNCT
ajlm-1555	59	1	the	the	DET
ajlm-1555	59	2	amplified	amplify	VERB
ajlm-1555	59	3	products	product	NOUN
ajlm-1555	59	4	(	(	PUNCT
ajlm-1555	59	5	602	602	NUM
ajlm-1555	59	6	base	base	NOUN
ajlm-1555	59	7	pairs	pair	NOUN
ajlm-1555	59	8	–	–	PUNCT
ajlm-1555	59	9	666	666	NUM
ajlm-1555	59	10	base	base	NOUN
ajlm-1555	59	11	pairs	pair	NOUN
ajlm-1555	59	12	)	)	PUNCT
ajlm-1555	59	13	were	be	AUX
ajlm-1555	59	14	detected	detect	VERB
ajlm-1555	59	15	using	use	VERB
ajlm-1555	59	16	agarose	agarose	NOUN
ajlm-1555	59	17	gel	gel	NOUN
ajlm-1555	59	18	electrophoresis	electrophoresis	NOUN
ajlm-1555	59	19	.	.	PUNCT
ajlm-1555	60	1	human	human	ADJ
ajlm-1555	60	2	papilloma	papilloma	NOUN
ajlm-1555	60	3	viruses	virus	NOUN
ajlm-1555	60	4	isolates	isolate	NOUN
ajlm-1555	60	5	were	be	AUX
ajlm-1555	60	6	typed	type	VERB
ajlm-1555	60	7	using	use	VERB
ajlm-1555	60	8	genotype	genotype	NOUN
ajlm-1555	60	9	specific	specific	ADJ
ajlm-1555	60	10	primers	primer	NOUN
ajlm-1555	60	11	targeting	target	VERB
ajlm-1555	60	12	the	the	DET
ajlm-1555	60	13	e6	e6	PROPN
ajlm-1555	60	14	/	/	SYM
ajlm-1555	60	15	e7	e7	PROPN
ajlm-1555	60	16	hpv	hpv	PROPN
ajlm-1555	60	17	virus	virus	NOUN
ajlm-1555	60	18	gene	gene	NOUN
ajlm-1555	60	19	as	as	ADP
ajlm-1555	60	20	previously	previously	ADV
ajlm-1555	60	21	described15	described15	X
ajlm-1555	60	22	(	(	PUNCT
ajlm-1555	60	23	table	table	NOUN
ajlm-1555	60	24	1	1	NUM
ajlm-1555	60	25	)	)	PUNCT
ajlm-1555	60	26	.	.	PUNCT
ajlm-1555	61	1	the	the	DET
ajlm-1555	61	2	primers	primer	NOUN
ajlm-1555	61	3	used	use	VERB
ajlm-1555	61	4	could	could	AUX
ajlm-1555	61	5	not	not	PART
ajlm-1555	61	6	differentiate	differentiate	VERB
ajlm-1555	61	7	between	between	ADP
ajlm-1555	61	8	genotypes	genotype	NOUN
ajlm-1555	61	9	6	6	NUM
ajlm-1555	61	10	and	and	CCONJ
ajlm-1555	61	11	11	11	NUM
ajlm-1555	61	12	,	,	PUNCT
ajlm-1555	61	13	thus	thus	ADV
ajlm-1555	61	14	,	,	PUNCT
ajlm-1555	61	15	it	it	PRON
ajlm-1555	61	16	is	be	AUX
ajlm-1555	61	17	referred	refer	VERB
ajlm-1555	61	18	to	to	ADP
ajlm-1555	61	19	as	as	ADP
ajlm-1555	61	20	genotype	genotype	NOUN
ajlm-1555	61	21	6/11	6/11	NUM
ajlm-1555	61	22	.	.	PUNCT
ajlm-1555	62	1	table	table	NOUN
ajlm-1555	62	2	1	1	NUM
ajlm-1555	62	3	:	:	PUNCT
ajlm-1555	62	4	 	 	SPACE
ajlm-1555	62	5	list	list	NOUN
ajlm-1555	62	6	of	of	ADP
ajlm-1555	62	7	primres	primre	NOUN
ajlm-1555	62	8	used	use	VERB
ajlm-1555	62	9	and	and	CCONJ
ajlm-1555	62	10	the	the	DET
ajlm-1555	62	11	amplicon	amplicon	NOUN
ajlm-1555	62	12	size	size	NOUN
ajlm-1555	62	13	.	.	PUNCT
ajlm-1555	63	1	data	datum	NOUN
ajlm-1555	63	2	analysis	analysis	NOUN
ajlm-1555	63	3	the	the	DET
ajlm-1555	63	4	data	data	NOUN
ajlm-1555	63	5	anlalysis	anlalysis	NOUN
ajlm-1555	63	6	was	be	AUX
ajlm-1555	63	7	done	do	VERB
ajlm-1555	63	8	using	use	VERB
ajlm-1555	63	9	statistical	statistical	ADJ
ajlm-1555	63	10	package	package	NOUN
ajlm-1555	63	11	for	for	ADP
ajlm-1555	63	12	social	social	ADJ
ajlm-1555	63	13	sciences	science	NOUN
ajlm-1555	63	14	(	(	PUNCT
ajlm-1555	63	15	spss	spss	PROPN
ajlm-1555	63	16	)	)	PUNCT
ajlm-1555	63	17	version	version	NOUN
ajlm-1555	63	18	18.2	18.2	NUM
ajlm-1555	63	19	(	(	PUNCT
ajlm-1555	63	20	ibm	ibm	PROPN
ajlm-1555	63	21	corp	corp	PROPN
ajlm-1555	63	22	.	.	PROPN
ajlm-1555	63	23	armonk	armonk	PROPN
ajlm-1555	63	24	,	,	PUNCT
ajlm-1555	63	25	new	new	PROPN
ajlm-1555	63	26	york	york	PROPN
ajlm-1555	63	27	,	,	PUNCT
ajlm-1555	63	28	united	united	PROPN
ajlm-1555	63	29	states	states	PROPN
ajlm-1555	63	30	)	)	PUNCT
ajlm-1555	63	31	.	.	PUNCT
ajlm-1555	64	1	all	all	DET
ajlm-1555	64	2	the	the	DET
ajlm-1555	64	3	data	datum	NOUN
ajlm-1555	64	4	generated	generate	VERB
ajlm-1555	64	5	were	be	AUX
ajlm-1555	64	6	analysed	analyse	VERB
ajlm-1555	64	7	using	use	VERB
ajlm-1555	64	8	descriptive	descriptive	ADJ
ajlm-1555	64	9	statistics	statistic	NOUN
ajlm-1555	64	10	such	such	ADJ
ajlm-1555	64	11	as	as	ADP
ajlm-1555	64	12	mean	mean	ADJ
ajlm-1555	64	13	and	and	CCONJ
ajlm-1555	64	14	standard	standard	ADJ
ajlm-1555	64	15	deviation	deviation	NOUN
ajlm-1555	64	16	and	and	CCONJ
ajlm-1555	64	17	results	result	NOUN
ajlm-1555	64	18	were	be	AUX
ajlm-1555	64	19	analysed	analyse	VERB
ajlm-1555	64	20	using	use	VERB
ajlm-1555	64	21	chi	chi	NOUN
ajlm-1555	64	22	-	-	PUNCT
ajlm-1555	64	23	square	square	NOUN
ajlm-1555	64	24	at	at	ADP
ajlm-1555	64	25	α	α	NOUN
ajlm-1555	64	26	=	=	NOUN
ajlm-1555	64	27	0.05	0.05	NUM
ajlm-1555	64	28	.	.	PUNCT
ajlm-1555	65	1	results	result	VERB
ajlm-1555	65	2	characteristics	characteristic	NOUN
ajlm-1555	65	3	of	of	ADP
ajlm-1555	65	4	the	the	DET
ajlm-1555	65	5	study	study	NOUN
ajlm-1555	65	6	population	population	NOUN
ajlm-1555	65	7	a	a	DET
ajlm-1555	65	8	total	total	NOUN
ajlm-1555	65	9	of	of	ADP
ajlm-1555	65	10	231	231	NUM
ajlm-1555	65	11	study	study	NOUN
ajlm-1555	65	12	participants	participant	NOUN
ajlm-1555	65	13	were	be	AUX
ajlm-1555	65	14	recruited	recruit	VERB
ajlm-1555	65	15	for	for	ADP
ajlm-1555	65	16	this	this	DET
ajlm-1555	65	17	study	study	NOUN
ajlm-1555	65	18	,	,	PUNCT
ajlm-1555	65	19	out	out	ADP
ajlm-1555	65	20	of	of	ADP
ajlm-1555	65	21	which	which	PRON
ajlm-1555	65	22	129	129	NUM
ajlm-1555	65	23	(	(	PUNCT
ajlm-1555	65	24	55.9	55.9	NUM
ajlm-1555	65	25	%	%	NOUN
ajlm-1555	65	26	)	)	PUNCT
ajlm-1555	65	27	were	be	AUX
ajlm-1555	65	28	female	female	ADJ
ajlm-1555	65	29	.	.	PUNCT
ajlm-1555	66	1	their	their	PRON
ajlm-1555	66	2	mean	mean	ADJ
ajlm-1555	66	3	age	age	NOUN
ajlm-1555	66	4	was	be	AUX
ajlm-1555	66	5	42.59	42.59	NUM
ajlm-1555	66	6	(	(	PUNCT
ajlm-1555	66	7	range	range	NOUN
ajlm-1555	66	8	:	:	PUNCT
ajlm-1555	66	9	18–62	18–62	NUM
ajlm-1555	66	10	years	year	NOUN
ajlm-1555	66	11	)	)	PUNCT
ajlm-1555	66	12	(	(	PUNCT
ajlm-1555	66	13	table	table	NOUN
ajlm-1555	66	14	2	2	NUM
ajlm-1555	66	15	)	)	PUNCT
ajlm-1555	66	16	.	.	PUNCT
ajlm-1555	67	1	all	all	DET
ajlm-1555	67	2	the	the	DET
ajlm-1555	67	3	participants	participant	NOUN
ajlm-1555	67	4	reported	report	VERB
ajlm-1555	67	5	having	have	VERB
ajlm-1555	67	6	sexual	sexual	ADJ
ajlm-1555	67	7	experience	experience	NOUN
ajlm-1555	67	8	,	,	PUNCT
ajlm-1555	67	9	while	while	SCONJ
ajlm-1555	67	10	46	46	NUM
ajlm-1555	67	11	(	(	PUNCT
ajlm-1555	67	12	20.0	20.0	NUM
ajlm-1555	67	13	%	%	NOUN
ajlm-1555	67	14	)	)	PUNCT
ajlm-1555	67	15	had	have	AUX
ajlm-1555	67	16	engaged	engage	VERB
ajlm-1555	67	17	in	in	ADP
ajlm-1555	67	18	oral	oral	ADJ
ajlm-1555	67	19	sex	sex	NOUN
ajlm-1555	67	20	.	.	PUNCT
ajlm-1555	68	1	thirty	thirty	NUM
ajlm-1555	68	2	-	-	PUNCT
ajlm-1555	68	3	six	six	NUM
ajlm-1555	68	4	(	(	PUNCT
ajlm-1555	68	5	15.6	15.6	NUM
ajlm-1555	68	6	%	%	NOUN
ajlm-1555	68	7	)	)	PUNCT
ajlm-1555	68	8	of	of	ADP
ajlm-1555	68	9	the	the	DET
ajlm-1555	68	10	participants	participant	NOUN
ajlm-1555	68	11	had	have	VERB
ajlm-1555	68	12	warts	wart	NOUN
ajlm-1555	68	13	,	,	PUNCT
ajlm-1555	68	14	either	either	CCONJ
ajlm-1555	68	15	oral	oral	ADJ
ajlm-1555	68	16	or	or	CCONJ
ajlm-1555	68	17	genital	genital	ADJ
ajlm-1555	68	18	,	,	PUNCT
ajlm-1555	68	19	while	while	SCONJ
ajlm-1555	68	20	24	24	NUM
ajlm-1555	68	21	(	(	PUNCT
ajlm-1555	68	22	10.4	10.4	NUM
ajlm-1555	68	23	%	%	NOUN
ajlm-1555	68	24	)	)	PUNCT
ajlm-1555	68	25	were	be	AUX
ajlm-1555	68	26	smokers	smoker	NOUN
ajlm-1555	68	27	.	.	PUNCT
ajlm-1555	69	1	fifty	fifty	NUM
ajlm-1555	69	2	-	-	PUNCT
ajlm-1555	69	3	four	four	NUM
ajlm-1555	69	4	(	(	PUNCT
ajlm-1555	69	5	23.4	23.4	NUM
ajlm-1555	69	6	%	%	NOUN
ajlm-1555	69	7	)	)	PUNCT
ajlm-1555	69	8	of	of	ADP
ajlm-1555	69	9	the	the	DET
ajlm-1555	69	10	participants	participant	NOUN
ajlm-1555	69	11	had	have	VERB
ajlm-1555	69	12	more	more	ADJ
ajlm-1555	69	13	than	than	ADP
ajlm-1555	69	14	one	one	NUM
ajlm-1555	69	15	sexual	sexual	ADJ
ajlm-1555	69	16	partner	partner	NOUN
ajlm-1555	69	17	,	,	PUNCT
ajlm-1555	69	18	and	and	CCONJ
ajlm-1555	69	19	none	none	NOUN
ajlm-1555	69	20	had	have	AUX
ajlm-1555	69	21	received	receive	VERB
ajlm-1555	69	22	any	any	DET
ajlm-1555	69	23	hpv	hpv	ADJ
ajlm-1555	69	24	vaccination	vaccination	NOUN
ajlm-1555	69	25	.	.	PUNCT
ajlm-1555	70	1	table	table	NOUN
ajlm-1555	70	2	2	2	NUM
ajlm-1555	70	3	:	:	PUNCT
ajlm-1555	70	4	 	 	SPACE
ajlm-1555	70	5	age	age	NOUN
ajlm-1555	70	6	distribution	distribution	NOUN
ajlm-1555	70	7	of	of	ADP
ajlm-1555	70	8	dental	dental	ADJ
ajlm-1555	70	9	clinic	clinic	NOUN
ajlm-1555	70	10	attendees	attendee	NOUN
ajlm-1555	70	11	in	in	ADP
ajlm-1555	70	12	ibadan	ibadan	PROPN
ajlm-1555	70	13	,	,	PUNCT
ajlm-1555	70	14	nigeria	nigeria	PROPN
ajlm-1555	70	15	,	,	PUNCT
ajlm-1555	70	16	january	january	PROPN
ajlm-1555	70	17	2016	2016	NUM
ajlm-1555	70	18	to	to	ADP
ajlm-1555	70	19	march	march	PROPN
ajlm-1555	70	20	2017	2017	NUM
ajlm-1555	70	21	.	.	PUNCT
ajlm-1555	71	1	human	human	ADJ
ajlm-1555	71	2	papilloma	papilloma	PROPN
ajlm-1555	71	3	virus	virus	NOUN
ajlm-1555	71	4	dna	dna	PROPN
ajlm-1555	71	5	prevalence	prevalence	NOUN
ajlm-1555	71	6	and	and	CCONJ
ajlm-1555	71	7	genotypes	genotype	NOUN
ajlm-1555	71	8	of	of	ADP
ajlm-1555	71	9	the	the	DET
ajlm-1555	71	10	231	231	NUM
ajlm-1555	71	11	oral	oral	ADJ
ajlm-1555	71	12	swabs	swab	NOUN
ajlm-1555	71	13	tested	test	VERB
ajlm-1555	71	14	,	,	PUNCT
ajlm-1555	71	15	23	23	NUM
ajlm-1555	71	16	(	(	PUNCT
ajlm-1555	71	17	9.9	9.9	NUM
ajlm-1555	71	18	%	%	NOUN
ajlm-1555	71	19	)	)	PUNCT
ajlm-1555	71	20	had	have	AUX
ajlm-1555	71	21	hpv	hpv	ADJ
ajlm-1555	71	22	dna	dna	NOUN
ajlm-1555	71	23	,	,	PUNCT
ajlm-1555	71	24	of	of	ADP
ajlm-1555	71	25	which	which	PRON
ajlm-1555	71	26	21	21	NUM
ajlm-1555	71	27	were	be	AUX
ajlm-1555	71	28	high	high	ADJ
ajlm-1555	71	29	-	-	PUNCT
ajlm-1555	71	30	risk	risk	NOUN
ajlm-1555	71	31	and	and	CCONJ
ajlm-1555	71	32	two	two	NUM
ajlm-1555	71	33	were	be	AUX
ajlm-1555	71	34	low	low	ADJ
ajlm-1555	71	35	-	-	PUNCT
ajlm-1555	71	36	risk	risk	NOUN
ajlm-1555	71	37	hpv	hpv	NOUN
ajlm-1555	71	38	.	.	PUNCT
ajlm-1555	72	1	of	of	ADP
ajlm-1555	72	2	the	the	DET
ajlm-1555	72	3	23	23	NUM
ajlm-1555	72	4	hpv	hpv	ADJ
ajlm-1555	72	5	dna	dna	ADJ
ajlm-1555	72	6	-	-	PUNCT
ajlm-1555	72	7	positive	positive	ADJ
ajlm-1555	72	8	participants	participant	NOUN
ajlm-1555	72	9	,	,	PUNCT
ajlm-1555	72	10	13	13	NUM
ajlm-1555	72	11	(	(	PUNCT
ajlm-1555	72	12	56.5	56.5	NUM
ajlm-1555	72	13	%	%	NOUN
ajlm-1555	72	14	)	)	PUNCT
ajlm-1555	72	15	were	be	AUX
ajlm-1555	72	16	male	male	ADJ
ajlm-1555	72	17	and	and	CCONJ
ajlm-1555	72	18	10	10	NUM
ajlm-1555	72	19	(	(	PUNCT
ajlm-1555	72	20	43.5	43.5	NUM
ajlm-1555	72	21	%	%	NOUN
ajlm-1555	72	22	)	)	PUNCT
ajlm-1555	73	1	were	be	AUX
ajlm-1555	73	2	female	female	ADJ
ajlm-1555	73	3	.	.	PUNCT
ajlm-1555	74	1	also	also	ADV
ajlm-1555	74	2	,	,	PUNCT
ajlm-1555	74	3	18	18	NUM
ajlm-1555	74	4	(	(	PUNCT
ajlm-1555	74	5	78.3	78.3	NUM
ajlm-1555	74	6	%	%	NOUN
ajlm-1555	74	7	)	)	PUNCT
ajlm-1555	74	8	of	of	ADP
ajlm-1555	74	9	the	the	DET
ajlm-1555	74	10	23	23	NUM
ajlm-1555	74	11	participants	participant	NOUN
ajlm-1555	74	12	with	with	ADP
ajlm-1555	74	13	hpv	hpv	NOUN
ajlm-1555	74	14	had	have	AUX
ajlm-1555	74	15	previously	previously	ADV
ajlm-1555	74	16	engaged	engage	VERB
ajlm-1555	74	17	in	in	ADP
ajlm-1555	74	18	oral	oral	ADJ
ajlm-1555	74	19	sex	sex	NOUN
ajlm-1555	74	20	.	.	PUNCT
ajlm-1555	75	1	participants	participant	NOUN
ajlm-1555	75	2	in	in	ADP
ajlm-1555	75	3	the	the	DET
ajlm-1555	75	4	age	age	NOUN
ajlm-1555	75	5	group	group	NOUN
ajlm-1555	75	6	21–40	21–40	NUM
ajlm-1555	75	7	years	year	NOUN
ajlm-1555	75	8	had	have	VERB
ajlm-1555	75	9	the	the	DET
ajlm-1555	75	10	highest	high	ADJ
ajlm-1555	75	11	rate	rate	NOUN
ajlm-1555	75	12	of	of	ADP
ajlm-1555	75	13	positivity	positivity	NOUN
ajlm-1555	75	14	(	(	PUNCT
ajlm-1555	75	15	14.5	14.5	NUM
ajlm-1555	75	16	%	%	NOUN
ajlm-1555	75	17	)	)	PUNCT
ajlm-1555	75	18	,	,	PUNCT
ajlm-1555	75	19	whereas	whereas	SCONJ
ajlm-1555	75	20	those	those	PRON
ajlm-1555	75	21	aged	aged	ADJ
ajlm-1555	75	22	60	60	NUM
ajlm-1555	75	23	years	year	NOUN
ajlm-1555	75	24	or	or	CCONJ
ajlm-1555	75	25	older	old	ADJ
ajlm-1555	75	26	had	have	VERB
ajlm-1555	75	27	the	the	DET
ajlm-1555	75	28	lowest	low	ADJ
ajlm-1555	75	29	rate	rate	NOUN
ajlm-1555	75	30	(	(	PUNCT
ajlm-1555	75	31	2.1	2.1	NUM
ajlm-1555	75	32	%	%	NOUN
ajlm-1555	75	33	)	)	PUNCT
ajlm-1555	76	1	(	(	PUNCT
ajlm-1555	76	2	p	p	X
ajlm-1555	76	3	=	=	NOUN
ajlm-1555	76	4	0.241	0.241	NUM
ajlm-1555	76	5	)	)	PUNCT
ajlm-1555	76	6	(	(	PUNCT
ajlm-1555	76	7	table	table	NOUN
ajlm-1555	76	8	3	3	NUM
ajlm-1555	76	9	)	)	PUNCT
ajlm-1555	76	10	.	.	PUNCT
ajlm-1555	77	1	table	table	NOUN
ajlm-1555	77	2	3	3	NUM
ajlm-1555	77	3	:	:	PUNCT
ajlm-1555	77	4	 	 	SPACE
ajlm-1555	77	5	distribution	distribution	NOUN
ajlm-1555	77	6	of	of	ADP
ajlm-1555	77	7	human	human	ADJ
ajlm-1555	77	8	papilloma	papilloma	NOUN
ajlm-1555	77	9	virus	virus	NOUN
ajlm-1555	77	10	infection	infection	NOUN
ajlm-1555	77	11	among	among	ADP
ajlm-1555	77	12	dental	dental	ADJ
ajlm-1555	77	13	clinic	clinic	NOUN
ajlm-1555	77	14	attendees	attendee	NOUN
ajlm-1555	77	15	in	in	ADP
ajlm-1555	77	16	ibadan	ibadan	PROPN
ajlm-1555	77	17	,	,	PUNCT
ajlm-1555	77	18	nigeria	nigeria	PROPN
ajlm-1555	77	19	,	,	PUNCT
ajlm-1555	77	20	january	january	PROPN
ajlm-1555	77	21	2016	2016	NUM
ajlm-1555	77	22	to	to	ADP
ajlm-1555	77	23	march	march	PROPN
ajlm-1555	77	24	2017	2017	NUM
ajlm-1555	77	25	.	.	PUNCT
ajlm-1555	78	1	of	of	ADP
ajlm-1555	78	2	the	the	DET
ajlm-1555	78	3	23	23	NUM
ajlm-1555	78	4	participants	participant	NOUN
ajlm-1555	78	5	with	with	ADP
ajlm-1555	78	6	hpv	hpv	ADJ
ajlm-1555	78	7	infection	infection	NOUN
ajlm-1555	78	8	,	,	PUNCT
ajlm-1555	78	9	16	16	NUM
ajlm-1555	78	10	had	have	VERB
ajlm-1555	78	11	mono	mono	PROPN
ajlm-1555	78	12	infections	infection	NOUN
ajlm-1555	78	13	while	while	SCONJ
ajlm-1555	78	14	seven	seven	NUM
ajlm-1555	78	15	had	have	VERB
ajlm-1555	78	16	co	co	NOUN
ajlm-1555	78	17	-	-	NOUN
ajlm-1555	78	18	infections	infection	NOUN
ajlm-1555	78	19	with	with	ADP
ajlm-1555	78	20	either	either	CCONJ
ajlm-1555	78	21	other	other	ADJ
ajlm-1555	78	22	high	high	ADJ
ajlm-1555	78	23	-	-	PUNCT
ajlm-1555	78	24	risk	risk	NOUN
ajlm-1555	78	25	or	or	CCONJ
ajlm-1555	78	26	low	low	ADJ
ajlm-1555	78	27	-	-	PUNCT
ajlm-1555	78	28	risk	risk	NOUN
ajlm-1555	78	29	genotypes	genotype	NOUN
ajlm-1555	78	30	.	.	PUNCT
ajlm-1555	79	1	the	the	DET
ajlm-1555	79	2	most	most	ADV
ajlm-1555	79	3	common	common	ADJ
ajlm-1555	79	4	genotypes	genotype	NOUN
ajlm-1555	79	5	detected	detect	VERB
ajlm-1555	79	6	in	in	ADP
ajlm-1555	79	7	this	this	DET
ajlm-1555	79	8	study	study	NOUN
ajlm-1555	79	9	were	be	AUX
ajlm-1555	79	10	genotypes	genotype	NOUN
ajlm-1555	79	11	16	16	NUM
ajlm-1555	79	12	and	and	CCONJ
ajlm-1555	79	13	18	18	NUM
ajlm-1555	79	14	.	.	PUNCT
ajlm-1555	79	15	hpv	hpv	PROPN
ajlm-1555	79	16	genotype	genotype	NOUN
ajlm-1555	79	17	16	16	NUM
ajlm-1555	79	18	was	be	AUX
ajlm-1555	79	19	detected	detect	VERB
ajlm-1555	79	20	in	in	ADP
ajlm-1555	79	21	ten	ten	NUM
ajlm-1555	79	22	participants	participant	NOUN
ajlm-1555	79	23	,	,	PUNCT
ajlm-1555	79	24	eight	eight	NUM
ajlm-1555	79	25	of	of	ADP
ajlm-1555	79	26	which	which	PRON
ajlm-1555	79	27	were	be	AUX
ajlm-1555	79	28	single	single	ADJ
ajlm-1555	79	29	infection	infection	NOUN
ajlm-1555	79	30	and	and	CCONJ
ajlm-1555	79	31	one	one	NUM
ajlm-1555	79	32	co	co	NOUN
ajlm-1555	79	33	-	-	NOUN
ajlm-1555	79	34	infection	infection	NOUN
ajlm-1555	79	35	with	with	ADP
ajlm-1555	79	36	genotype	genotype	NOUN
ajlm-1555	79	37	33	33	NUM
ajlm-1555	79	38	,	,	PUNCT
ajlm-1555	79	39	the	the	DET
ajlm-1555	79	40	other	other	ADJ
ajlm-1555	79	41	one	one	NUM
ajlm-1555	79	42	were	be	AUX
ajlm-1555	79	43	the	the	DET
ajlm-1555	79	44	low	low	ADJ
ajlm-1555	79	45	risk	risk	NOUN
ajlm-1555	79	46	group	group	NOUN
ajlm-1555	79	47	(	(	PUNCT
ajlm-1555	79	48	6/11	6/11	NUM
ajlm-1555	79	49	)	)	PUNCT
ajlm-1555	79	50	.	.	PUNCT
ajlm-1555	80	1	genotype	genotype	NOUN
ajlm-1555	80	2	18	18	NUM
ajlm-1555	80	3	was	be	AUX
ajlm-1555	80	4	also	also	ADV
ajlm-1555	80	5	detected	detect	VERB
ajlm-1555	80	6	in	in	ADP
ajlm-1555	80	7	four	four	NUM
ajlm-1555	80	8	participants	participant	NOUN
ajlm-1555	80	9	,	,	PUNCT
ajlm-1555	80	10	of	of	ADP
ajlm-1555	80	11	which	which	PRON
ajlm-1555	80	12	three	three	NUM
ajlm-1555	80	13	were	be	AUX
ajlm-1555	80	14	single	single	ADJ
ajlm-1555	80	15	infection	infection	NOUN
ajlm-1555	80	16	and	and	CCONJ
ajlm-1555	80	17	one	one	NUM
ajlm-1555	80	18	co	co	NOUN
ajlm-1555	80	19	-	-	NOUN
ajlm-1555	80	20	infection	infection	NOUN
ajlm-1555	80	21	with	with	ADP
ajlm-1555	80	22	genotype	genotype	NOUN
ajlm-1555	80	23	31	31	NUM
ajlm-1555	80	24	.	.	PUNCT
ajlm-1555	81	1	genotypes	genotype	NOUN
ajlm-1555	81	2	31	31	NUM
ajlm-1555	81	3	and	and	CCONJ
ajlm-1555	81	4	33	33	NUM
ajlm-1555	81	5	were	be	AUX
ajlm-1555	81	6	each	each	PRON
ajlm-1555	81	7	detected	detect	VERB
ajlm-1555	81	8	in	in	ADP
ajlm-1555	81	9	three	three	NUM
ajlm-1555	81	10	participants	participant	NOUN
ajlm-1555	81	11	,	,	PUNCT
ajlm-1555	81	12	two	two	NUM
ajlm-1555	81	13	as	as	ADP
ajlm-1555	81	14	single	single	ADJ
ajlm-1555	81	15	infection	infection	NOUN
ajlm-1555	81	16	and	and	CCONJ
ajlm-1555	81	17	one	one	NUM
ajlm-1555	81	18	each	each	DET
ajlm-1555	81	19	as	as	ADP
ajlm-1555	81	20	co	co	NOUN
ajlm-1555	81	21	-	-	NOUN
ajlm-1555	81	22	infection	infection	NOUN
ajlm-1555	81	23	with	with	ADP
ajlm-1555	81	24	other	other	ADJ
ajlm-1555	81	25	genotype	genotype	NOUN
ajlm-1555	81	26	.	.	PUNCT
ajlm-1555	82	1	genotype	genotype	NOUN
ajlm-1555	82	2	39	39	NUM
ajlm-1555	82	3	was	be	AUX
ajlm-1555	82	4	the	the	DET
ajlm-1555	82	5	least	least	ADJ
ajlm-1555	82	6	prevalent	prevalent	ADJ
ajlm-1555	82	7	genotype	genotype	NOUN
ajlm-1555	82	8	detected	detect	VERB
ajlm-1555	82	9	in	in	ADP
ajlm-1555	82	10	only	only	ADV
ajlm-1555	82	11	one	one	NUM
ajlm-1555	82	12	participants	participant	NOUN
ajlm-1555	82	13	.	.	PUNCT
ajlm-1555	83	1	a	a	DET
ajlm-1555	83	2	total	total	NOUN
ajlm-1555	83	3	of	of	ADP
ajlm-1555	83	4	21	21	NUM
ajlm-1555	83	5	participants	participant	NOUN
ajlm-1555	83	6	had	have	VERB
ajlm-1555	83	7	high	high	ADJ
ajlm-1555	83	8	-	-	PUNCT
ajlm-1555	83	9	risk	risk	NOUN
ajlm-1555	83	10	hpv	hpv	PROPN
ajlm-1555	83	11	dna	dna	PROPN
ajlm-1555	83	12	.	.	PUNCT
ajlm-1555	84	1	discussion	discussion	NOUN
ajlm-1555	84	2	the	the	DET
ajlm-1555	84	3	prevalence	prevalence	NOUN
ajlm-1555	84	4	of	of	ADP
ajlm-1555	84	5	oral	oral	ADJ
ajlm-1555	84	6	hpv	hpv	NOUN
ajlm-1555	84	7	infection	infection	NOUN
ajlm-1555	84	8	and	and	CCONJ
ajlm-1555	84	9	the	the	DET
ajlm-1555	84	10	circulating	circulate	VERB
ajlm-1555	84	11	genotypes	genotype	NOUN
ajlm-1555	84	12	among	among	ADP
ajlm-1555	84	13	dental	dental	ADJ
ajlm-1555	84	14	clinic	clinic	NOUN
ajlm-1555	84	15	attendees	attendee	NOUN
ajlm-1555	84	16	in	in	ADP
ajlm-1555	84	17	ibadan	ibadan	PROPN
ajlm-1555	84	18	,	,	PUNCT
ajlm-1555	84	19	nigeria	nigeria	PROPN
ajlm-1555	84	20	,	,	PUNCT
ajlm-1555	84	21	was	be	AUX
ajlm-1555	84	22	determined	determine	VERB
ajlm-1555	84	23	in	in	ADP
ajlm-1555	84	24	this	this	DET
ajlm-1555	84	25	study	study	NOUN
ajlm-1555	84	26	.	.	PUNCT
ajlm-1555	85	1	an	an	DET
ajlm-1555	85	2	oral	oral	ADJ
ajlm-1555	85	3	hpv	hpv	ADJ
ajlm-1555	85	4	prevalence	prevalence	NOUN
ajlm-1555	85	5	of	of	ADP
ajlm-1555	85	6	9.9	9.9	NUM
ajlm-1555	85	7	%	%	NOUN
ajlm-1555	85	8	was	be	AUX
ajlm-1555	85	9	observed	observe	VERB
ajlm-1555	85	10	.	.	PUNCT
ajlm-1555	86	1	previous	previous	ADJ
ajlm-1555	86	2	reports	report	NOUN
ajlm-1555	86	3	on	on	ADP
ajlm-1555	86	4	the	the	DET
ajlm-1555	86	5	rates	rate	NOUN
ajlm-1555	86	6	of	of	ADP
ajlm-1555	86	7	oral	oral	ADJ
ajlm-1555	86	8	hpv	hpv	ADJ
ajlm-1555	86	9	infection	infection	NOUN
ajlm-1555	86	10	among	among	ADP
ajlm-1555	86	11	asymptomatic	asymptomatic	ADJ
ajlm-1555	86	12	individuals	individual	NOUN
ajlm-1555	86	13	varied	vary	VERB
ajlm-1555	86	14	between	between	ADP
ajlm-1555	86	15	different	different	ADJ
ajlm-1555	86	16	geographic	geographic	ADJ
ajlm-1555	86	17	areas	area	NOUN
ajlm-1555	86	18	.	.	PUNCT
ajlm-1555	87	1	it	it	PRON
ajlm-1555	87	2	ranged	range	VERB
ajlm-1555	87	3	from	from	ADP
ajlm-1555	87	4	12.0	12.0	NUM
ajlm-1555	87	5	%	%	NOUN
ajlm-1555	87	6	in	in	ADP
ajlm-1555	87	7	south	south	PROPN
ajlm-1555	87	8	africa	africa	PROPN
ajlm-1555	87	9	to	to	ADP
ajlm-1555	87	10	5.0	5.0	NUM
ajlm-1555	87	11	%	%	NOUN
ajlm-1555	87	12	in	in	ADP
ajlm-1555	87	13	the	the	DET
ajlm-1555	87	14	united	united	PROPN
ajlm-1555	87	15	states	states	PROPN
ajlm-1555	87	16	.	.	PUNCT
ajlm-1555	88	1	the	the	DET
ajlm-1555	88	2	prevalence	prevalence	NOUN
ajlm-1555	88	3	obtained	obtain	VERB
ajlm-1555	88	4	among	among	ADP
ajlm-1555	88	5	dental	dental	ADJ
ajlm-1555	88	6	clinic	clinic	NOUN
ajlm-1555	88	7	attendees	attendee	NOUN
ajlm-1555	88	8	in	in	ADP
ajlm-1555	88	9	this	this	DET
ajlm-1555	88	10	study	study	NOUN
ajlm-1555	88	11	is	be	AUX
ajlm-1555	88	12	lower	low	ADJ
ajlm-1555	88	13	than	than	ADP
ajlm-1555	88	14	the	the	DET
ajlm-1555	88	15	12	12	NUM
ajlm-1555	88	16	%	%	NOUN
ajlm-1555	88	17	reported	report	VERB
ajlm-1555	88	18	from	from	ADP
ajlm-1555	88	19	south	south	PROPN
ajlm-1555	88	20	africa	africa	PROPN
ajlm-1555	88	21	among	among	ADP
ajlm-1555	88	22	individuals	individual	NOUN
ajlm-1555	88	23	attending	attend	VERB
ajlm-1555	88	24	hiv	hiv	PROPN
ajlm-1555	88	25	testing	testing	NOUN
ajlm-1555	88	26	centres13	centres13	NOUN
ajlm-1555	88	27	and	and	CCONJ
ajlm-1555	88	28	higher	high	ADJ
ajlm-1555	88	29	than	than	ADP
ajlm-1555	88	30	the	the	DET
ajlm-1555	88	31	7.3	7.3	NUM
ajlm-1555	88	32	%	%	NOUN
ajlm-1555	88	33	and	and	CCONJ
ajlm-1555	88	34	6.9	6.9	NUM
ajlm-1555	88	35	%	%	NOUN
ajlm-1555	88	36	reported	report	VERB
ajlm-1555	88	37	from	from	ADP
ajlm-1555	88	38	the	the	DET
ajlm-1555	88	39	general	general	ADJ
ajlm-1555	88	40	population	population	NOUN
ajlm-1555	88	41	in	in	ADP
ajlm-1555	88	42	the	the	DET
ajlm-1555	88	43	united	united	PROPN
ajlm-1555	88	44	states.16,17	states.16,17	PROPN
ajlm-1555	88	45	the	the	DET
ajlm-1555	88	46	differences	difference	NOUN
ajlm-1555	88	47	obtained	obtain	VERB
ajlm-1555	88	48	could	could	AUX
ajlm-1555	88	49	be	be	AUX
ajlm-1555	88	50	due	due	ADJ
ajlm-1555	88	51	to	to	ADP
ajlm-1555	88	52	the	the	DET
ajlm-1555	88	53	population	population	NOUN
ajlm-1555	88	54	tested	test	VERB
ajlm-1555	88	55	.	.	PUNCT
ajlm-1555	89	1	the	the	DET
ajlm-1555	89	2	higher	high	ADJ
ajlm-1555	89	3	prevalence	prevalence	NOUN
ajlm-1555	89	4	in	in	ADP
ajlm-1555	89	5	the	the	DET
ajlm-1555	89	6	south	south	ADJ
ajlm-1555	89	7	african	african	ADJ
ajlm-1555	89	8	population	population	NOUN
ajlm-1555	89	9	could	could	AUX
ajlm-1555	89	10	be	be	AUX
ajlm-1555	89	11	due	due	ADJ
ajlm-1555	89	12	to	to	ADP
ajlm-1555	89	13	the	the	DET
ajlm-1555	89	14	underlying	underlie	VERB
ajlm-1555	89	15	hiv	hiv	PROPN
ajlm-1555	89	16	infection	infection	NOUN
ajlm-1555	89	17	.	.	PUNCT
ajlm-1555	90	1	it	it	PRON
ajlm-1555	90	2	was	be	AUX
ajlm-1555	90	3	also	also	ADV
ajlm-1555	90	4	noted	note	VERB
ajlm-1555	90	5	that	that	SCONJ
ajlm-1555	90	6	the	the	DET
ajlm-1555	90	7	prevalence	prevalence	NOUN
ajlm-1555	90	8	of	of	ADP
ajlm-1555	90	9	oral	oral	ADJ
ajlm-1555	90	10	hpv	hpv	NOUN
ajlm-1555	90	11	among	among	ADP
ajlm-1555	90	12	hiv	hiv	PROPN
ajlm-1555	90	13	-	-	PUNCT
ajlm-1555	90	14	positive	positive	ADJ
ajlm-1555	90	15	individuals	individual	NOUN
ajlm-1555	90	16	in	in	ADP
ajlm-1555	90	17	the	the	DET
ajlm-1555	90	18	united	united	PROPN
ajlm-1555	90	19	states	states	PROPN
ajlm-1555	90	20	is	be	AUX
ajlm-1555	90	21	also	also	ADV
ajlm-1555	90	22	high	high	ADJ
ajlm-1555	90	23	.	.	PUNCT
ajlm-1555	91	1	the	the	DET
ajlm-1555	91	2	primers	primer	NOUN
ajlm-1555	91	3	used	use	VERB
ajlm-1555	91	4	for	for	ADP
ajlm-1555	91	5	the	the	DET
ajlm-1555	91	6	detection	detection	NOUN
ajlm-1555	91	7	of	of	ADP
ajlm-1555	91	8	hpv	hpv	PROPN
ajlm-1555	91	9	dna	dna	PROPN
ajlm-1555	91	10	in	in	ADP
ajlm-1555	91	11	this	this	DET
ajlm-1555	91	12	study	study	NOUN
ajlm-1555	91	13	target	target	VERB
ajlm-1555	91	14	the	the	DET
ajlm-1555	91	15	e6/7	e6/7	ADJ
ajlm-1555	91	16	region	region	NOUN
ajlm-1555	91	17	of	of	ADP
ajlm-1555	91	18	the	the	DET
ajlm-1555	91	19	virus	virus	NOUN
ajlm-1555	91	20	.	.	PUNCT
ajlm-1555	92	1	this	this	DET
ajlm-1555	92	2	region	region	NOUN
ajlm-1555	92	3	is	be	AUX
ajlm-1555	92	4	part	part	NOUN
ajlm-1555	92	5	of	of	ADP
ajlm-1555	92	6	the	the	DET
ajlm-1555	92	7	viral	viral	ADJ
ajlm-1555	92	8	oncogenes	oncogene	NOUN
ajlm-1555	92	9	and	and	CCONJ
ajlm-1555	92	10	is	be	AUX
ajlm-1555	92	11	usually	usually	ADV
ajlm-1555	92	12	integrated	integrate	VERB
ajlm-1555	92	13	into	into	ADP
ajlm-1555	92	14	the	the	DET
ajlm-1555	92	15	host	host	NOUN
ajlm-1555	92	16	genome	genome	NOUN
ajlm-1555	92	17	.	.	PUNCT
ajlm-1555	93	1	thus	thus	ADV
ajlm-1555	93	2	,	,	PUNCT
ajlm-1555	93	3	primers	primer	NOUN
ajlm-1555	93	4	targeting	target	VERB
ajlm-1555	93	5	this	this	DET
ajlm-1555	93	6	region	region	NOUN
ajlm-1555	93	7	are	be	AUX
ajlm-1555	93	8	more	more	ADV
ajlm-1555	93	9	sensitive	sensitive	ADJ
ajlm-1555	93	10	than	than	ADP
ajlm-1555	93	11	the	the	DET
ajlm-1555	93	12	l1	l1	PROPN
ajlm-1555	93	13	region	region	NOUN
ajlm-1555	93	14	most	most	ADV
ajlm-1555	93	15	commonly	commonly	ADV
ajlm-1555	93	16	used	use	VERB
ajlm-1555	93	17	.	.	PUNCT
ajlm-1555	94	1	other	other	ADJ
ajlm-1555	94	2	studies	study	NOUN
ajlm-1555	94	3	have	have	AUX
ajlm-1555	94	4	shown	show	VERB
ajlm-1555	94	5	that	that	SCONJ
ajlm-1555	94	6	pcr	pcr	ADJ
ajlm-1555	94	7	protocols	protocol	NOUN
ajlm-1555	94	8	targeting	target	VERB
ajlm-1555	94	9	the	the	DET
ajlm-1555	94	10	l1	l1	PROPN
ajlm-1555	94	11	region	region	NOUN
ajlm-1555	94	12	of	of	ADP
ajlm-1555	94	13	the	the	DET
ajlm-1555	94	14	hpv	hpv	NOUN
ajlm-1555	94	15	genome	genome	NOUN
ajlm-1555	94	16	are	be	AUX
ajlm-1555	94	17	likely	likely	ADJ
ajlm-1555	94	18	to	to	PART
ajlm-1555	94	19	miss	miss	VERB
ajlm-1555	94	20	some	some	DET
ajlm-1555	94	21	infections	infection	NOUN
ajlm-1555	94	22	if	if	SCONJ
ajlm-1555	94	23	the	the	DET
ajlm-1555	94	24	viral	viral	ADJ
ajlm-1555	94	25	dna	dna	NOUN
ajlm-1555	94	26	has	have	AUX
ajlm-1555	94	27	been	be	AUX
ajlm-1555	94	28	integrated	integrate	VERB
ajlm-1555	94	29	,	,	PUNCT
ajlm-1555	94	30	as	as	SCONJ
ajlm-1555	94	31	the	the	DET
ajlm-1555	94	32	l1	l1	PROPN
ajlm-1555	94	33	region	region	NOUN
ajlm-1555	94	34	of	of	ADP
ajlm-1555	94	35	the	the	DET
ajlm-1555	94	36	viral	viral	ADJ
ajlm-1555	94	37	genome	genome	NOUN
ajlm-1555	94	38	is	be	AUX
ajlm-1555	94	39	usually	usually	ADV
ajlm-1555	94	40	deleted	delete	VERB
ajlm-1555	94	41	during	during	ADP
ajlm-1555	94	42	viral	viral	ADJ
ajlm-1555	94	43	integration.18,19	integration.18,19	NOUN
ajlm-1555	94	44	in	in	ADP
ajlm-1555	94	45	addition	addition	NOUN
ajlm-1555	94	46	,	,	PUNCT
ajlm-1555	94	47	the	the	DET
ajlm-1555	94	48	detection	detection	NOUN
ajlm-1555	94	49	of	of	ADP
ajlm-1555	94	50	the	the	DET
ajlm-1555	94	51	e6/7	e6/7	ADJ
ajlm-1555	94	52	genes	gene	NOUN
ajlm-1555	94	53	of	of	ADP
ajlm-1555	94	54	the	the	DET
ajlm-1555	94	55	hpv	hpv	NOUN
ajlm-1555	94	56	can	can	AUX
ajlm-1555	94	57	suggest	suggest	VERB
ajlm-1555	94	58	a	a	DET
ajlm-1555	94	59	persistent	persistent	ADJ
ajlm-1555	94	60	hpv	hpv	NOUN
ajlm-1555	94	61	infection	infection	NOUN
ajlm-1555	94	62	,	,	PUNCT
ajlm-1555	94	63	which	which	PRON
ajlm-1555	94	64	could	could	AUX
ajlm-1555	94	65	be	be	AUX
ajlm-1555	94	66	used	use	VERB
ajlm-1555	94	67	to	to	PART
ajlm-1555	94	68	predict	predict	VERB
ajlm-1555	94	69	people	people	NOUN
ajlm-1555	94	70	at	at	ADP
ajlm-1555	94	71	risk	risk	NOUN
ajlm-1555	94	72	of	of	ADP
ajlm-1555	94	73	oropharyngeal	oropharyngeal	ADJ
ajlm-1555	94	74	carcinoma	carcinoma	NOUN
ajlm-1555	94	75	.	.	PUNCT
ajlm-1555	95	1	in	in	ADP
ajlm-1555	95	2	this	this	DET
ajlm-1555	95	3	study	study	NOUN
ajlm-1555	95	4	,	,	PUNCT
ajlm-1555	95	5	people	people	NOUN
ajlm-1555	95	6	aged	age	VERB
ajlm-1555	95	7	60	60	NUM
ajlm-1555	95	8	years	year	NOUN
ajlm-1555	95	9	and	and	CCONJ
ajlm-1555	95	10	older	old	ADJ
ajlm-1555	95	11	had	have	VERB
ajlm-1555	95	12	the	the	DET
ajlm-1555	95	13	lowest	low	ADJ
ajlm-1555	95	14	prevalence	prevalence	NOUN
ajlm-1555	95	15	(	(	PUNCT
ajlm-1555	95	16	2.1	2.1	NUM
ajlm-1555	95	17	%	%	NOUN
ajlm-1555	95	18	)	)	PUNCT
ajlm-1555	95	19	of	of	ADP
ajlm-1555	95	20	hpv	hpv	ADJ
ajlm-1555	95	21	infection	infection	NOUN
ajlm-1555	95	22	,	,	PUNCT
ajlm-1555	95	23	while	while	SCONJ
ajlm-1555	95	24	those	those	PRON
ajlm-1555	95	25	in	in	ADP
ajlm-1555	95	26	the	the	DET
ajlm-1555	95	27	age	age	NOUN
ajlm-1555	95	28	group	group	NOUN
ajlm-1555	95	29	of	of	ADP
ajlm-1555	95	30	21–40	21–40	NUM
ajlm-1555	95	31	years	year	NOUN
ajlm-1555	95	32	had	have	VERB
ajlm-1555	95	33	the	the	DET
ajlm-1555	95	34	highest	high	ADJ
ajlm-1555	95	35	rate	rate	NOUN
ajlm-1555	95	36	(	(	PUNCT
ajlm-1555	95	37	14.5	14.5	NUM
ajlm-1555	95	38	%	%	NOUN
ajlm-1555	95	39	)	)	PUNCT
ajlm-1555	95	40	(	(	PUNCT
ajlm-1555	95	41	table	table	NOUN
ajlm-1555	95	42	3	3	NUM
ajlm-1555	95	43	)	)	PUNCT
ajlm-1555	95	44	.	.	PUNCT
ajlm-1555	96	1	the	the	DET
ajlm-1555	96	2	21–40	21–40	NUM
ajlm-1555	96	3	age	age	NOUN
ajlm-1555	96	4	group	group	NOUN
ajlm-1555	96	5	is	be	AUX
ajlm-1555	96	6	the	the	DET
ajlm-1555	96	7	most	most	ADV
ajlm-1555	96	8	sexually	sexually	ADV
ajlm-1555	96	9	active	active	ADJ
ajlm-1555	96	10	age	age	NOUN
ajlm-1555	96	11	group	group	NOUN
ajlm-1555	96	12	;	;	PUNCT
ajlm-1555	96	13	thus	thus	ADV
ajlm-1555	96	14	,	,	PUNCT
ajlm-1555	96	15	the	the	DET
ajlm-1555	96	16	pattern	pattern	NOUN
ajlm-1555	96	17	may	may	AUX
ajlm-1555	96	18	result	result	VERB
ajlm-1555	96	19	from	from	ADP
ajlm-1555	96	20	sexual	sexual	ADJ
ajlm-1555	96	21	activities	activity	NOUN
ajlm-1555	96	22	and	and	CCONJ
ajlm-1555	96	23	engagement	engagement	NOUN
ajlm-1555	96	24	in	in	ADP
ajlm-1555	96	25	oral	oral	ADJ
ajlm-1555	96	26	sex	sex	NOUN
ajlm-1555	96	27	among	among	ADP
ajlm-1555	96	28	the	the	DET
ajlm-1555	96	29	persons	person	NOUN
ajlm-1555	96	30	within	within	ADP
ajlm-1555	96	31	this	this	DET
ajlm-1555	96	32	age	age	NOUN
ajlm-1555	96	33	range	range	NOUN
ajlm-1555	96	34	.	.	PUNCT
ajlm-1555	97	1	studies	study	NOUN
ajlm-1555	97	2	have	have	AUX
ajlm-1555	97	3	shown	show	VERB
ajlm-1555	97	4	that	that	SCONJ
ajlm-1555	97	5	this	this	PRON
ajlm-1555	97	6	is	be	AUX
ajlm-1555	97	7	the	the	DET
ajlm-1555	97	8	age	age	NOUN
ajlm-1555	97	9	group	group	NOUN
ajlm-1555	97	10	most	most	ADV
ajlm-1555	97	11	likely	likely	ADJ
ajlm-1555	97	12	to	to	PART
ajlm-1555	97	13	engage	engage	VERB
ajlm-1555	97	14	in	in	ADP
ajlm-1555	97	15	oral	oral	ADJ
ajlm-1555	97	16	sex	sex	NOUN
ajlm-1555	97	17	.	.	PUNCT
ajlm-1555	98	1	in	in	ADP
ajlm-1555	98	2	addition	addition	NOUN
ajlm-1555	98	3	,	,	PUNCT
ajlm-1555	98	4	oral	oral	ADJ
ajlm-1555	98	5	sex	sex	NOUN
ajlm-1555	98	6	was	be	AUX
ajlm-1555	98	7	not	not	PART
ajlm-1555	98	8	as	as	ADV
ajlm-1555	98	9	common	common	ADJ
ajlm-1555	98	10	in	in	ADP
ajlm-1555	98	11	the	the	DET
ajlm-1555	98	12	past	past	NOUN
ajlm-1555	98	13	as	as	SCONJ
ajlm-1555	98	14	it	it	PRON
ajlm-1555	98	15	is	be	AUX
ajlm-1555	98	16	now	now	ADV
ajlm-1555	98	17	.	.	PUNCT
ajlm-1555	99	1	this	this	PRON
ajlm-1555	99	2	may	may	AUX
ajlm-1555	99	3	be	be	AUX
ajlm-1555	99	4	why	why	SCONJ
ajlm-1555	99	5	the	the	DET
ajlm-1555	99	6	prevalence	prevalence	NOUN
ajlm-1555	99	7	of	of	ADP
ajlm-1555	99	8	oral	oral	ADJ
ajlm-1555	99	9	hpv	hpv	ADJ
ajlm-1555	99	10	infection	infection	NOUN
ajlm-1555	99	11	is	be	AUX
ajlm-1555	99	12	higher	high	ADJ
ajlm-1555	99	13	among	among	ADP
ajlm-1555	99	14	younger	young	ADJ
ajlm-1555	99	15	participants	participant	NOUN
ajlm-1555	99	16	.	.	PUNCT
ajlm-1555	100	1	the	the	DET
ajlm-1555	100	2	age	age	NOUN
ajlm-1555	100	3	distribution	distribution	NOUN
ajlm-1555	100	4	found	find	VERB
ajlm-1555	100	5	in	in	ADP
ajlm-1555	100	6	this	this	DET
ajlm-1555	100	7	study	study	NOUN
ajlm-1555	100	8	is	be	AUX
ajlm-1555	100	9	similar	similar	ADJ
ajlm-1555	100	10	to	to	ADP
ajlm-1555	100	11	what	what	PRON
ajlm-1555	100	12	was	be	AUX
ajlm-1555	100	13	reported	report	VERB
ajlm-1555	100	14	by	by	ADP
ajlm-1555	100	15	antonsson	antonsson	PROPN
ajlm-1555	100	16	et	et	PROPN
ajlm-1555	100	17	al.20	al.20	PROPN
ajlm-1555	100	18	in	in	ADP
ajlm-1555	100	19	australia	australia	PROPN
ajlm-1555	100	20	but	but	CCONJ
ajlm-1555	100	21	different	different	ADJ
ajlm-1555	100	22	from	from	ADP
ajlm-1555	100	23	the	the	DET
ajlm-1555	100	24	pattern	pattern	NOUN
ajlm-1555	100	25	reported	report	VERB
ajlm-1555	100	26	in	in	ADP
ajlm-1555	100	27	the	the	DET
ajlm-1555	100	28	united	united	PROPN
ajlm-1555	100	29	states	states	PROPN
ajlm-1555	100	30	by	by	ADP
ajlm-1555	100	31	sanders	sanders	PROPN
ajlm-1555	100	32	et	et	PROPN
ajlm-1555	100	33	al	al	PROPN
ajlm-1555	100	34	.	.	PROPN
ajlm-1555	100	35	,16	,16	PUNCT
ajlm-1555	100	36	where	where	SCONJ
ajlm-1555	100	37	the	the	DET
ajlm-1555	100	38	highest	high	ADJ
ajlm-1555	100	39	prevalence	prevalence	NOUN
ajlm-1555	100	40	(	(	PUNCT
ajlm-1555	100	41	11.3	11.3	NUM
ajlm-1555	100	42	%	%	NOUN
ajlm-1555	100	43	)	)	PUNCT
ajlm-1555	100	44	was	be	AUX
ajlm-1555	100	45	observed	observe	VERB
ajlm-1555	100	46	among	among	ADP
ajlm-1555	100	47	the	the	DET
ajlm-1555	100	48	age	age	NOUN
ajlm-1555	100	49	group	group	NOUN
ajlm-1555	100	50	55–64	55–64	NUM
ajlm-1555	100	51	years	year	NOUN
ajlm-1555	100	52	.	.	PUNCT
ajlm-1555	101	1	gender	gender	NOUN
ajlm-1555	101	2	differences	difference	NOUN
ajlm-1555	101	3	have	have	AUX
ajlm-1555	101	4	been	be	AUX
ajlm-1555	101	5	observed	observe	VERB
ajlm-1555	101	6	in	in	ADP
ajlm-1555	101	7	the	the	DET
ajlm-1555	101	8	distribution	distribution	NOUN
ajlm-1555	101	9	of	of	ADP
ajlm-1555	101	10	oral	oral	ADJ
ajlm-1555	101	11	hpv.8,9	hpv.8,9	PROPN
ajlm-1555	101	12	in	in	ADP
ajlm-1555	101	13	this	this	DET
ajlm-1555	101	14	study	study	NOUN
ajlm-1555	101	15	,	,	PUNCT
ajlm-1555	101	16	there	there	PRON
ajlm-1555	101	17	are	be	VERB
ajlm-1555	101	18	no	no	DET
ajlm-1555	101	19	significant	significant	ADJ
ajlm-1555	101	20	differences	difference	NOUN
ajlm-1555	101	21	in	in	ADP
ajlm-1555	101	22	the	the	DET
ajlm-1555	101	23	gender	gender	NOUN
ajlm-1555	101	24	distribution	distribution	NOUN
ajlm-1555	101	25	of	of	ADP
ajlm-1555	101	26	hpv	hpv	NOUN
ajlm-1555	101	27	dna.21,20	dna.21,20	PROPN
ajlm-1555	101	28	furthermore	furthermore	ADV
ajlm-1555	101	29	,	,	PUNCT
ajlm-1555	101	30	findings	finding	NOUN
ajlm-1555	101	31	from	from	ADP
ajlm-1555	101	32	this	this	DET
ajlm-1555	101	33	study	study	NOUN
ajlm-1555	101	34	showed	show	VERB
ajlm-1555	101	35	that	that	SCONJ
ajlm-1555	101	36	participants	participant	NOUN
ajlm-1555	101	37	with	with	ADP
ajlm-1555	101	38	more	more	ADJ
ajlm-1555	101	39	than	than	ADP
ajlm-1555	101	40	one	one	NUM
ajlm-1555	101	41	sexual	sexual	ADJ
ajlm-1555	101	42	partner	partner	NOUN
ajlm-1555	101	43	had	have	VERB
ajlm-1555	101	44	a	a	DET
ajlm-1555	101	45	higher	high	ADJ
ajlm-1555	101	46	prevalence	prevalence	NOUN
ajlm-1555	101	47	of	of	ADP
ajlm-1555	101	48	oral	oral	ADJ
ajlm-1555	101	49	hpv	hpv	ADJ
ajlm-1555	101	50	infection	infection	NOUN
ajlm-1555	101	51	.	.	PUNCT
ajlm-1555	102	1	positive	positive	ADJ
ajlm-1555	102	2	oral	oral	ADJ
ajlm-1555	102	3	hpv	hpv	NOUN
ajlm-1555	102	4	testing	testing	NOUN
ajlm-1555	102	5	is	be	AUX
ajlm-1555	102	6	significantly	significantly	ADV
ajlm-1555	102	7	positively	positively	ADV
ajlm-1555	102	8	correlated	correlate	VERB
ajlm-1555	102	9	with	with	ADP
ajlm-1555	102	10	an	an	DET
ajlm-1555	102	11	increase	increase	NOUN
ajlm-1555	102	12	in	in	ADP
ajlm-1555	102	13	vaginal	vaginal	ADJ
ajlm-1555	102	14	sexual	sexual	ADJ
ajlm-1555	102	15	partners.21	partners.21	NOUN
ajlm-1555	102	16	there	there	PRON
ajlm-1555	102	17	was	be	VERB
ajlm-1555	102	18	also	also	ADV
ajlm-1555	102	19	no	no	DET
ajlm-1555	102	20	significant	significant	ADJ
ajlm-1555	102	21	difference	difference	NOUN
ajlm-1555	102	22	in	in	ADP
ajlm-1555	102	23	prevalence	prevalence	NOUN
ajlm-1555	102	24	of	of	ADP
ajlm-1555	102	25	hpv	hpv	PROPN
ajlm-1555	102	26	dna	dna	PROPN
ajlm-1555	102	27	as	as	ADP
ajlm-1555	102	28	per	per	ADP
ajlm-1555	102	29	marital	marital	ADJ
ajlm-1555	102	30	status	status	NOUN
ajlm-1555	102	31	of	of	ADP
ajlm-1555	102	32	the	the	DET
ajlm-1555	102	33	participants	participant	NOUN
ajlm-1555	102	34	in	in	ADP
ajlm-1555	102	35	this	this	DET
ajlm-1555	102	36	study	study	NOUN
ajlm-1555	102	37	,	,	PUNCT
ajlm-1555	102	38	although	although	SCONJ
ajlm-1555	102	39	kero	kero	PROPN
ajlm-1555	102	40	et	et	PROPN
ajlm-1555	102	41	al.22	al.22	PROPN
ajlm-1555	102	42	reported	report	VERB
ajlm-1555	102	43	that	that	SCONJ
ajlm-1555	102	44	stable	stable	ADJ
ajlm-1555	102	45	marital	marital	ADJ
ajlm-1555	102	46	relationships	relationship	NOUN
ajlm-1555	102	47	protect	protect	VERB
ajlm-1555	102	48	men	man	NOUN
ajlm-1555	102	49	from	from	ADP
ajlm-1555	102	50	oral	oral	ADJ
ajlm-1555	102	51	and	and	CCONJ
ajlm-1555	102	52	genital	genital	ADJ
ajlm-1555	102	53	hpv	hpv	ADJ
ajlm-1555	102	54	infection	infection	NOUN
ajlm-1555	102	55	.	.	PUNCT
ajlm-1555	103	1	this	this	DET
ajlm-1555	103	2	study	study	NOUN
ajlm-1555	103	3	also	also	ADV
ajlm-1555	103	4	noted	note	VERB
ajlm-1555	103	5	that	that	SCONJ
ajlm-1555	103	6	participants	participant	NOUN
ajlm-1555	103	7	who	who	PRON
ajlm-1555	103	8	engaged	engage	VERB
ajlm-1555	103	9	in	in	ADP
ajlm-1555	103	10	oral	oral	ADJ
ajlm-1555	103	11	sex	sex	NOUN
ajlm-1555	103	12	had	have	VERB
ajlm-1555	103	13	a	a	DET
ajlm-1555	103	14	significantly	significantly	ADV
ajlm-1555	103	15	higher	high	ADJ
ajlm-1555	103	16	prevalence	prevalence	NOUN
ajlm-1555	103	17	of	of	ADP
ajlm-1555	103	18	oral	oral	ADJ
ajlm-1555	103	19	hpv	hpv	ADJ
ajlm-1555	103	20	infection	infection	NOUN
ajlm-1555	103	21	.	.	PUNCT
ajlm-1555	104	1	oral	oral	ADJ
ajlm-1555	104	2	sex	sex	NOUN
ajlm-1555	104	3	is	be	AUX
ajlm-1555	104	4	a	a	DET
ajlm-1555	104	5	major	major	ADJ
ajlm-1555	104	6	route	route	NOUN
ajlm-1555	104	7	for	for	ADP
ajlm-1555	104	8	hpv	hpv	NOUN
ajlm-1555	104	9	transmission.21,23,24	transmission.21,23,24	ADV
ajlm-1555	104	10	although	although	SCONJ
ajlm-1555	104	11	oral	oral	ADJ
ajlm-1555	104	12	sex	sex	NOUN
ajlm-1555	104	13	and	and	CCONJ
ajlm-1555	104	14	having	have	VERB
ajlm-1555	104	15	multiple	multiple	ADJ
ajlm-1555	104	16	sexual	sexual	ADJ
ajlm-1555	104	17	partners	partner	NOUN
ajlm-1555	104	18	are	be	AUX
ajlm-1555	104	19	shown	show	VERB
ajlm-1555	104	20	to	to	PART
ajlm-1555	104	21	be	be	AUX
ajlm-1555	104	22	significantly	significantly	ADV
ajlm-1555	104	23	associated	associate	VERB
ajlm-1555	104	24	with	with	ADP
ajlm-1555	104	25	oral	oral	ADJ
ajlm-1555	104	26	hpv	hpv	NOUN
ajlm-1555	104	27	positivity	positivity	NOUN
ajlm-1555	104	28	,	,	PUNCT
ajlm-1555	104	29	other	other	ADJ
ajlm-1555	104	30	behaviours	behaviour	NOUN
ajlm-1555	104	31	such	such	ADJ
ajlm-1555	104	32	as	as	ADP
ajlm-1555	104	33	kissing	kissing	NOUN
ajlm-1555	104	34	can	can	AUX
ajlm-1555	104	35	transmit	transmit	VERB
ajlm-1555	104	36	hpv.25	hpv.25	VERB
ajlm-1555	104	37	this	this	DET
ajlm-1555	104	38	study	study	NOUN
ajlm-1555	104	39	detected	detect	VERB
ajlm-1555	104	40	low	low	ADJ
ajlm-1555	104	41	risk	risk	NOUN
ajlm-1555	104	42	hpv	hpv	NOUN
ajlm-1555	104	43	genotype	genotype	NOUN
ajlm-1555	104	44	6/11	6/11	NUM
ajlm-1555	104	45	and	and	CCONJ
ajlm-1555	104	46	high	high	ADJ
ajlm-1555	104	47	-	-	PUNCT
ajlm-1555	104	48	risk	risk	NOUN
ajlm-1555	104	49	genotypes	genotype	NOUN
ajlm-1555	104	50	16	16	NUM
ajlm-1555	104	51	,	,	PUNCT
ajlm-1555	104	52	18	18	NUM
ajlm-1555	104	53	,	,	PUNCT
ajlm-1555	104	54	31	31	NUM
ajlm-1555	104	55	,	,	PUNCT
ajlm-1555	104	56	33	33	NUM
ajlm-1555	104	57	and	and	CCONJ
ajlm-1555	104	58	39	39	NUM
ajlm-1555	104	59	among	among	ADP
ajlm-1555	104	60	dental	dental	ADJ
ajlm-1555	104	61	clinic	clinic	NOUN
ajlm-1555	104	62	attendees	attendee	NOUN
ajlm-1555	104	63	in	in	ADP
ajlm-1555	104	64	oyo	oyo	NOUN
ajlm-1555	104	65	state	state	NOUN
ajlm-1555	104	66	,	,	PUNCT
ajlm-1555	104	67	nigeria	nigeria	PROPN
ajlm-1555	104	68	.	.	PUNCT
ajlm-1555	105	1	among	among	ADP
ajlm-1555	105	2	the	the	DET
ajlm-1555	105	3	previously	previously	ADV
ajlm-1555	105	4	reported	report	VERB
ajlm-1555	105	5	circulating	circulate	VERB
ajlm-1555	105	6	genital	genital	ADJ
ajlm-1555	105	7	hpv	hpv	NOUN
ajlm-1555	105	8	types	type	NOUN
ajlm-1555	105	9	among	among	ADP
ajlm-1555	105	10	women	woman	NOUN
ajlm-1555	105	11	in	in	ADP
ajlm-1555	105	12	ibadan	ibadan	PROPN
ajlm-1555	105	13	,	,	PUNCT
ajlm-1555	105	14	nigeria	nigeria	PROPN
ajlm-1555	105	15	,	,	PUNCT
ajlm-1555	105	16	according	accord	VERB
ajlm-1555	105	17	to	to	ADP
ajlm-1555	105	18	nejo	nejo	PROPN
ajlm-1555	105	19	et	et	PROPN
ajlm-1555	105	20	al	al	PROPN
ajlm-1555	105	21	.	.	PROPN
ajlm-1555	105	22	and	and	CCONJ
ajlm-1555	105	23	thomas	thomas	PROPN
ajlm-1555	105	24	et	et	PROPN
ajlm-1555	105	25	al.26,27	al.26,27	PROPN
ajlm-1555	105	26	the	the	DET
ajlm-1555	105	27	most	most	ADV
ajlm-1555	105	28	common	common	ADJ
ajlm-1555	105	29	hpv	hpv	NOUN
ajlm-1555	105	30	genotype	genotype	NOUN
ajlm-1555	105	31	(	(	PUNCT
ajlm-1555	105	32	type	type	NOUN
ajlm-1555	105	33	16	16	NUM
ajlm-1555	105	34	)	)	PUNCT
ajlm-1555	105	35	in	in	ADP
ajlm-1555	105	36	this	this	DET
ajlm-1555	105	37	study	study	NOUN
ajlm-1555	105	38	is	be	AUX
ajlm-1555	105	39	similar	similar	ADJ
ajlm-1555	105	40	to	to	ADP
ajlm-1555	105	41	the	the	DET
ajlm-1555	105	42	findings	finding	NOUN
ajlm-1555	105	43	of	of	ADP
ajlm-1555	105	44	thomas	thomas	PROPN
ajlm-1555	105	45	et	et	PROPN
ajlm-1555	105	46	al	al	PROPN
ajlm-1555	105	47	.	.	PUNCT
ajlm-1555	106	1	but	but	CCONJ
ajlm-1555	106	2	different	different	ADJ
ajlm-1555	106	3	from	from	ADP
ajlm-1555	106	4	the	the	DET
ajlm-1555	106	5	report	report	NOUN
ajlm-1555	106	6	of	of	ADP
ajlm-1555	106	7	nejo	nejo	NOUN
ajlm-1555	106	8	et	et	PROPN
ajlm-1555	106	9	al	al	PROPN
ajlm-1555	106	10	.	.	PROPN
ajlm-1555	106	11	,	,	PUNCT
ajlm-1555	106	12	which	which	PRON
ajlm-1555	106	13	reported	report	VERB
ajlm-1555	106	14	hpv	hpv	ADJ
ajlm-1555	106	15	genotype	genotype	NOUN
ajlm-1555	106	16	31	31	NUM
ajlm-1555	106	17	as	as	ADP
ajlm-1555	106	18	the	the	DET
ajlm-1555	106	19	most	most	ADV
ajlm-1555	106	20	prevalent	prevalent	ADJ
ajlm-1555	106	21	.	.	PUNCT
ajlm-1555	107	1	human	human	ADJ
ajlm-1555	107	2	papilloma	papilloma	PROPN
ajlm-1555	107	3	viruses	virus	NOUN
ajlm-1555	107	4	genotype	genotype	NOUN
ajlm-1555	107	5	16	16	NUM
ajlm-1555	107	6	has	have	AUX
ajlm-1555	107	7	also	also	ADV
ajlm-1555	107	8	been	be	AUX
ajlm-1555	107	9	reported	report	VERB
ajlm-1555	107	10	from	from	ADP
ajlm-1555	107	11	other	other	ADJ
ajlm-1555	107	12	parts	part	NOUN
ajlm-1555	107	13	of	of	ADP
ajlm-1555	107	14	the	the	DET
ajlm-1555	107	15	world	world	NOUN
ajlm-1555	107	16	as	as	ADP
ajlm-1555	107	17	the	the	DET
ajlm-1555	107	18	most	most	ADV
ajlm-1555	107	19	common	common	ADJ
ajlm-1555	107	20	oral	oral	ADJ
ajlm-1555	107	21	hpv	hpv	NOUN
ajlm-1555	107	22	type	type	NOUN
ajlm-1555	107	23	.	.	PUNCT
ajlm-1555	108	1	finally	finally	ADV
ajlm-1555	108	2	,	,	PUNCT
ajlm-1555	108	3	the	the	DET
ajlm-1555	108	4	inclusion	inclusion	NOUN
ajlm-1555	108	5	of	of	ADP
ajlm-1555	108	6	the	the	DET
ajlm-1555	108	7	hpv	hpv	ADJ
ajlm-1555	108	8	vaccine	vaccine	NOUN
ajlm-1555	108	9	into	into	ADP
ajlm-1555	108	10	the	the	DET
ajlm-1555	108	11	national	national	ADJ
ajlm-1555	108	12	vaccination	vaccination	NOUN
ajlm-1555	108	13	programme	programme	NOUN
ajlm-1555	108	14	to	to	PART
ajlm-1555	108	15	cover	cover	VERB
ajlm-1555	108	16	both	both	DET
ajlm-1555	108	17	boys	boy	NOUN
ajlm-1555	108	18	and	and	CCONJ
ajlm-1555	108	19	girls	girl	NOUN
ajlm-1555	108	20	in	in	ADP
ajlm-1555	108	21	nigeria	nigeria	PROPN
ajlm-1555	108	22	will	will	AUX
ajlm-1555	108	23	reduce	reduce	VERB
ajlm-1555	108	24	the	the	DET
ajlm-1555	108	25	prevalence	prevalence	NOUN
ajlm-1555	108	26	of	of	ADP
ajlm-1555	108	27	oral	oral	ADJ
ajlm-1555	108	28	hpv	hpv	NOUN
ajlm-1555	108	29	infection	infection	NOUN
ajlm-1555	108	30	and	and	CCONJ
ajlm-1555	108	31	,	,	PUNCT
ajlm-1555	108	32	ultimately	ultimately	ADV
ajlm-1555	108	33	,	,	PUNCT
ajlm-1555	108	34	hpv	hpv	ADJ
ajlm-1555	108	35	-	-	PUNCT
ajlm-1555	108	36	associated	associate	VERB
ajlm-1555	108	37	oropharyngeal	oropharyngeal	NOUN
ajlm-1555	108	38	cancer	cancer	NOUN
ajlm-1555	108	39	in	in	ADP
ajlm-1555	108	40	nigeria	nigeria	PROPN
ajlm-1555	108	41	.	.	PUNCT
ajlm-1555	109	1	presently	presently	ADV
ajlm-1555	109	2	,	,	PUNCT
ajlm-1555	109	3	the	the	DET
ajlm-1555	109	4	most	most	ADV
ajlm-1555	109	5	common	common	ADJ
ajlm-1555	109	6	vaccine	vaccine	NOUN
ajlm-1555	109	7	in	in	ADP
ajlm-1555	109	8	nigeria	nigeria	PROPN
ajlm-1555	109	9	(	(	PUNCT
ajlm-1555	109	10	cervarix	cervarix	NOUN
ajlm-1555	109	11	marketed	market	VERB
ajlm-1555	109	12	by	by	ADP
ajlm-1555	109	13	glaxosmithkline	glaxosmithkline	PROPN
ajlm-1555	109	14	)	)	PUNCT
ajlm-1555	109	15	targets	target	VERB
ajlm-1555	109	16	hpv	hpv	NOUN
ajlm-1555	109	17	16	16	NUM
ajlm-1555	109	18	and	and	CCONJ
ajlm-1555	109	19	18	18	NUM
ajlm-1555	109	20	and	and	CCONJ
ajlm-1555	109	21	gardasil	gardasil	PROPN
ajlm-1555	109	22	(	(	PUNCT
ajlm-1555	109	23	marketed	market	VERB
ajlm-1555	109	24	by	by	ADP
ajlm-1555	109	25	merk	merk	PROPN
ajlm-1555	109	26	&	&	CCONJ
ajlm-1555	109	27	co.	co.	PROPN
ajlm-1555	109	28	)	)	PUNCT
ajlm-1555	109	29	targets	target	VERB
ajlm-1555	109	30	only	only	ADV
ajlm-1555	109	31	hpv	hpv	PROPN
ajlm-1555	109	32	16	16	NUM
ajlm-1555	109	33	,	,	PUNCT
ajlm-1555	109	34	18	18	NUM
ajlm-1555	109	35	,	,	PUNCT
ajlm-1555	109	36	6	6	NUM
ajlm-1555	109	37	and	and	CCONJ
ajlm-1555	109	38	11	11	NUM
ajlm-1555	109	39	whereas	whereas	SCONJ
ajlm-1555	109	40	this	this	DET
ajlm-1555	109	41	study	study	NOUN
ajlm-1555	109	42	and	and	CCONJ
ajlm-1555	109	43	previous	previous	ADJ
ajlm-1555	109	44	nigerian	nigerian	ADJ
ajlm-1555	109	45	studies	study	NOUN
ajlm-1555	109	46	have	have	AUX
ajlm-1555	109	47	identified	identify	VERB
ajlm-1555	109	48	other	other	ADJ
ajlm-1555	109	49	genotypes	genotype	NOUN
ajlm-1555	109	50	.	.	PUNCT
ajlm-1555	110	1	thus	thus	ADV
ajlm-1555	110	2	,	,	PUNCT
ajlm-1555	110	3	introducing	introduce	VERB
ajlm-1555	110	4	hpv	hpv	ADJ
ajlm-1555	110	5	vaccine	vaccine	NOUN
ajlm-1555	110	6	that	that	PRON
ajlm-1555	110	7	will	will	AUX
ajlm-1555	110	8	cover	cover	VERB
ajlm-1555	110	9	other	other	ADJ
ajlm-1555	110	10	circulating	circulate	VERB
ajlm-1555	110	11	strains	strain	NOUN
ajlm-1555	110	12	in	in	ADP
ajlm-1555	110	13	addition	addition	NOUN
ajlm-1555	110	14	to	to	ADP
ajlm-1555	110	15	the	the	DET
ajlm-1555	110	16	ones	one	NOUN
ajlm-1555	110	17	they	they	PRON
ajlm-1555	110	18	cover	cover	VERB
ajlm-1555	110	19	presently	presently	ADV
ajlm-1555	110	20	will	will	AUX
ajlm-1555	110	21	make	make	VERB
ajlm-1555	110	22	the	the	DET
ajlm-1555	110	23	vaccination	vaccination	NOUN
ajlm-1555	110	24	programme	programme	NOUN
ajlm-1555	110	25	more	more	ADV
ajlm-1555	110	26	effective	effective	ADJ
ajlm-1555	110	27	.	.	PUNCT
ajlm-1555	111	1	the	the	DET
ajlm-1555	111	2	study	study	NOUN
ajlm-1555	111	3	by	by	ADP
ajlm-1555	111	4	herrero	herrero	PROPN
ajlm-1555	111	5	et	et	PROPN
ajlm-1555	111	6	al.28	al.28	PROPN
ajlm-1555	111	7	has	have	AUX
ajlm-1555	111	8	demonstrated	demonstrate	VERB
ajlm-1555	111	9	the	the	DET
ajlm-1555	111	10	efficacy	efficacy	NOUN
ajlm-1555	111	11	of	of	ADP
ajlm-1555	111	12	hpv	hpv	NOUN
ajlm-1555	111	13	vaccination	vaccination	NOUN
ajlm-1555	111	14	in	in	ADP
ajlm-1555	111	15	reducing	reduce	VERB
ajlm-1555	111	16	prevalence	prevalence	NOUN
ajlm-1555	111	17	of	of	ADP
ajlm-1555	111	18	oral	oral	ADJ
ajlm-1555	111	19	hpv	hpv	NOUN
ajlm-1555	111	20	after	after	ADP
ajlm-1555	111	21	four	four	NUM
ajlm-1555	111	22	years	year	NOUN
ajlm-1555	111	23	of	of	ADP
ajlm-1555	111	24	vaccinating	vaccinate	VERB
ajlm-1555	111	25	women	woman	NOUN
ajlm-1555	111	26	in	in	ADP
ajlm-1555	111	27	costa	costa	PROPN
ajlm-1555	111	28	rica	rica	PROPN
ajlm-1555	111	29	.	.	PUNCT
ajlm-1555	112	1	limitations	limitation	NOUN
ajlm-1555	112	2	patients	patient	NOUN
ajlm-1555	112	3	with	with	ADP
ajlm-1555	112	4	symptoms	symptom	NOUN
ajlm-1555	112	5	of	of	ADP
ajlm-1555	112	6	oropharyngeal	oropharyngeal	ADJ
ajlm-1555	112	7	cancer	cancer	NOUN
ajlm-1555	112	8	were	be	AUX
ajlm-1555	112	9	not	not	PART
ajlm-1555	112	10	included	include	VERB
ajlm-1555	112	11	in	in	ADP
ajlm-1555	112	12	this	this	DET
ajlm-1555	112	13	study	study	NOUN
ajlm-1555	112	14	to	to	PART
ajlm-1555	112	15	identify	identify	VERB
ajlm-1555	112	16	the	the	DET
ajlm-1555	112	17	virus	virus	NOUN
ajlm-1555	112	18	genotypes	genotype	NOUN
ajlm-1555	112	19	associated	associate	VERB
ajlm-1555	112	20	with	with	ADP
ajlm-1555	112	21	oropharyngeal	oropharyngeal	ADJ
ajlm-1555	112	22	cancer	cancer	NOUN
ajlm-1555	112	23	in	in	ADP
ajlm-1555	112	24	this	this	DET
ajlm-1555	112	25	region	region	NOUN
ajlm-1555	112	26	.	.	PUNCT
ajlm-1555	113	1	information	information	NOUN
ajlm-1555	113	2	about	about	ADP
ajlm-1555	113	3	the	the	DET
ajlm-1555	113	4	number	number	NOUN
ajlm-1555	113	5	of	of	ADP
ajlm-1555	113	6	kissing	kiss	VERB
ajlm-1555	113	7	partners	partner	NOUN
ajlm-1555	113	8	of	of	ADP
ajlm-1555	113	9	the	the	DET
ajlm-1555	113	10	participants	participant	NOUN
ajlm-1555	113	11	was	be	AUX
ajlm-1555	113	12	also	also	ADV
ajlm-1555	113	13	not	not	PART
ajlm-1555	113	14	accessed	access	VERB
ajlm-1555	113	15	in	in	ADP
ajlm-1555	113	16	the	the	DET
ajlm-1555	113	17	study	study	NOUN
ajlm-1555	113	18	.	.	PUNCT
ajlm-1555	114	1	the	the	DET
ajlm-1555	114	2	size	size	NOUN
ajlm-1555	114	3	of	of	ADP
ajlm-1555	114	4	the	the	DET
ajlm-1555	114	5	study	study	NOUN
ajlm-1555	114	6	population	population	NOUN
ajlm-1555	114	7	is	be	AUX
ajlm-1555	114	8	also	also	ADV
ajlm-1555	114	9	a	a	DET
ajlm-1555	114	10	limitation	limitation	NOUN
ajlm-1555	114	11	of	of	ADP
ajlm-1555	114	12	the	the	DET
ajlm-1555	114	13	study	study	NOUN
ajlm-1555	114	14	.	.	PUNCT
ajlm-1555	115	1	conclusion	conclusion	NOUN
ajlm-1555	115	2	this	this	DET
ajlm-1555	115	3	study	study	NOUN
ajlm-1555	115	4	describes	describe	VERB
ajlm-1555	115	5	a	a	DET
ajlm-1555	115	6	high	high	ADJ
ajlm-1555	115	7	prevalence	prevalence	NOUN
ajlm-1555	115	8	of	of	ADP
ajlm-1555	115	9	oral	oral	ADJ
ajlm-1555	115	10	hpv	hpv	ADJ
ajlm-1555	115	11	infection	infection	NOUN
ajlm-1555	115	12	among	among	ADP
ajlm-1555	115	13	dental	dental	ADJ
ajlm-1555	115	14	clinic	clinic	NOUN
ajlm-1555	115	15	attendees	attendee	NOUN
ajlm-1555	115	16	in	in	ADP
ajlm-1555	115	17	ibadan	ibadan	PROPN
ajlm-1555	115	18	,	,	PUNCT
ajlm-1555	115	19	oyo	oyo	NOUN
ajlm-1555	115	20	state	state	NOUN
ajlm-1555	115	21	,	,	PUNCT
ajlm-1555	115	22	nigeria	nigeria	PROPN
ajlm-1555	115	23	,	,	PUNCT
ajlm-1555	115	24	by	by	ADP
ajlm-1555	115	25	detecting	detect	VERB
ajlm-1555	115	26	hpv	hpv	ADJ
ajlm-1555	115	27	dna	dna	PROPN
ajlm-1555	115	28	from	from	ADP
ajlm-1555	115	29	the	the	DET
ajlm-1555	115	30	oral	oral	ADJ
ajlm-1555	115	31	swabs	swab	NOUN
ajlm-1555	115	32	of	of	ADP
ajlm-1555	115	33	the	the	DET
ajlm-1555	115	34	study	study	NOUN
ajlm-1555	115	35	participants	participant	NOUN
ajlm-1555	115	36	using	use	VERB
ajlm-1555	115	37	pcr	pcr	PROPN
ajlm-1555	115	38	.	.	PUNCT
ajlm-1555	116	1	a	a	DET
ajlm-1555	116	2	prevalence	prevalence	NOUN
ajlm-1555	116	3	of	of	ADP
ajlm-1555	116	4	9.9	9.9	NUM
ajlm-1555	116	5	%	%	NOUN
ajlm-1555	116	6	of	of	ADP
ajlm-1555	116	7	hpv	hpv	ADJ
ajlm-1555	116	8	infection	infection	NOUN
ajlm-1555	116	9	was	be	AUX
ajlm-1555	116	10	identified	identify	VERB
ajlm-1555	116	11	and	and	CCONJ
ajlm-1555	116	12	also	also	ADV
ajlm-1555	116	13	showed	show	VERB
ajlm-1555	116	14	that	that	SCONJ
ajlm-1555	116	15	hpv	hpv	NOUN
ajlm-1555	116	16	type	type	NOUN
ajlm-1555	116	17	16	16	NUM
ajlm-1555	116	18	and	and	CCONJ
ajlm-1555	116	19	18	18	NUM
ajlm-1555	116	20	are	be	AUX
ajlm-1555	116	21	the	the	DET
ajlm-1555	116	22	most	most	ADV
ajlm-1555	116	23	common	common	ADJ
ajlm-1555	116	24	types	type	NOUN
ajlm-1555	116	25	detected	detect	VERB
ajlm-1555	116	26	among	among	ADP
ajlm-1555	116	27	the	the	DET
ajlm-1555	116	28	study	study	NOUN
ajlm-1555	116	29	participants	participant	NOUN
ajlm-1555	116	30	.	.	PUNCT
ajlm-1555	117	1	oral	oral	ADJ
ajlm-1555	117	2	sex	sex	NOUN
ajlm-1555	117	3	was	be	AUX
ajlm-1555	117	4	also	also	ADV
ajlm-1555	117	5	significantly	significantly	ADV
ajlm-1555	117	6	associated	associate	VERB
ajlm-1555	117	7	with	with	ADP
ajlm-1555	117	8	hpv	hpv	ADJ
ajlm-1555	117	9	infection	infection	NOUN
ajlm-1555	117	10	.	.	PUNCT
ajlm-1555	118	1	the	the	DET
ajlm-1555	118	2	hpv	hpv	PROPN
ajlm-1555	118	3	vaccine	vaccine	NOUN
ajlm-1555	118	4	for	for	ADP
ajlm-1555	118	5	use	use	NOUN
ajlm-1555	118	6	in	in	ADP
ajlm-1555	118	7	nigeria	nigeria	PROPN
ajlm-1555	118	8	should	should	AUX
ajlm-1555	118	9	cover	cover	VERB
ajlm-1555	118	10	at	at	ADP
ajlm-1555	118	11	least	least	ADJ
ajlm-1555	118	12	the	the	DET
ajlm-1555	118	13	commonest	commonest	NOUN
ajlm-1555	118	14	circulating	circulate	VERB
ajlm-1555	118	15	genotypes	genotype	NOUN
ajlm-1555	118	16	to	to	PART
ajlm-1555	118	17	reduce	reduce	VERB
ajlm-1555	118	18	the	the	DET
ajlm-1555	118	19	risk	risk	NOUN
ajlm-1555	118	20	of	of	ADP
ajlm-1555	118	21	hpv	hpv	NOUN
ajlm-1555	118	22	-	-	PUNCT
ajlm-1555	118	23	associated	associate	VERB
ajlm-1555	118	24	oropharyngeal	oropharyngeal	NOUN
ajlm-1555	118	25	and	and	CCONJ
ajlm-1555	118	26	other	other	ADJ
ajlm-1555	118	27	cancers	cancer	NOUN
ajlm-1555	118	28	in	in	ADP
ajlm-1555	118	29	nigeria	nigeria	PROPN
ajlm-1555	118	30	.	.	PUNCT
ajlm-1555	119	1	acknowledgements	acknowledgement	NOUN
ajlm-1555	119	2	we	we	PRON
ajlm-1555	119	3	are	be	AUX
ajlm-1555	119	4	grateful	grateful	ADJ
ajlm-1555	119	5	to	to	ADP
ajlm-1555	119	6	the	the	DET
ajlm-1555	119	7	members	member	NOUN
ajlm-1555	119	8	of	of	ADP
ajlm-1555	119	9	staff	staff	NOUN
ajlm-1555	119	10	of	of	ADP
ajlm-1555	119	11	oyo	oyo	NOUN
ajlm-1555	119	12	state	state	NOUN
ajlm-1555	119	13	dental	dental	ADJ
ajlm-1555	119	14	clinic	clinic	NOUN
ajlm-1555	119	15	,	,	PUNCT
ajlm-1555	119	16	ibadan	ibadan	PROPN
ajlm-1555	119	17	,	,	PUNCT
ajlm-1555	119	18	for	for	ADP
ajlm-1555	119	19	their	their	PRON
ajlm-1555	119	20	assistance	assistance	NOUN
ajlm-1555	119	21	in	in	ADP
ajlm-1555	119	22	collecting	collect	VERB
ajlm-1555	119	23	samples	sample	NOUN
ajlm-1555	119	24	analysed	analyse	VERB
ajlm-1555	119	25	,	,	PUNCT
ajlm-1555	119	26	as	as	ADV
ajlm-1555	119	27	well	well	ADV
ajlm-1555	119	28	as	as	ADP
ajlm-1555	119	29	the	the	DET
ajlm-1555	119	30	participants	participant	NOUN
ajlm-1555	119	31	in	in	ADP
ajlm-1555	119	32	this	this	DET
ajlm-1555	119	33	study	study	NOUN
ajlm-1555	119	34	.	.	PUNCT
ajlm-1555	120	1	competing	compete	VERB
ajlm-1555	120	2	interests	interest	NOUN
ajlm-1555	120	3	the	the	DET
ajlm-1555	120	4	authors	author	NOUN
ajlm-1555	120	5	declare	declare	VERB
ajlm-1555	120	6	that	that	SCONJ
ajlm-1555	120	7	they	they	PRON
ajlm-1555	120	8	have	have	VERB
ajlm-1555	120	9	no	no	DET
ajlm-1555	120	10	financial	financial	ADJ
ajlm-1555	120	11	or	or	CCONJ
ajlm-1555	120	12	personal	personal	ADJ
ajlm-1555	120	13	relationships	relationship	NOUN
ajlm-1555	120	14	that	that	PRON
ajlm-1555	120	15	may	may	AUX
ajlm-1555	120	16	have	have	AUX
ajlm-1555	120	17	inappropriately	inappropriately	ADV
ajlm-1555	120	18	influenced	influence	VERB
ajlm-1555	120	19	them	they	PRON
ajlm-1555	120	20	,	,	PUNCT
ajlm-1555	120	21	as	as	ADV
ajlm-1555	120	22	well	well	ADV
ajlm-1555	120	23	as	as	ADP
ajlm-1555	120	24	the	the	DET
ajlm-1555	120	25	participants	participant	NOUN
ajlm-1555	120	26	in	in	ADP
ajlm-1555	120	27	writing	write	VERB
ajlm-1555	120	28	this	this	DET
ajlm-1555	120	29	article	article	NOUN
ajlm-1555	120	30	.	.	PUNCT
ajlm-1555	121	1	authors	author	NOUN
ajlm-1555	121	2	’	’	PART
ajlm-1555	121	3	contributions	contribution	NOUN
ajlm-1555	121	4	a.o.f	a.o.f	NOUN
ajlm-1555	121	5	.	.	PUNCT
ajlm-1555	121	6	was	be	AUX
ajlm-1555	121	7	responsible	responsible	ADJ
ajlm-1555	121	8	for	for	ADP
ajlm-1555	121	9	conceptualisation	conceptualisation	NOUN
ajlm-1555	121	10	of	of	ADP
ajlm-1555	121	11	the	the	DET
ajlm-1555	121	12	idea	idea	NOUN
ajlm-1555	121	13	,	,	PUNCT
ajlm-1555	121	14	sample	sample	NOUN
ajlm-1555	121	15	collection	collection	NOUN
ajlm-1555	121	16	,	,	PUNCT
ajlm-1555	121	17	sample	sample	NOUN
ajlm-1555	121	18	analysis	analysis	NOUN
ajlm-1555	121	19	,	,	PUNCT
ajlm-1555	121	20	writing	writing	NOUN
ajlm-1555	121	21	of	of	ADP
ajlm-1555	121	22	the	the	DET
ajlm-1555	121	23	draft	draft	NOUN
ajlm-1555	121	24	manuscript	manuscript	NOUN
ajlm-1555	121	25	and	and	CCONJ
ajlm-1555	121	26	manuscript	manuscript	PROPN
ajlm-1555	121	27	review	review	PROPN
ajlm-1555	121	28	.	.	PUNCT
ajlm-1555	122	1	o.s.b	o.s.b	PROPN
ajlm-1555	122	2	.	.	PROPN
ajlm-1555	122	3	contributed	contribute	VERB
ajlm-1555	122	4	to	to	ADP
ajlm-1555	122	5	conceptualisation	conceptualisation	NOUN
ajlm-1555	122	6	of	of	ADP
ajlm-1555	122	7	the	the	DET
ajlm-1555	122	8	idea	idea	NOUN
ajlm-1555	122	9	,	,	PUNCT
ajlm-1555	122	10	sample	sample	NOUN
ajlm-1555	122	11	collection	collection	NOUN
ajlm-1555	122	12	,	,	PUNCT
ajlm-1555	122	13	sample	sample	NOUN
ajlm-1555	122	14	analysis	analysis	NOUN
ajlm-1555	122	15	and	and	CCONJ
ajlm-1555	122	16	manuscript	manuscript	NOUN
ajlm-1555	122	17	review	review	NOUN
ajlm-1555	122	18	.	.	PUNCT
ajlm-1555	123	1	g.n.o	g.n.o	NOUN
ajlm-1555	123	2	.	.	PUNCT
ajlm-1555	124	1	and	and	CCONJ
ajlm-1555	124	2	o.d.o	o.d.o	NOUN
ajlm-1555	124	3	.	.	PUNCT
ajlm-1555	124	4	were	be	AUX
ajlm-1555	124	5	involved	involve	VERB
ajlm-1555	124	6	in	in	ADP
ajlm-1555	124	7	conceptualisation	conceptualisation	NOUN
ajlm-1555	124	8	of	of	ADP
ajlm-1555	124	9	the	the	DET
ajlm-1555	124	10	idea	idea	NOUN
ajlm-1555	124	11	,	,	PUNCT
ajlm-1555	124	12	sample	sample	VERB
ajlm-1555	124	13	analysis	analysis	NOUN
ajlm-1555	124	14	and	and	CCONJ
ajlm-1555	124	15	manuscript	manuscript	NOUN
ajlm-1555	124	16	review	review	NOUN
ajlm-1555	124	17	,	,	PUNCT
ajlm-1555	124	18	while	while	SCONJ
ajlm-1555	124	19	j.a	j.a	PROPN
ajlm-1555	124	20	.	.	PROPN
ajlm-1555	124	21	contributed	contribute	VERB
ajlm-1555	124	22	to	to	ADP
ajlm-1555	124	23	conceptualisation	conceptualisation	NOUN
ajlm-1555	124	24	of	of	ADP
ajlm-1555	124	25	the	the	DET
ajlm-1555	124	26	idea	idea	NOUN
ajlm-1555	124	27	,	,	PUNCT
ajlm-1555	124	28	sample	sample	NOUN
ajlm-1555	124	29	collection	collection	NOUN
ajlm-1555	124	30	and	and	CCONJ
ajlm-1555	124	31	manuscript	manuscript	PROPN
ajlm-1555	124	32	review	review	NOUN
ajlm-1555	124	33	.	.	PUNCT
ajlm-1555	125	1	sources	source	NOUN
ajlm-1555	125	2	of	of	ADP
ajlm-1555	125	3	support	support	NOUN
ajlm-1555	125	4	this	this	DET
ajlm-1555	125	5	study	study	NOUN
ajlm-1555	125	6	was	be	AUX
ajlm-1555	125	7	partly	partly	ADV
ajlm-1555	125	8	funded	fund	VERB
ajlm-1555	125	9	by	by	ADP
ajlm-1555	125	10	the	the	DET
ajlm-1555	125	11	college	college	NOUN
ajlm-1555	125	12	of	of	ADP
ajlm-1555	125	13	medicine	medicine	NOUN
ajlm-1555	125	14	seed	seed	NOUN
ajlm-1555	125	15	award	award	PROPN
ajlm-1555	125	16	2014	2014	NUM
ajlm-1555	125	17	.	.	PUNCT
ajlm-1555	126	1	the	the	DET
ajlm-1555	126	2	manuscript	manuscript	NOUN
ajlm-1555	126	3	writing	writing	NOUN
ajlm-1555	126	4	of	of	ADP
ajlm-1555	126	5	the	the	DET
ajlm-1555	126	6	project	project	NOUN
ajlm-1555	126	7	described	describe	VERB
ajlm-1555	126	8	was	be	AUX
ajlm-1555	126	9	supported	support	VERB
ajlm-1555	126	10	by	by	ADP
ajlm-1555	126	11	the	the	DET
ajlm-1555	126	12	medical	medical	ADJ
ajlm-1555	126	13	education	education	PROPN
ajlm-1555	126	14	partnership	partnership	NOUN
ajlm-1555	126	15	initiative	initiative	NOUN
ajlm-1555	126	16	in	in	ADP
ajlm-1555	126	17	nigeria	nigeria	PROPN
ajlm-1555	126	18	project	project	NOUN
ajlm-1555	126	19	funded	fund	VERB
ajlm-1555	126	20	by	by	ADP
ajlm-1555	126	21	fogarty	fogarty	PROPN
ajlm-1555	126	22	international	international	PROPN
ajlm-1555	126	23	,	,	PUNCT
ajlm-1555	126	24	the	the	DET
ajlm-1555	126	25	office	office	NOUN
ajlm-1555	126	26	of	of	ADP
ajlm-1555	126	27	aids	aids	PROPN
ajlm-1555	126	28	research	research	NOUN
ajlm-1555	126	29	,	,	PUNCT
ajlm-1555	126	30	and	and	CCONJ
ajlm-1555	126	31	the	the	DET
ajlm-1555	126	32	national	national	ADJ
ajlm-1555	126	33	human	human	ADJ
ajlm-1555	126	34	genome	genome	NOUN
ajlm-1555	126	35	research	research	NOUN
ajlm-1555	126	36	institute	institute	NOUN
ajlm-1555	126	37	of	of	ADP
ajlm-1555	126	38	the	the	DET
ajlm-1555	126	39	united	united	PROPN
ajlm-1555	126	40	states	states	PROPN
ajlm-1555	126	41	national	national	PROPN
ajlm-1555	126	42	institutes	institutes	PROPN
ajlm-1555	126	43	of	of	ADP
ajlm-1555	126	44	health	health	NOUN
ajlm-1555	126	45	,	,	PUNCT
ajlm-1555	126	46	the	the	DET
ajlm-1555	126	47	health	health	NOUN
ajlm-1555	126	48	resources	resource	NOUN
ajlm-1555	126	49	and	and	CCONJ
ajlm-1555	126	50	services	service	NOUN
ajlm-1555	126	51	administration	administration	NOUN
ajlm-1555	126	52	and	and	CCONJ
ajlm-1555	126	53	the	the	DET
ajlm-1555	126	54	office	office	NOUN
ajlm-1555	126	55	of	of	ADP
ajlm-1555	126	56	the	the	DET
ajlm-1555	126	57	united	united	PROPN
ajlm-1555	126	58	states	states	PROPN
ajlm-1555	126	59	global	global	ADJ
ajlm-1555	126	60	aids	aids	PROPN
ajlm-1555	126	61	coordinator	coordinator	NOUN
ajlm-1555	126	62	under	under	ADP
ajlm-1555	126	63	award	award	NOUN
ajlm-1555	126	64	number	number	NOUN
ajlm-1555	126	65	r24tw008878	r24tw008878	PROPN
ajlm-1555	126	66	.	.	PUNCT
ajlm-1555	127	1	data	datum	NOUN
ajlm-1555	127	2	availability	availability	NOUN
ajlm-1555	127	3	the	the	DET
ajlm-1555	127	4	authors	author	NOUN
ajlm-1555	127	5	confirm	confirm	VERB
ajlm-1555	127	6	that	that	SCONJ
ajlm-1555	127	7	the	the	DET
ajlm-1555	127	8	data	datum	NOUN
ajlm-1555	127	9	supporting	support	VERB
ajlm-1555	127	10	the	the	DET
ajlm-1555	127	11	findings	finding	NOUN
ajlm-1555	127	12	of	of	ADP
ajlm-1555	127	13	this	this	DET
ajlm-1555	127	14	study	study	NOUN
ajlm-1555	127	15	are	be	AUX
ajlm-1555	127	16	available	available	ADJ
ajlm-1555	127	17	within	within	ADP
ajlm-1555	127	18	the	the	DET
ajlm-1555	127	19	article	article	NOUN
ajlm-1555	127	20	.	.	PUNCT
ajlm-1555	128	1	disclaimer	disclaimer	VERB
ajlm-1555	128	2	the	the	DET
ajlm-1555	128	3	views	view	NOUN
ajlm-1555	128	4	and	and	CCONJ
ajlm-1555	128	5	opinions	opinion	NOUN
ajlm-1555	128	6	expressed	express	VERB
ajlm-1555	128	7	in	in	ADP
ajlm-1555	128	8	this	this	DET
ajlm-1555	128	9	article	article	NOUN
ajlm-1555	128	10	are	be	AUX
ajlm-1555	128	11	those	those	PRON
ajlm-1555	128	12	of	of	ADP
ajlm-1555	128	13	the	the	DET
ajlm-1555	128	14	authors	author	NOUN
ajlm-1555	128	15	and	and	CCONJ
ajlm-1555	128	16	do	do	AUX
ajlm-1555	128	17	not	not	PART
ajlm-1555	128	18	necessarily	necessarily	ADV
ajlm-1555	128	19	reflect	reflect	VERB
ajlm-1555	128	20	the	the	DET
ajlm-1555	128	21	official	official	ADJ
ajlm-1555	128	22	policy	policy	NOUN
ajlm-1555	128	23	or	or	CCONJ
ajlm-1555	128	24	position	position	NOUN
ajlm-1555	128	25	of	of	ADP
ajlm-1555	128	26	any	any	DET
ajlm-1555	128	27	affiliated	affiliated	ADJ
ajlm-1555	128	28	agency	agency	NOUN
ajlm-1555	128	29	of	of	ADP
ajlm-1555	128	30	the	the	DET
ajlm-1555	128	31	authors	author	NOUN
ajlm-1555	128	32	.	.	PUNCT
ajlm-1555	129	1	the	the	DET
ajlm-1555	129	2	content	content	NOUN
ajlm-1555	129	3	is	be	AUX
ajlm-1555	129	4	solely	solely	ADV
ajlm-1555	129	5	the	the	DET
ajlm-1555	129	6	responsibility	responsibility	NOUN
ajlm-1555	129	7	of	of	ADP
ajlm-1555	129	8	the	the	DET
ajlm-1555	129	9	authors	author	NOUN
ajlm-1555	129	10	and	and	CCONJ
ajlm-1555	129	11	does	do	AUX
ajlm-1555	129	12	not	not	PART
ajlm-1555	129	13	necessarily	necessarily	ADV
ajlm-1555	129	14	represent	represent	VERB
ajlm-1555	129	15	the	the	DET
ajlm-1555	129	16	official	official	ADJ
ajlm-1555	129	17	views	view	NOUN
ajlm-1555	129	18	of	of	ADP
ajlm-1555	129	19	the	the	DET
ajlm-1555	129	20	funding	funding	NOUN
ajlm-1555	129	21	organisations	organisation	NOUN
ajlm-1555	129	22	.	.	PUNCT
ajlm-1555	130	1	references	reference	NOUN
ajlm-1555	130	2	gillison	gillison	VERB
ajlm-1555	130	3	ml	ml	PROPN
ajlm-1555	130	4	,	,	PUNCT
ajlm-1555	130	5	koch	koch	PROPN
ajlm-1555	130	6	wm	wm	PROPN
ajlm-1555	130	7	,	,	PUNCT
ajlm-1555	130	8	capone	capone	PROPN
ajlm-1555	130	9	rb	rb	PROPN
ajlm-1555	130	10	,	,	PUNCT
ajlm-1555	130	11	et	et	PROPN
ajlm-1555	130	12	al	al	PROPN
ajlm-1555	130	13	.	.	PROPN
ajlm-1555	130	14	evidence	evidence	NOUN
ajlm-1555	130	15	for	for	ADP
ajlm-1555	130	16	a	a	DET
ajlm-1555	130	17	causal	causal	ADJ
ajlm-1555	130	18	association	association	NOUN
ajlm-1555	130	19	between	between	ADP
ajlm-1555	130	20	human	human	ADJ
ajlm-1555	130	21	papillomavirus	papillomavirus	NOUN
ajlm-1555	130	22	and	and	CCONJ
ajlm-1555	130	23	a	a	DET
ajlm-1555	130	24	subset	subset	NOUN
ajlm-1555	130	25	of	of	ADP
ajlm-1555	130	26	head	head	NOUN
ajlm-1555	130	27	and	and	CCONJ
ajlm-1555	130	28	neck	neck	NOUN
ajlm-1555	130	29	cancers	cancer	NOUN
ajlm-1555	130	30	.	.	PUNCT
ajlm-1555	131	1	j	j	PROPN
ajlm-1555	131	2	natl	natl	PROPN
ajlm-1555	131	3	cancer	cancer	PROPN
ajlm-1555	131	4	inst	inst	PROPN
ajlm-1555	131	5	.	.	PUNCT
ajlm-1555	132	1	2000;92(9):709–720	2000;92(9):709–720	X
ajlm-1555	132	2	.	.	PUNCT
ajlm-1555	133	1	https://doi.org/10.1093/jnci/92.9.709	https://doi.org/10.1093/jnci/92.9.709	PROPN
ajlm-1555	133	2	greenspan	greenspan	PROPN
ajlm-1555	133	3	d	d	PROPN
ajlm-1555	133	4	,	,	PUNCT
ajlm-1555	133	5	de	de	X
ajlm-1555	133	6	villiers	villiers	PROPN
ajlm-1555	133	7	em	em	PRON
ajlm-1555	133	8	,	,	PUNCT
ajlm-1555	133	9	greenspan	greenspan	PROPN
ajlm-1555	133	10	js	js	PROPN
ajlm-1555	133	11	,	,	PUNCT
ajlm-1555	133	12	de	de	PROPN
ajlm-1555	133	13	souza	souza	PROPN
ajlm-1555	133	14	yg	yg	PROPN
ajlm-1555	133	15	,	,	PUNCT
ajlm-1555	133	16	zur	zur	PROPN
ajlm-1555	133	17	hausen	hausen	PROPN
ajlm-1555	133	18	h.	h.	PROPN
ajlm-1555	133	19	unusual	unusual	ADJ
ajlm-1555	133	20	hpv	hpv	ADJ
ajlm-1555	133	21	types	type	NOUN
ajlm-1555	133	22	in	in	ADP
ajlm-1555	133	23	oral	oral	ADJ
ajlm-1555	133	24	warts	wart	NOUN
ajlm-1555	133	25	in	in	ADP
ajlm-1555	133	26	association	association	NOUN
ajlm-1555	133	27	with	with	ADP
ajlm-1555	133	28	hiv	hiv	PROPN
ajlm-1555	133	29	infection	infection	NOUN
ajlm-1555	133	30	.	.	PUNCT
ajlm-1555	134	1	j	j	PROPN
ajlm-1555	134	2	oral	oral	ADJ
ajlm-1555	134	3	pathol	pathol	NOUN
ajlm-1555	134	4	.	.	PUNCT
ajlm-1555	135	1	1988;17(9–10):482–488	1988;17(9–10):482–488	NUM
ajlm-1555	135	2	.	.	PUNCT
ajlm-1555	136	1	https://doi.org/10.1111/j.1600-0714.1988.tb01321.x	https://doi.org/10.1111/j.1600-0714.1988.tb01321.x	PROPN
ajlm-1555	136	2	wood	wood	PROPN
ajlm-1555	136	3	nh	nh	PROPN
ajlm-1555	136	4	,	,	PUNCT
ajlm-1555	136	5	makua	makua	NOUN
ajlm-1555	136	6	ks	ks	PROPN
ajlm-1555	136	7	,	,	PUNCT
ajlm-1555	136	8	lebelo	lebelo	NOUN
ajlm-1555	136	9	rl	rl	PROPN
ajlm-1555	136	10	,	,	PUNCT
ajlm-1555	136	11	et	et	PROPN
ajlm-1555	136	12	al	al	PROPN
ajlm-1555	136	13	.	.	PROPN
ajlm-1555	137	1	human	human	ADJ
ajlm-1555	137	2	papillomavirus	papillomavirus	NOUN
ajlm-1555	137	3	prevalence	prevalence	NOUN
ajlm-1555	137	4	in	in	ADP
ajlm-1555	137	5	oral	oral	ADJ
ajlm-1555	137	6	and	and	CCONJ
ajlm-1555	137	7	oropharyngeal	oropharyngeal	ADJ
ajlm-1555	137	8	rinse	rinse	NOUN
ajlm-1555	137	9	and	and	CCONJ
ajlm-1555	137	10	gargle	gargle	NOUN
ajlm-1555	137	11	specimens	specimen	NOUN
ajlm-1555	137	12	of	of	ADP
ajlm-1555	137	13	dental	dental	ADJ
ajlm-1555	137	14	patients	patient	NOUN
ajlm-1555	137	15	and	and	CCONJ
ajlm-1555	137	16	of	of	ADP
ajlm-1555	137	17	an	an	DET
ajlm-1555	137	18	hiv	hiv	NOUN
ajlm-1555	137	19	-	-	PUNCT
ajlm-1555	137	20	positive	positive	ADJ
ajlm-1555	137	21	cohort	cohort	NOUN
ajlm-1555	137	22	from	from	ADP
ajlm-1555	137	23	pretoria	pretoria	PROPN
ajlm-1555	137	24	,	,	PUNCT
ajlm-1555	137	25	south	south	PROPN
ajlm-1555	137	26	africa	africa	PROPN
ajlm-1555	137	27	.	.	PUNCT
ajlm-1555	138	1	adv	adv	PROPN
ajlm-1555	138	2	virol	virol	PROPN
ajlm-1555	138	3	.	.	PUNCT
ajlm-1555	139	1	2020;2020:2395219	2020;2020:2395219	NUM
ajlm-1555	139	2	.	.	PUNCT
ajlm-1555	140	1	https://doi.org/10.1155/2020/2395219	https://doi.org/10.1155/2020/2395219	PROPN
ajlm-1555	140	2	beachler	beachler	PROPN
ajlm-1555	140	3	dc	dc	PROPN
ajlm-1555	140	4	,	,	PUNCT
ajlm-1555	140	5	weber	weber	PROPN
ajlm-1555	140	6	km	km	PROPN
ajlm-1555	140	7	,	,	PUNCT
ajlm-1555	140	8	margolick	margolick	PROPN
ajlm-1555	140	9	jb	jb	PROPN
ajlm-1555	140	10	,	,	PUNCT
ajlm-1555	140	11	et	et	PROPN
ajlm-1555	140	12	al	al	PROPN
ajlm-1555	140	13	.	.	PUNCT
ajlm-1555	140	14	risk	risk	NOUN
ajlm-1555	140	15	factors	factor	NOUN
ajlm-1555	140	16	for	for	ADP
ajlm-1555	140	17	oral	oral	ADJ
ajlm-1555	140	18	hpv	hpv	ADJ
ajlm-1555	140	19	infection	infection	NOUN
ajlm-1555	140	20	among	among	ADP
ajlm-1555	140	21	a	a	DET
ajlm-1555	140	22	high	high	ADJ
ajlm-1555	140	23	prevalence	prevalence	NOUN
ajlm-1555	140	24	population	population	NOUN
ajlm-1555	140	25	of	of	ADP
ajlm-1555	140	26	hiv	hiv	PROPN
ajlm-1555	140	27	-	-	PUNCT
ajlm-1555	140	28	positive	positive	ADJ
ajlm-1555	140	29	and	and	CCONJ
ajlm-1555	140	30	at	at	ADP
ajlm-1555	140	31	-	-	PUNCT
ajlm-1555	140	32	risk	risk	NOUN
ajlm-1555	140	33	hiv	hiv	NOUN
ajlm-1555	140	34	-	-	PUNCT
ajlm-1555	140	35	negative	negative	ADJ
ajlm-1555	140	36	adults	adult	NOUN
ajlm-1555	140	37	.	.	PUNCT
ajlm-1555	141	1	cancer	cancer	NOUN
ajlm-1555	141	2	epidemiol	epidemiol	PROPN
ajlm-1555	141	3	biomarkers	biomarker	NOUN
ajlm-1555	141	4	prev	prev	AUX
ajlm-1555	141	5	.	.	PUNCT
ajlm-1555	142	1	2012;21(1):122–133	2012;21(1):122–133	NUM
ajlm-1555	142	2	.	.	PUNCT
ajlm-1555	143	1	https://doi.org/10.1158/1055-9965.epi-11-0734	https://doi.org/10.1158/1055-9965.epi-11-0734	CCONJ
ajlm-1555	143	2	cogliano	cogliano	PROPN
ajlm-1555	143	3	v	v	NOUN
ajlm-1555	143	4	,	,	PUNCT
ajlm-1555	143	5	baan	baan	PROPN
ajlm-1555	143	6	r	r	PROPN
ajlm-1555	143	7	,	,	PUNCT
ajlm-1555	143	8	straif	straif	PROPN
ajlm-1555	143	9	k	k	PROPN
ajlm-1555	143	10	,	,	PUNCT
ajlm-1555	143	11	grosse	grosse	PROPN
ajlm-1555	143	12	y	y	PROPN
ajlm-1555	143	13	,	,	PUNCT
ajlm-1555	143	14	secretan	secretan	PROPN
ajlm-1555	143	15	b	b	PROPN
ajlm-1555	143	16	,	,	PUNCT
ajlm-1555	143	17	el	el	PROPN
ajlm-1555	143	18	ghissassi	ghissassi	PROPN
ajlm-1555	143	19	f.	f.	PROPN
ajlm-1555	143	20	carcinogenicity	carcinogenicity	NOUN
ajlm-1555	143	21	of	of	ADP
ajlm-1555	143	22	human	human	ADJ
ajlm-1555	143	23	papillomaviruses	papillomaviruse	NOUN
ajlm-1555	143	24	.	.	PUNCT
ajlm-1555	144	1	lancet	lancet	PROPN
ajlm-1555	144	2	oncol	oncol	PROPN
ajlm-1555	144	3	.	.	PUNCT
ajlm-1555	145	1	2005;6(4):204	2005;6(4):204	X
ajlm-1555	145	2	.	.	PUNCT
ajlm-1555	146	1	https://doi.org/10.1016/s1470-2045(05)70086-3	https://doi.org/10.1016/s1470-2045(05)70086-3	AUX
ajlm-1555	146	2	kurose	kurose	PROPN
ajlm-1555	146	3	k	k	PROPN
ajlm-1555	146	4	,	,	PUNCT
ajlm-1555	146	5	terai	terai	PROPN
ajlm-1555	146	6	m	m	PROPN
ajlm-1555	146	7	,	,	PUNCT
ajlm-1555	146	8	soedarsono	soedarsono	VERB
ajlm-1555	146	9	n	n	CCONJ
ajlm-1555	146	10	,	,	PUNCT
ajlm-1555	146	11	et	et	PROPN
ajlm-1555	146	12	al	al	PROPN
ajlm-1555	146	13	.	.	PUNCT
ajlm-1555	147	1	low	low	ADJ
ajlm-1555	147	2	prevalence	prevalence	NOUN
ajlm-1555	147	3	of	of	ADP
ajlm-1555	147	4	hpv	hpv	ADJ
ajlm-1555	147	5	infection	infection	NOUN
ajlm-1555	147	6	and	and	CCONJ
ajlm-1555	147	7	its	its	PRON
ajlm-1555	147	8	natural	natural	ADJ
ajlm-1555	147	9	history	history	NOUN
ajlm-1555	147	10	in	in	ADP
ajlm-1555	147	11	normal	normal	ADJ
ajlm-1555	147	12	oral	oral	ADJ
ajlm-1555	147	13	mucosa	mucosa	NOUN
ajlm-1555	147	14	among	among	ADP
ajlm-1555	147	15	volunteers	volunteer	NOUN
ajlm-1555	147	16	on	on	ADP
ajlm-1555	147	17	miyako	miyako	PROPN
ajlm-1555	147	18	island	island	PROPN
ajlm-1555	147	19	,	,	PUNCT
ajlm-1555	147	20	japan	japan	PROPN
ajlm-1555	147	21	.	.	PUNCT
ajlm-1555	148	1	oral	oral	ADJ
ajlm-1555	148	2	surg	surg	PROPN
ajlm-1555	148	3	oral	oral	ADJ
ajlm-1555	148	4	med	med	ADJ
ajlm-1555	148	5	oral	oral	ADJ
ajlm-1555	148	6	pathol	pathol	NOUN
ajlm-1555	148	7	oral	oral	ADJ
ajlm-1555	148	8	radiol	radiol	NOUN
ajlm-1555	148	9	endod	endod	PROPN
ajlm-1555	148	10	.	.	PUNCT
ajlm-1555	149	1	2004;98(1):91–96	2004;98(1):91–96	X
ajlm-1555	149	2	.	.	PUNCT
ajlm-1555	149	3	https://doi.org/10.1016/j.tripleo.2003.12.029	https://doi.org/10.1016/j.tripleo.2003.12.029	PROPN
ajlm-1555	149	4	d’souza	d’souza	PROPN
ajlm-1555	149	5	g	g	PROPN
ajlm-1555	149	6	,	,	PUNCT
ajlm-1555	149	7	kreimer	kreimer	PROPN
ajlm-1555	149	8	ar	ar	PROPN
ajlm-1555	149	9	,	,	PUNCT
ajlm-1555	149	10	viscidi	viscidi	NOUN
ajlm-1555	149	11	r	r	NOUN
ajlm-1555	149	12	,	,	PUNCT
ajlm-1555	149	13	et	et	PROPN
ajlm-1555	149	14	al	al	PROPN
ajlm-1555	149	15	.	.	PUNCT
ajlm-1555	149	16	case	case	NOUN
ajlm-1555	149	17	-	-	PUNCT
ajlm-1555	149	18	control	control	NOUN
ajlm-1555	149	19	study	study	NOUN
ajlm-1555	149	20	of	of	ADP
ajlm-1555	149	21	human	human	ADJ
ajlm-1555	149	22	papillomavirus	papillomavirus	NOUN
ajlm-1555	149	23	and	and	CCONJ
ajlm-1555	149	24	oropharyngeal	oropharyngeal	NOUN
ajlm-1555	149	25	cancer	cancer	NOUN
ajlm-1555	149	26	.	.	PUNCT
ajlm-1555	150	1	n	n	PROPN
ajlm-1555	150	2	engl	engl	PROPN
ajlm-1555	150	3	j	j	PROPN
ajlm-1555	150	4	med	med	PROPN
ajlm-1555	150	5	.	.	PUNCT
ajlm-1555	151	1	2007;356(19):1944–1956	2007;356(19):1944–1956	NUM
ajlm-1555	151	2	.	.	PUNCT
ajlm-1555	152	1	https://doi.org/10.1056/nejmoa065497	https://doi.org/10.1056/nejmoa065497	PROPN
ajlm-1555	152	2	de	de	PROPN
ajlm-1555	152	3	villiers	villiers	PROPN
ajlm-1555	152	4	e	e	PROPN
ajlm-1555	152	5	-	-	NOUN
ajlm-1555	152	6	m	m	PROPN
ajlm-1555	152	7	,	,	PUNCT
ajlm-1555	152	8	gunst	gunst	PROPN
ajlm-1555	152	9	k	k	PROPN
ajlm-1555	152	10	,	,	PUNCT
ajlm-1555	152	11	stein	stein	PROPN
ajlm-1555	152	12	h	h	PROPN
ajlm-1555	152	13	,	,	PUNCT
ajlm-1555	152	14	scherübl	scherübl	PROPN
ajlm-1555	152	15	h.	h.	PROPN
ajlm-1555	152	16	esophageal	esophageal	ADJ
ajlm-1555	152	17	squamous	squamous	ADJ
ajlm-1555	152	18	cell	cell	NOUN
ajlm-1555	152	19	cancer	cancer	NOUN
ajlm-1555	152	20	in	in	ADP
ajlm-1555	152	21	patients	patient	NOUN
ajlm-1555	152	22	with	with	ADP
ajlm-1555	152	23	head	head	NOUN
ajlm-1555	152	24	and	and	CCONJ
ajlm-1555	152	25	neck	neck	NOUN
ajlm-1555	152	26	cancer	cancer	NOUN
ajlm-1555	152	27	:	:	PUNCT
ajlm-1555	152	28	prevalence	prevalence	NOUN
ajlm-1555	152	29	of	of	ADP
ajlm-1555	152	30	human	human	ADJ
ajlm-1555	152	31	papillomavirus	papillomavirus	NOUN
ajlm-1555	152	32	dna	dna	PROPN
ajlm-1555	152	33	sequences	sequence	NOUN
ajlm-1555	152	34	.	.	PUNCT
ajlm-1555	153	1	int	int	PROPN
ajlm-1555	153	2	j	j	PROPN
ajlm-1555	153	3	cancer	cancer	NOUN
ajlm-1555	153	4	.	.	PUNCT
ajlm-1555	154	1	2004;109(2):253–258	2004;109(2):253–258	X
ajlm-1555	154	2	.	.	PUNCT
ajlm-1555	155	1	https://doi.org/10.1002/ijc.11685	https://doi.org/10.1002/ijc.11685	PROPN
ajlm-1555	155	2	bruni	bruni	PROPN
ajlm-1555	155	3	l	l	PROPN
ajlm-1555	155	4	,	,	PUNCT
ajlm-1555	155	5	albero	albero	PROPN
ajlm-1555	155	6	g	g	PROPN
ajlm-1555	155	7	,	,	PUNCT
ajlm-1555	155	8	serrano	serrano	PROPN
ajlm-1555	155	9	b	b	NUM
ajlm-1555	155	10	,	,	PUNCT
ajlm-1555	155	11	et	et	PROPN
ajlm-1555	155	12	al	al	PROPN
ajlm-1555	155	13	.	.	PROPN
ajlm-1555	156	1	human	human	ADJ
ajlm-1555	156	2	papillomavirus	papillomavirus	NOUN
ajlm-1555	156	3	and	and	CCONJ
ajlm-1555	156	4	related	relate	VERB
ajlm-1555	156	5	diseases	disease	NOUN
ajlm-1555	156	6	in	in	ADP
ajlm-1555	156	7	africa	africa	PROPN
ajlm-1555	156	8	.	.	PUNCT
ajlm-1555	157	1	summary	summary	NOUN
ajlm-1555	157	2	report	report	NOUN
ajlm-1555	158	1	[	[	X
ajlm-1555	158	2	homepage	homepage	NOUN
ajlm-1555	158	3	on	on	ADP
ajlm-1555	158	4	the	the	DET
ajlm-1555	158	5	internet	internet	NOUN
ajlm-1555	158	6	]	]	PUNCT
ajlm-1555	158	7	.	.	PUNCT
ajlm-1555	158	8	2021	2021	NUM
ajlm-1555	159	1	[	[	X
ajlm-1555	159	2	cited	cite	VERB
ajlm-1555	159	3	2017	2017	NUM
ajlm-1555	159	4	mar	mar	PROPN
ajlm-1555	159	5	29	29	NUM
ajlm-1555	159	6	]	]	PUNCT
ajlm-1555	159	7	.	.	PUNCT
ajlm-1555	160	1	available	available	ADJ
ajlm-1555	160	2	from	from	ADP
ajlm-1555	160	3	:	:	PUNCT
ajlm-1555	160	4	http://www.hpvcentre.net/statistics/reports/xfx.pdf	http://www.hpvcentre.net/statistics/reports/xfx.pdf	PROPN
ajlm-1555	160	5	bruni	bruni	PROPN
ajlm-1555	160	6	l	l	PROPN
ajlm-1555	160	7	,	,	PUNCT
ajlm-1555	160	8	barrionuevo	barrionuevo	ADJ
ajlm-1555	160	9	-	-	PUNCT
ajlm-1555	160	10	rosas	rosa	NOUN
ajlm-1555	160	11	l	l	PROPN
ajlm-1555	160	12	,	,	PUNCT
ajlm-1555	160	13	albero	albero	PROPN
ajlm-1555	160	14	g	g	PROPN
ajlm-1555	160	15	,	,	PUNCT
ajlm-1555	160	16	et	et	PROPN
ajlm-1555	160	17	al	al	PROPN
ajlm-1555	160	18	.	.	PUNCT
ajlm-1555	160	19	executive	executive	ADJ
ajlm-1555	160	20	summary	summary	NOUN
ajlm-1555	161	1	[	[	X
ajlm-1555	161	2	document	document	NOUN
ajlm-1555	161	3	on	on	ADP
ajlm-1555	161	4	the	the	DET
ajlm-1555	161	5	internet	internet	NOUN
ajlm-1555	161	6	]	]	PUNCT
ajlm-1555	161	7	.	.	PUNCT
ajlm-1555	162	1	ico	ico	PROPN
ajlm-1555	162	2	/	/	SYM
ajlm-1555	162	3	iarc	iarc	NOUN
ajlm-1555	162	4	information	information	NOUN
ajlm-1555	162	5	centre	centre	PROPN
ajlm-1555	162	6	hpv	hpv	NOUN
ajlm-1555	162	7	cancer	cancer	NOUN
ajlm-1555	162	8	,	,	PUNCT
ajlm-1555	162	9	hpv	hpv	ADJ
ajlm-1555	162	10	information	information	NOUN
ajlm-1555	162	11	centre	centre	NOUN
ajlm-1555	162	12	;	;	PUNCT
ajlm-1555	162	13	2017	2017	NUM
ajlm-1555	162	14	[	[	PUNCT
ajlm-1555	162	15	cited	cite	VERB
ajlm-1555	162	16	2018	2018	NUM
ajlm-1555	162	17	july	july	PROPN
ajlm-1555	162	18	15	15	NUM
ajlm-1555	162	19	]	]	PUNCT
ajlm-1555	162	20	.	.	PUNCT
ajlm-1555	163	1	available	available	ADJ
ajlm-1555	163	2	from	from	ADP
ajlm-1555	163	3	:	:	PUNCT
ajlm-1555	163	4	http://www.hpvcentre.net/statistics/reports/nga.pdf	http://www.hpvcentre.net/statistics/reports/nga.pdf	PROPN
ajlm-1555	163	5	world	world	PROPN
ajlm-1555	163	6	health	health	PROPN
ajlm-1555	163	7	organization	organization	PROPN
ajlm-1555	163	8	.	.	PUNCT
ajlm-1555	164	1	human	human	ADJ
ajlm-1555	164	2	papillomavirus	papillomavirus	NOUN
ajlm-1555	164	3	(	(	PUNCT
ajlm-1555	164	4	hpv	hpv	NOUN
ajlm-1555	164	5	)	)	PUNCT
ajlm-1555	164	6	and	and	CCONJ
ajlm-1555	164	7	cervical	cervical	ADJ
ajlm-1555	164	8	cancer	cancer	NOUN
ajlm-1555	164	9	:	:	PUNCT
ajlm-1555	164	10	fact	fact	NOUN
ajlm-1555	164	11	sheets	sheet	NOUN
ajlm-1555	165	1	[	[	X
ajlm-1555	165	2	homepage	homepage	NOUN
ajlm-1555	165	3	on	on	ADP
ajlm-1555	165	4	the	the	DET
ajlm-1555	165	5	internet	internet	NOUN
ajlm-1555	165	6	]	]	PUNCT
ajlm-1555	165	7	.	.	PUNCT
ajlm-1555	166	1	2019	2019	NUM
ajlm-1555	167	1	[	[	X
ajlm-1555	167	2	cited	cite	VERB
ajlm-1555	167	3	2019	2019	NUM
ajlm-1555	167	4	sep	sep	NOUN
ajlm-1555	167	5	11	11	NUM
ajlm-1555	167	6	]	]	PUNCT
ajlm-1555	167	7	.	.	PUNCT
ajlm-1555	168	1	available	available	ADJ
ajlm-1555	168	2	from	from	ADP
ajlm-1555	168	3	:	:	PUNCT
ajlm-1555	168	4	https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer	https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer	PROPN
ajlm-1555	168	5	world	world	PROPN
ajlm-1555	168	6	health	health	PROPN
ajlm-1555	168	7	organization	organization	PROPN
ajlm-1555	168	8	regional	regional	ADJ
ajlm-1555	168	9	office	office	PROPN
ajlm-1555	168	10	for	for	ADP
ajlm-1555	168	11	africa	africa	PROPN
ajlm-1555	168	12	.	.	PUNCT
ajlm-1555	169	1	nigeria	nigeria	PROPN
ajlm-1555	169	2	’s	’s	PART
ajlm-1555	169	3	call	call	NOUN
ajlm-1555	169	4	to	to	ADP
ajlm-1555	169	5	action	action	NOUN
ajlm-1555	169	6	–	–	PUNCT
ajlm-1555	169	7	time	time	NOUN
ajlm-1555	169	8	to	to	PART
ajlm-1555	169	9	eliminate	eliminate	VERB
ajlm-1555	169	10	cervical	cervical	ADJ
ajlm-1555	169	11	cancer	cancer	NOUN
ajlm-1555	169	12	in	in	ADP
ajlm-1555	169	13	nigeria	nigeria	PROPN
ajlm-1555	170	1	[	[	X
ajlm-1555	170	2	homepage	homepage	NOUN
ajlm-1555	170	3	on	on	ADP
ajlm-1555	170	4	the	the	DET
ajlm-1555	170	5	internet	internet	NOUN
ajlm-1555	170	6	]	]	PUNCT
ajlm-1555	170	7	.	.	PUNCT
ajlm-1555	170	8	2019	2019	NUM
ajlm-1555	171	1	[	[	X
ajlm-1555	171	2	cited	cite	VERB
ajlm-1555	171	3	2021	2021	NUM
ajlm-1555	171	4	june	june	PROPN
ajlm-1555	171	5	8	8	NUM
ajlm-1555	171	6	]	]	PUNCT
ajlm-1555	171	7	.	.	PUNCT
ajlm-1555	172	1	available	available	ADJ
ajlm-1555	172	2	from	from	ADP
ajlm-1555	172	3	:	:	PUNCT
ajlm-1555	172	4	https://www.afro.who.int/news/nigerias-call-action-time-eliminate-cervical-cancer-nigeria	https://www.afro.who.int/news/nigerias-call-action-time-eliminate-cervical-cancer-nigeria	PROPN
ajlm-1555	172	5	vogt	vogt	PROPN
ajlm-1555	172	6	sl	sl	PROPN
ajlm-1555	172	7	,	,	PUNCT
ajlm-1555	172	8	gravitt	gravitt	X
ajlm-1555	172	9	pe	pe	PROPN
ajlm-1555	172	10	,	,	PUNCT
ajlm-1555	172	11	martinson	martinson	NOUN
ajlm-1555	172	12	na	na	PROPN
ajlm-1555	172	13	,	,	PUNCT
ajlm-1555	172	14	hoffmann	hoffmann	PROPN
ajlm-1555	172	15	j	j	PROPN
ajlm-1555	172	16	,	,	PUNCT
ajlm-1555	172	17	d’souza	d’souza	PROPN
ajlm-1555	172	18	g.	g.	PROPN
ajlm-1555	172	19	concordant	concordant	VERB
ajlm-1555	172	20	oral	oral	ADJ
ajlm-1555	172	21	-	-	PUNCT
ajlm-1555	172	22	genital	genital	ADJ
ajlm-1555	172	23	hpv	hpv	NOUN
ajlm-1555	172	24	infection	infection	NOUN
ajlm-1555	172	25	in	in	ADP
ajlm-1555	172	26	south	south	PROPN
ajlm-1555	172	27	africa	africa	PROPN
ajlm-1555	172	28	couples	couple	NOUN
ajlm-1555	172	29	:	:	PUNCT
ajlm-1555	172	30	evidence	evidence	NOUN
ajlm-1555	172	31	for	for	ADP
ajlm-1555	172	32	transmission	transmission	NOUN
ajlm-1555	172	33	.	.	PUNCT
ajlm-1555	173	1	front	front	ADJ
ajlm-1555	173	2	oncol	oncol	ADJ
ajlm-1555	173	3	.	.	PUNCT
ajlm-1555	174	1	2013;3:303	2013;3:303	NUM
ajlm-1555	174	2	.	.	PUNCT
ajlm-1555	175	1	https://doi.org/10.3389/fonc.2013.00303	https://doi.org/10.3389/fonc.2013.00303	PROPN
ajlm-1555	175	2	taherdoost	taherdoost	ADJ
ajlm-1555	175	3	h.	h.	NOUN
ajlm-1555	175	4	sampling	sample	VERB
ajlm-1555	175	5	methods	method	NOUN
ajlm-1555	175	6	in	in	ADP
ajlm-1555	175	7	research	research	NOUN
ajlm-1555	175	8	methodology	methodology	NOUN
ajlm-1555	175	9	:	:	PUNCT
ajlm-1555	175	10	how	how	SCONJ
ajlm-1555	175	11	to	to	PART
ajlm-1555	175	12	choose	choose	VERB
ajlm-1555	175	13	a	a	DET
ajlm-1555	175	14	sampling	sample	VERB
ajlm-1555	175	15	tech	tech	NOUN
ajlm-1555	175	16	-	-	PUNCT
ajlm-1555	175	17	nique	nique	NOUN
ajlm-1555	175	18	for	for	ADP
ajlm-1555	175	19	research	research	NOUN
ajlm-1555	175	20	[	[	X
ajlm-1555	175	21	homepage	homepage	NOUN
ajlm-1555	175	22	on	on	ADP
ajlm-1555	175	23	the	the	DET
ajlm-1555	175	24	internet	internet	NOUN
ajlm-1555	175	25	]	]	PUNCT
ajlm-1555	175	26	.	.	PUNCT
ajlm-1555	176	1	2016	2016	NUM
ajlm-1555	177	1	[	[	X
ajlm-1555	177	2	cited	cite	VERB
ajlm-1555	177	3	2021	2021	NUM
ajlm-1555	177	4	may	may	AUX
ajlm-1555	177	5	20	20	NUM
ajlm-1555	177	6	]	]	PUNCT
ajlm-1555	177	7	.	.	PUNCT
ajlm-1555	178	1	available	available	ADJ
ajlm-1555	178	2	from	from	ADP
ajlm-1555	178	3	:	:	PUNCT
ajlm-1555	178	4	https://hal.archives-ouvertes.fr/hal-02546796	https://hal.archives-ouvertes.fr/hal-02546796	NOUN
ajlm-1555	178	5	sotlar	sotlar	ADJ
ajlm-1555	178	6	k	k	NOUN
ajlm-1555	178	7	,	,	PUNCT
ajlm-1555	179	1	stubner	stubner	NOUN
ajlm-1555	179	2	a	a	NOUN
ajlm-1555	179	3	,	,	PUNCT
ajlm-1555	179	4	diemer	diemer	NOUN
ajlm-1555	179	5	d	d	PROPN
ajlm-1555	179	6	,	,	PUNCT
ajlm-1555	179	7	et	et	PROPN
ajlm-1555	179	8	al	al	PROPN
ajlm-1555	179	9	.	.	PUNCT
ajlm-1555	179	10	detection	detection	NOUN
ajlm-1555	179	11	of	of	ADP
ajlm-1555	179	12	high	high	ADJ
ajlm-1555	179	13	-	-	PUNCT
ajlm-1555	179	14	risk	risk	NOUN
ajlm-1555	179	15	human	human	ADJ
ajlm-1555	179	16	papillomavirus	papillomavirus	NOUN
ajlm-1555	179	17	e6	e6	NOUN
ajlm-1555	179	18	and	and	CCONJ
ajlm-1555	179	19	e7	e7	PROPN
ajlm-1555	179	20	oncogene	oncogene	NOUN
ajlm-1555	179	21	transcripts	transcript	NOUN
ajlm-1555	179	22	in	in	ADP
ajlm-1555	179	23	cervica	cervica	PROPN
ajlm-1555	179	24	scrapes	scrape	NOUN
ajlm-1555	179	25	by	by	ADP
ajlm-1555	179	26	nested	nest	VERB
ajlm-1555	179	27	rt	rt	PROPN
ajlm-1555	179	28	-	-	PUNCT
ajlm-1555	179	29	polymerase	polymerase	NOUN
ajlm-1555	179	30	chain	chain	NOUN
ajlm-1555	179	31	reaction	reaction	NOUN
ajlm-1555	179	32	.	.	PUNCT
ajlm-1555	180	1	j	j	PROPN
ajlm-1555	180	2	med	med	PROPN
ajlm-1555	180	3	virol	virol	NOUN
ajlm-1555	180	4	.	.	PUNCT
ajlm-1555	181	1	2004;74(1):107–116	2004;74(1):107–116	X
ajlm-1555	181	2	.	.	PUNCT
ajlm-1555	182	1	https://doi.org/10.1002/jmv.20153	https://doi.org/10.1002/jmv.20153	PROPN
ajlm-1555	182	2	sanders	sanders	PROPN
ajlm-1555	182	3	ae	ae	PROPN
ajlm-1555	182	4	,	,	PUNCT
ajlm-1555	182	5	slade	slade	PROPN
ajlm-1555	182	6	gd	gd	PROPN
ajlm-1555	182	7	,	,	PUNCT
ajlm-1555	182	8	patton	patton	PROPN
ajlm-1555	182	9	ll	ll	PROPN
ajlm-1555	182	10	.	.	PUNCT
ajlm-1555	183	1	national	national	ADJ
ajlm-1555	183	2	prevalence	prevalence	NOUN
ajlm-1555	183	3	of	of	ADP
ajlm-1555	183	4	oral	oral	ADJ
ajlm-1555	183	5	hpv	hpv	NOUN
ajlm-1555	183	6	infection	infection	NOUN
ajlm-1555	183	7	and	and	CCONJ
ajlm-1555	183	8	related	relate	VERB
ajlm-1555	183	9	risk	risk	NOUN
ajlm-1555	183	10	factors	factor	NOUN
ajlm-1555	183	11	in	in	ADP
ajlm-1555	183	12	the	the	DET
ajlm-1555	183	13	u.s	u.s	PROPN
ajlm-1555	183	14	.	.	PROPN
ajlm-1555	183	15	adult	adult	PROPN
ajlm-1555	183	16	population	population	NOUN
ajlm-1555	183	17	.	.	PUNCT
ajlm-1555	184	1	oral	oral	ADJ
ajlm-1555	184	2	dis	dis	PROPN
ajlm-1555	184	3	.	.	PUNCT
ajlm-1555	185	1	2012;18(5):430–441	2012;18(5):430–441	NUM
ajlm-1555	185	2	.	.	PUNCT
ajlm-1555	185	3	https://doi.org/10.1111/j.1601-0825.2011.01892.x	https://doi.org/10.1111/j.1601-0825.2011.01892.x	PROPN
ajlm-1555	185	4	gillison	gillison	NOUN
ajlm-1555	185	5	ml	ml	VERB
ajlm-1555	185	6	,	,	PUNCT
ajlm-1555	185	7	broutian	broutian	PROPN
ajlm-1555	185	8	t	t	PROPN
ajlm-1555	185	9	,	,	PUNCT
ajlm-1555	185	10	pickard	pickard	PROPN
ajlm-1555	185	11	rkl	rkl	PROPN
ajlm-1555	185	12	,	,	PUNCT
ajlm-1555	185	13	et	et	PROPN
ajlm-1555	185	14	al	al	PROPN
ajlm-1555	185	15	.	.	PUNCT
ajlm-1555	186	1	prevalence	prevalence	NOUN
ajlm-1555	186	2	of	of	ADP
ajlm-1555	186	3	oral	oral	ADJ
ajlm-1555	186	4	hpv	hpv	ADJ
ajlm-1555	186	5	infection	infection	NOUN
ajlm-1555	186	6	in	in	ADP
ajlm-1555	186	7	the	the	DET
ajlm-1555	186	8	united	united	PROPN
ajlm-1555	186	9	states	states	PROPN
ajlm-1555	186	10	,	,	PUNCT
ajlm-1555	186	11	2009–2010	2009–2010	NUM
ajlm-1555	186	12	.	.	PUNCT
ajlm-1555	187	1	jama	jama	PROPN
ajlm-1555	187	2	.	.	PUNCT
ajlm-1555	188	1	2012;307(7):693–703	2012;307(7):693–703	X
ajlm-1555	188	2	.	.	PUNCT
ajlm-1555	189	1	https://doi.org/10.1001/jama.2012.101	https://doi.org/10.1001/jama.2012.101	PROPN
ajlm-1555	189	2	schneider	schneider	NOUN
ajlm-1555	189	3	-	-	PUNCT
ajlm-1555	189	4	maunoury	maunoury	PROPN
ajlm-1555	189	5	s	s	NOUN
ajlm-1555	189	6	,	,	PUNCT
ajlm-1555	189	7	croissant	croissant	ADJ
ajlm-1555	189	8	o	o	NOUN
ajlm-1555	189	9	,	,	PUNCT
ajlm-1555	189	10	orth	orth	PROPN
ajlm-1555	189	11	g.	g.	PROPN
ajlm-1555	189	12	integration	integration	NOUN
ajlm-1555	189	13	of	of	ADP
ajlm-1555	189	14	human	human	ADJ
ajlm-1555	189	15	papillomavirus	papillomavirus	NOUN
ajlm-1555	189	16	type	type	NOUN
ajlm-1555	189	17	16	16	NUM
ajlm-1555	189	18	dna	dna	PROPN
ajlm-1555	189	19	sequences	sequence	NOUN
ajlm-1555	189	20	:	:	PUNCT
ajlm-1555	189	21	a	a	DET
ajlm-1555	189	22	possible	possible	ADJ
ajlm-1555	189	23	early	early	ADJ
ajlm-1555	189	24	event	event	NOUN
ajlm-1555	189	25	in	in	ADP
ajlm-1555	189	26	the	the	DET
ajlm-1555	189	27	progression	progression	NOUN
ajlm-1555	189	28	of	of	ADP
ajlm-1555	189	29	genital	genital	ADJ
ajlm-1555	189	30	tumors	tumor	NOUN
ajlm-1555	189	31	.	.	PUNCT
ajlm-1555	190	1	j	j	PROPN
ajlm-1555	190	2	virol	virol	PROPN
ajlm-1555	190	3	.	.	PUNCT
ajlm-1555	191	1	1987;61(10):3295–3298	1987;61(10):3295–3298	X
ajlm-1555	191	2	.	.	PUNCT
ajlm-1555	192	1	https://doi.org/10.1128/jvi.61.10.3295-3298.1987	https://doi.org/10.1128/jvi.61.10.3295-3298.1987	PROPN
ajlm-1555	192	2	de	de	PROPN
ajlm-1555	192	3	andrea	andrea	PROPN
ajlm-1555	192	4	m	m	PROPN
ajlm-1555	192	5	,	,	PUNCT
ajlm-1555	192	6	kiyono	kiyono	PROPN
ajlm-1555	192	7	t	t	PROPN
ajlm-1555	192	8	,	,	PUNCT
ajlm-1555	192	9	pal	pal	ADJ
ajlm-1555	192	10	a	a	PRON
ajlm-1555	192	11	,	,	PUNCT
ajlm-1555	192	12	kundu	kundu	PROPN
ajlm-1555	192	13	r.	r.	PROPN
ajlm-1555	192	14	human	human	PROPN
ajlm-1555	192	15	papillomavirus	papillomavirus	PROPN
ajlm-1555	192	16	e6	e6	PROPN
ajlm-1555	192	17	and	and	CCONJ
ajlm-1555	192	18	e7	e7	PROPN
ajlm-1555	192	19	:	:	PUNCT
ajlm-1555	192	20	the	the	DET
ajlm-1555	192	21	cervical	cervical	ADJ
ajlm-1555	192	22	cancer	cancer	NOUN
ajlm-1555	192	23	hallmarks	hallmark	NOUN
ajlm-1555	192	24	and	and	CCONJ
ajlm-1555	192	25	targets	target	NOUN
ajlm-1555	192	26	for	for	ADP
ajlm-1555	192	27	therapy	therapy	NOUN
ajlm-1555	192	28	.	.	PUNCT
ajlm-1555	193	1	front	front	ADJ
ajlm-1555	193	2	microbiol	microbiol	PROPN
ajlm-1555	193	3	.	.	PUNCT
ajlm-1555	194	1	2020;10:3116	2020;10:3116	X
ajlm-1555	194	2	.	.	PUNCT
ajlm-1555	195	1	https://doi.org/10.3389/fmicb.2019.03116	https://doi.org/10.3389/fmicb.2019.03116	PROPN
ajlm-1555	195	2	antonsson	antonsson	PROPN
ajlm-1555	195	3	a	a	PRON
ajlm-1555	195	4	,	,	PUNCT
ajlm-1555	195	5	cornford	cornford	PROPN
ajlm-1555	195	6	m	m	PROPN
ajlm-1555	195	7	,	,	PUNCT
ajlm-1555	195	8	perry	perry	PROPN
ajlm-1555	195	9	s	s	PROPN
ajlm-1555	195	10	,	,	PUNCT
ajlm-1555	195	11	davis	davis	PROPN
ajlm-1555	195	12	m	m	PROPN
ajlm-1555	195	13	,	,	PUNCT
ajlm-1555	195	14	dunne	dunne	PROPN
ajlm-1555	195	15	mp	mp	PROPN
ajlm-1555	195	16	,	,	PUNCT
ajlm-1555	195	17	whiteman	whiteman	PROPN
ajlm-1555	195	18	dc	dc	PROPN
ajlm-1555	195	19	.	.	PUNCT
ajlm-1555	196	1	prevalence	prevalence	NOUN
ajlm-1555	196	2	and	and	CCONJ
ajlm-1555	196	3	risk	risk	NOUN
ajlm-1555	196	4	factors	factor	NOUN
ajlm-1555	196	5	for	for	ADP
ajlm-1555	196	6	oral	oral	ADJ
ajlm-1555	196	7	hpv	hpv	ADJ
ajlm-1555	196	8	infection	infection	NOUN
ajlm-1555	196	9	in	in	ADP
ajlm-1555	196	10	young	young	ADJ
ajlm-1555	196	11	australians	australian	NOUN
ajlm-1555	196	12	.	.	PUNCT
ajlm-1555	197	1	plos	plos	PROPN
ajlm-1555	197	2	one	one	NUM
ajlm-1555	197	3	.	.	PUNCT
ajlm-1555	198	1	2014;9(3):e91761	2014;9(3):e91761	X
ajlm-1555	198	2	.	.	PUNCT
ajlm-1555	199	1	https://doi.org/10.1371/journal.pone.0091761	https://doi.org/10.1371/journal.pone.0091761	VERB
ajlm-1555	199	2	dalla	dalla	NOUN
ajlm-1555	199	3	torre	torre	PROPN
ajlm-1555	199	4	d	d	PROPN
ajlm-1555	199	5	,	,	PUNCT
ajlm-1555	199	6	burtscher	burtscher	NOUN
ajlm-1555	199	7	d	d	NOUN
ajlm-1555	199	8	,	,	PUNCT
ajlm-1555	199	9	sölder	sölder	NOUN
ajlm-1555	199	10	e	e	NOUN
ajlm-1555	199	11	,	,	PUNCT
ajlm-1555	199	12	widschwendter	widschwendter	PROPN
ajlm-1555	199	13	a	a	NOUN
ajlm-1555	199	14	,	,	PUNCT
ajlm-1555	199	15	rasse	rasse	PROPN
ajlm-1555	199	16	m	m	PROPN
ajlm-1555	199	17	,	,	PUNCT
ajlm-1555	199	18	puelacher	puelacher	PROPN
ajlm-1555	199	19	w.	w.	PROPN
ajlm-1555	199	20	the	the	DET
ajlm-1555	199	21	impact	impact	NOUN
ajlm-1555	199	22	of	of	ADP
ajlm-1555	199	23	sexual	sexual	ADJ
ajlm-1555	199	24	behavior	behavior	NOUN
ajlm-1555	199	25	on	on	ADP
ajlm-1555	199	26	oral	oral	ADJ
ajlm-1555	199	27	hpv	hpv	NOUN
ajlm-1555	199	28	infections	infection	NOUN
ajlm-1555	199	29	in	in	ADP
ajlm-1555	199	30	young	young	ADJ
ajlm-1555	199	31	unvaccinated	unvaccinate	VERB
ajlm-1555	199	32	adults	adult	NOUN
ajlm-1555	199	33	.	.	PUNCT
ajlm-1555	200	1	clin	clin	PROPN
ajlm-1555	200	2	oral	oral	PROPN
ajlm-1555	200	3	investig	investig	PROPN
ajlm-1555	200	4	.	.	PUNCT
ajlm-1555	201	1	2016;20:1551–1557	2016;20:1551–1557	X
ajlm-1555	201	2	.	.	PUNCT
ajlm-1555	202	1	https://doi.org/10.1007/s00784-015-1633-y	https://doi.org/10.1007/s00784-015-1633-y	PROPN
ajlm-1555	202	2	kero	kero	PROPN
ajlm-1555	202	3	km	km	PROPN
ajlm-1555	202	4	,	,	PUNCT
ajlm-1555	202	5	rautava	rautava	NOUN
ajlm-1555	202	6	j	j	PROPN
ajlm-1555	202	7	,	,	PUNCT
ajlm-1555	202	8	syrjänen	syrjänen	PROPN
ajlm-1555	202	9	k	k	PROPN
ajlm-1555	202	10	,	,	PUNCT
ajlm-1555	202	11	kortekangas	kortekangas	NOUN
ajlm-1555	202	12	-	-	PUNCT
ajlm-1555	202	13	savolainen	savolainen	NOUN
ajlm-1555	202	14	o	o	NOUN
ajlm-1555	202	15	,	,	PUNCT
ajlm-1555	202	16	grenman	grenman	NOUN
ajlm-1555	202	17	s	s	PROPN
ajlm-1555	202	18	,	,	PUNCT
ajlm-1555	202	19	syrjänen	syrjänen	PROPN
ajlm-1555	202	20	s.	s.	PROPN
ajlm-1555	202	21	stable	stable	ADJ
ajlm-1555	202	22	marital	marital	ADJ
ajlm-1555	202	23	relationship	relationship	NOUN
ajlm-1555	202	24	protects	protect	VERB
ajlm-1555	202	25	men	man	NOUN
ajlm-1555	202	26	from	from	ADP
ajlm-1555	202	27	oral	oral	ADJ
ajlm-1555	202	28	and	and	CCONJ
ajlm-1555	202	29	genital	genital	ADJ
ajlm-1555	202	30	hpv	hpv	NOUN
ajlm-1555	202	31	infections	infection	NOUN
ajlm-1555	202	32	.	.	PUNCT
ajlm-1555	203	1	eur	eur	PROPN
ajlm-1555	203	2	j	j	PROPN
ajlm-1555	203	3	clin	clin	PROPN
ajlm-1555	203	4	microbiol	microbiol	PROPN
ajlm-1555	203	5	infect	infect	VERB
ajlm-1555	203	6	dis	dis	PROPN
ajlm-1555	203	7	.	.	PUNCT
ajlm-1555	204	1	2014;33(7):1211–1221	2014;33(7):1211–1221	PROPN
ajlm-1555	204	2	.	.	PUNCT
ajlm-1555	205	1	https://doi.org/10.1007/s10096-014-2061-7	https://doi.org/10.1007/s10096-014-2061-7	PROPN
ajlm-1555	205	2	chung	chung	PROPN
ajlm-1555	205	3	ch	ch	PROPN
ajlm-1555	205	4	,	,	PUNCT
ajlm-1555	205	5	bagheri	bagheri	PROPN
ajlm-1555	205	6	a	a	X
ajlm-1555	205	7	,	,	PUNCT
ajlm-1555	205	8	d’souza	d’souza	NOUN
ajlm-1555	205	9	g.	g.	NOUN
ajlm-1555	205	10	epidemiology	epidemiology	NOUN
ajlm-1555	205	11	of	of	ADP
ajlm-1555	205	12	oral	oral	ADJ
ajlm-1555	205	13	human	human	ADJ
ajlm-1555	205	14	papillomavirus	papillomavirus	NOUN
ajlm-1555	205	15	infection	infection	NOUN
ajlm-1555	205	16	.	.	PUNCT
ajlm-1555	206	1	oral	oral	ADJ
ajlm-1555	206	2	oncol	oncol	ADJ
ajlm-1555	206	3	.	.	PUNCT
ajlm-1555	207	1	2014;50(5):364–369	2014;50(5):364–369	X
ajlm-1555	207	2	.	.	PUNCT
ajlm-1555	207	3	https://doi.org/10.1016/j.oraloncology.2013.09.003	https://doi.org/10.1016/j.oraloncology.2013.09.003	PROPN
ajlm-1555	207	4	d’souza	d’souza	NOUN
ajlm-1555	207	5	g	g	NOUN
ajlm-1555	207	6	,	,	PUNCT
ajlm-1555	207	7	cullen	cullen	VERB
ajlm-1555	207	8	k	k	PROPN
ajlm-1555	207	9	,	,	PUNCT
ajlm-1555	207	10	bowie	bowie	PROPN
ajlm-1555	207	11	j	j	PROPN
ajlm-1555	207	12	,	,	PUNCT
ajlm-1555	207	13	thorpe	thorpe	PROPN
ajlm-1555	207	14	r	r	PROPN
ajlm-1555	207	15	,	,	PUNCT
ajlm-1555	207	16	fakhry	fakhry	PROPN
ajlm-1555	207	17	c.	c.	NOUN
ajlm-1555	207	18	differences	difference	NOUN
ajlm-1555	207	19	in	in	ADP
ajlm-1555	207	20	oral	oral	ADJ
ajlm-1555	207	21	sexual	sexual	ADJ
ajlm-1555	207	22	behaviors	behavior	NOUN
ajlm-1555	207	23	by	by	ADP
ajlm-1555	207	24	gender	gender	NOUN
ajlm-1555	207	25	,	,	PUNCT
ajlm-1555	207	26	age	age	NOUN
ajlm-1555	207	27	,	,	PUNCT
ajlm-1555	207	28	and	and	CCONJ
ajlm-1555	207	29	race	race	NOUN
ajlm-1555	207	30	explain	explain	VERB
ajlm-1555	207	31	observed	observed	ADJ
ajlm-1555	207	32	differences	difference	NOUN
ajlm-1555	207	33	in	in	ADP
ajlm-1555	207	34	prevalence	prevalence	NOUN
ajlm-1555	207	35	of	of	ADP
ajlm-1555	207	36	oral	oral	ADJ
ajlm-1555	207	37	human	human	ADJ
ajlm-1555	207	38	papillomavirus	papillomavirus	NOUN
ajlm-1555	207	39	infection	infection	NOUN
ajlm-1555	207	40	.	.	PUNCT
ajlm-1555	208	1	plos	plos	PROPN
ajlm-1555	208	2	one	one	NUM
ajlm-1555	208	3	.	.	PUNCT
ajlm-1555	209	1	2014;9(1):e86023	2014;9(1):e86023	NUM
ajlm-1555	209	2	.	.	PUNCT
ajlm-1555	210	1	https://doi.org/10.1371/journal.pone.0086023	https://doi.org/10.1371/journal.pone.0086023	PROPN
ajlm-1555	210	2	touyz	touyz	NOUN
ajlm-1555	210	3	lzg	lzg	NOUN
ajlm-1555	210	4	.	.	PUNCT
ajlm-1555	211	1	kissing	kissing	NOUN
ajlm-1555	211	2	and	and	CCONJ
ajlm-1555	211	3	hpv	hpv	NOUN
ajlm-1555	211	4	:	:	PUNCT
ajlm-1555	211	5	honest	honest	ADJ
ajlm-1555	211	6	popular	popular	ADJ
ajlm-1555	211	7	visions	vision	NOUN
ajlm-1555	211	8	,	,	PUNCT
ajlm-1555	211	9	the	the	DET
ajlm-1555	211	10	human	human	ADJ
ajlm-1555	211	11	papilloma	papilloma	PROPN
ajlm-1555	211	12	virus	virus	NOUN
ajlm-1555	211	13	,	,	PUNCT
ajlm-1555	211	14	and	and	CCONJ
ajlm-1555	211	15	cancers	cancer	NOUN
ajlm-1555	211	16	.	.	PUNCT
ajlm-1555	212	1	curr	curr	PROPN
ajlm-1555	212	2	oncol	oncol	PROPN
ajlm-1555	212	3	.	.	PUNCT
ajlm-1555	213	1	2014;21(3):e515	2014;21(3):e515	NOUN
ajlm-1555	213	2	.	.	PUNCT
ajlm-1555	214	1	https://doi.org/10.3747/co.21.1970	https://doi.org/10.3747/co.21.1970	PROPN
ajlm-1555	214	2	nejo	nejo	PROPN
ajlm-1555	214	3	yt	yt	PROPN
ajlm-1555	214	4	,	,	PUNCT
ajlm-1555	214	5	olaleye	olaleye	PROPN
ajlm-1555	214	6	do	do	VERB
ajlm-1555	214	7	,	,	PUNCT
ajlm-1555	214	8	odaibo	odaibo	PROPN
ajlm-1555	214	9	gn	gn	PROPN
ajlm-1555	214	10	.	.	PROPN
ajlm-1555	214	11	molecular	molecular	ADJ
ajlm-1555	214	12	characterisation	characterisation	NOUN
ajlm-1555	214	13	of	of	ADP
ajlm-1555	214	14	genital	genital	ADJ
ajlm-1555	214	15	human	human	ADJ
ajlm-1555	214	16	papillomavirus	papillomavirus	NOUN
ajlm-1555	214	17	among	among	ADP
ajlm-1555	214	18	women	woman	NOUN
ajlm-1555	214	19	in	in	ADP
ajlm-1555	214	20	southwestern	southwestern	NOUN
ajlm-1555	214	21	,	,	PUNCT
ajlm-1555	214	22	nigeria	nigeria	PROPN
ajlm-1555	214	23	.	.	PUNCT
ajlm-1555	215	1	plos	plos	PROPN
ajlm-1555	215	2	one	one	NUM
ajlm-1555	215	3	.	.	PUNCT
ajlm-1555	216	1	2019;14(11	2019;14(11	NUM
ajlm-1555	216	2	)	)	PUNCT
ajlm-1555	216	3	.	.	PUNCT
ajlm-1555	217	1	https://doi.org/10.1371/journal.pone.0224748	https://doi.org/10.1371/journal.pone.0224748	PROPN
ajlm-1555	217	2	thomas	thomas	PROPN
ajlm-1555	217	3	jo	jo	PROPN
ajlm-1555	217	4	,	,	PUNCT
ajlm-1555	217	5	herrero	herrero	PROPN
ajlm-1555	217	6	r	r	PROPN
ajlm-1555	217	7	,	,	PUNCT
ajlm-1555	217	8	omigbodun	omigbodun	VERB
ajlm-1555	217	9	aa	aa	PROPN
ajlm-1555	217	10	,	,	PUNCT
ajlm-1555	217	11	et	et	PROPN
ajlm-1555	217	12	al	al	PROPN
ajlm-1555	217	13	.	.	PUNCT
ajlm-1555	218	1	prevalence	prevalence	NOUN
ajlm-1555	218	2	of	of	ADP
ajlm-1555	218	3	papillomavirus	papillomavirus	NOUN
ajlm-1555	218	4	infection	infection	NOUN
ajlm-1555	218	5	in	in	ADP
ajlm-1555	218	6	women	woman	NOUN
ajlm-1555	218	7	in	in	ADP
ajlm-1555	218	8	ibadan	ibadan	PROPN
ajlm-1555	218	9	,	,	PUNCT
ajlm-1555	218	10	nigeria	nigeria	PROPN
ajlm-1555	218	11	:	:	PUNCT
ajlm-1555	218	12	a	a	DET
ajlm-1555	218	13	population	population	NOUN
ajlm-1555	218	14	-	-	PUNCT
ajlm-1555	218	15	based	base	VERB
ajlm-1555	218	16	study	study	NOUN
ajlm-1555	218	17	.	.	PUNCT
ajlm-1555	219	1	2004:638–645	2004:638–645	X
ajlm-1555	219	2	.	.	PUNCT
ajlm-1555	220	1	https://doi.org/10.1038/sj.bjc.6601515	https://doi.org/10.1038/sj.bjc.6601515	X
ajlm-1555	220	2	herrero	herrero	PROPN
ajlm-1555	220	3	r	r	PROPN
ajlm-1555	220	4	,	,	PUNCT
ajlm-1555	220	5	quint	quint	PROPN
ajlm-1555	220	6	w	w	PROPN
ajlm-1555	220	7	,	,	PUNCT
ajlm-1555	220	8	hildesheim	hildesheim	PROPN
ajlm-1555	220	9	a	a	NOUN
ajlm-1555	220	10	,	,	PUNCT
ajlm-1555	220	11	et	et	PROPN
ajlm-1555	220	12	al	al	PROPN
ajlm-1555	220	13	.	.	PROPN
ajlm-1555	221	1	reduced	reduce	VERB
ajlm-1555	221	2	prevalence	prevalence	NOUN
ajlm-1555	221	3	of	of	ADP
ajlm-1555	221	4	oral	oral	ADJ
ajlm-1555	221	5	human	human	ADJ
ajlm-1555	221	6	papillomavirus	papillomavirus	NOUN
ajlm-1555	221	7	(	(	PUNCT
ajlm-1555	221	8	hpv	hpv	NOUN
ajlm-1555	221	9	)	)	PUNCT
ajlm-1555	221	10	4	4	NUM
ajlm-1555	221	11	years	year	NOUN
ajlm-1555	221	12	after	after	ADP
ajlm-1555	221	13	bivalent	bivalent	ADJ
ajlm-1555	221	14	hpv	hpv	NOUN
ajlm-1555	221	15	vaccination	vaccination	NOUN
ajlm-1555	221	16	in	in	ADP
ajlm-1555	221	17	a	a	DET
ajlm-1555	221	18	randomized	randomized	ADJ
ajlm-1555	221	19	clinical	clinical	ADJ
ajlm-1555	221	20	trial	trial	NOUN
ajlm-1555	221	21	in	in	ADP
ajlm-1555	221	22	costa	costa	PROPN
ajlm-1555	221	23	rica	rica	PROPN
ajlm-1555	221	24	.	.	PUNCT
ajlm-1555	222	1	plos	plos	PROPN
ajlm-1555	222	2	one	one	NUM
ajlm-1555	222	3	.	.	PUNCT
ajlm-1555	222	4	2013;8(7	2013;8(7	NUM
ajlm-1555	222	5	)	)	PUNCT
ajlm-1555	222	6	.	.	PUNCT
ajlm-1555	223	1	https://doi.org/10.1371/journal.pone.0068329	https://doi.org/10.1371/journal.pone.0068329	ADJ